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Despite improved intrapartum monitoring of the fetus, the rate of cerebral
palsy has not decreased. Many studies now suggest that the majority of
children with such disability may sustain damage in utero. Current
understanding and identification of antenatal brain injury is poor and
individual vulnerability may be important. Specific genotypes such as
Apolipoprotein E are disadvantageous to outcome in the context of adult
brain injury and may also be important in early development.
Objectives
An aim of this project was to identify clinical and genetic risk factors for
early neonatal mortality within the Scottish population with special
consideration for those infants born in an asphyxiated condition. A further
aim was to determine the prevalence of antenatal brain injury within this
population and to correlate neuropathology with clinical factors.
Methods
Clinical data and neuropathological specimens were collected as part of the
Scottish National Perinatal Neuropathology Study from all 22 delivery units
throughout Scotland. Birth asphyxia was defined and infants were classified
accordingly. Neuropathological examination was performed by a single
observer in Edinburgh who was blind to clinical detail. Apolipoprotein E
genotype was analysed and compared with known published data for adults
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and healthy newborns. Comparisons of categorical data were made with the
Chi-square test and numerical data were compared using the unpaired
student's t-test or the Mann Whitney U test.
Results
Clinical data was collected from 191 early neonatal deaths. Complications of
pregnancy were common in all neonatal deaths. The only predictive factors
for asphyxia were indicators of intrapartum fetal distress. Neuropathological
examination was possible in 59 infants surviving 3 days or less. Evidence of
prelabour brain injury was observed in nearly half of this cohort, and this
was significantly more common in asphyxiated infants and those who
developed an encephalopathy. The only clinical associations of such damage
were the presence of cardiotocograph abnormalities, meconium staining and
severe depression at birth. Apolipoprotein E analysis was performed in 252
perinatal deaths. There was an over representation of the s4 allele among
healthy newborns compared to perinatal deaths and adults.
Conclusions
Brain injury occurring in utero is a common finding among neonatal deaths,
particularly in those born with asphyxia. Current intrapartum indicators of
fetal distress may signify a fetus who has already suffered compromise prior
to the onset of labour. Differences in the Apolipoprotein s4 genotype in
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Introduction
The three major causes of neonatal death are lethal malformations,
prematurity and birth asphyxia1. Whilst major malformations and premature
birth are generally regarded as unavoidable mischance, birth asphyxia
implies a lack of care in labour. Although birth asphyxia is classically linked
to intrapartum hypoxia-ischemia in full term infants, often proceeding to a
neonatal encephalopathy, a proportion of preterm babies are also born in a
neurologically depressed condition almost certainly related to poor
oxygenation in labour. Asphyxia is acknowledged to be an imprecise term
but is still used regularly by the profession and parents. It may be implied by
one or more of the following features: a low Apgar score2"5 a baby who is
difficult to resuscitate, metabolic acidosis ascertained either in cord or in
early neonatal blood samples5' , or the development of neonatal
encephalopathy7^. A history of these particular features may be sought
retrospectively if an infant goes on to develop neurodevelopmental delay.
None of these indicators, when applied prospectively to infants born in poor
condition, has good sensitivity, specificity or predictive value for
neurodevelopmental delay or disability, though in full term infants the
development of neonatal encephalopathy is more specific9. It is clear that
perinatal asphyxia is not likely to be an important factor in the development
of every case of neonatal encephalopathy or in the majority of cases of
cerebral palsy7'10"14. This view has recently been endorsed by a statement
from the International Cerebral Palsy Task Force15.
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Obstetric care has seen dramatic changes over the last few decades. Most
changes have contributed to the steadily falling stillbirth and neonatal death
rates1'16"18'18'19. However despite better clinical care and widespread use of
fetal monitoring and fetal blood sampling, full term infants continue to be
born in a neurologically depressed condition. Such infants cause
considerable distress to parents and staff. They contribute both to early
neonatal mortality and to the pool of children who display later
neurodevelopmental disability with cerebral palsy. Although in some cases
obstetric risk factors can be identified, affected children also result from
pregnancies and labours, which, even when scrutinized critically, appear to
have been normal.
Litigation for perceived perinatal mismanagement is increasingly common,
particularly in relation to infants born in a neurologically depressed
condition- usually manifest by a poor Apgar score, and often reflexly
labelled 'birth asphyxia'. Some recent anecdotal reports and small series of
infants born in poor condition have shown neuropathological abnormality at
autopsy that must have preceded the onset of labour. These generally
represent the collected experience of specialist referral centres20"22'22"24 or
focus on a particular age group of infants, for example those born preterm25"
2 9
. Only rarely do the neuropathological studies include correlation with
"3 A "3 A
clinical factors " . Some insight into clinico-neuropathological correlation
in the first weeks of life is now being achieved by neuroimaging33.
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Research into the genetics of brain damage in later life suggest that adults
may have an individual vulnerability for neurological impairment following
trauma and hypoxic-ischemia34"37. The Apolipoprotein E (APOE) genotype in
38*39
particular is thought to affect different aspects of cell repair and death ' .
Little is known about the role of APOE in paediatric or neonatal brain injury
but it is likely that mechanisms are similar. Recent work in normal infants
suggests APOE genotype may predict neurodevelopmental scores at 24
months of age40.
The aim of this thesis is to describe the neuropathology of the infant who
dies in the first week of life and to attempt to delineate aetiological or
predisposing factors. The role of these factors in fetal and neonatal brain




The overall aims of this thesis are to:
1. describe the clinical characteristics of a population of infants dying within
the first week of life.
2. describe the neuropathology of this population.
3. determine the allele frequencies of APOE in a population of perinatal
deaths and compare these with
a) a population of healthy newborns
b) a population of healthy adults
More specific aims are to:
1. compare maternal sociodemographic, pregnancy and labour characteristics
of infants born in an asphyxiated state with those born in good condition.
2. ascertain the prevalence of antenatal brain damage in a population of early
neonatal deaths.
3. compare the prevalence of antenatal brain damage between asphyxiated
and non-asphyxiated infants.
4. delineate any specific clinical risk factors for brain damage, particularly
amongst asphyxiated infants.




The Scottish Perinatal Neuropathology Study
Design
The Scottish Perinatal Neuropathology Study was a prospective
observational and experimental population-based study involving all twenty-
two delivery units within Scotland between January 1996 and January 1999.
The study was funded by the Scottish Office Home and Health Department
(R26389 and K/MRS/50/C2307) and Wellbeing (Ml/95).
Aims
The study had 4 overall research aims:
1. to assess the clinical characteristics of the mother, pregnancy, labour and
infant where pregnancy ends in a perinatal death.
2. to determine whether the antepartum and intrapartum characteristics of
asphyxiated early neonatal deaths were different to those of non-asphyxiated
neonatal deaths
3. to investigate the neuropathological status in those infants in whom a post
mortem was authorised, and to determine whether lesions could be of
prelabour origin.
4. to correlate any neuropathology found with the clinical characteristics of
the mother, pregnancy, labour and infant
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Methods
The role of the author
The author was the clinical coordinator for the study. This role involved
application to each hospital's local ethics committee, the setting up of a
system for case identification, recruitment and acquisition of patient data and
the creation and maintenance of the study database. The author needed to
identify a link midwife and lead obstetric and paediatric consultants in each
of the twenty-two delivery units involved and liase with these persons to
ensure optimal case recruitment and completion of study data forms. The role
involved regular presentations in each of the units to optimise staff
awareness and the circulation of a bimonthly newsletter to promote the
study. A list of delivery units and neonatal units who took part in the study
can be found in Appendix 1.
Patients
Inclusions
The base study considered all perinatal deaths that were > 24 weeks gestation
at birth and < 7 days of age at time of death delivered in Scotland over a two
year period. This thesis concerns the epidemiology and neuropathology of
the liveborn subset of the study cohort only. APOE analysis of perinatal
deaths included the stillborn cohort also.
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Exclusions
Infants with central nervous system (CNS) or cardiac malformations, major
chromosomal abnormalities or CNS infection were excluded as it was felt
that the neuropathological changes associated with such conditions might
interfere with the interpretation of any changes superimposed by a perinatal
insult.
Clinical Dataset
For each case a detailed questionnaire was completed by specially trained
midwives or other local staff who recorded a battery of clinical information
and the results of investigations relating to each pregnancy, labour, delivery
and neonatal course. The dataset can be found in Appendix 2. The author
met with the midwife and clinician involved in the case of a neonatal death
to elucidate all the relevant details. Clinical data could be collected on all
eligible cases irrespective of enrolment in the pathology study and data was
entered into a central database (SPSS) by the author.
Ethical and consent procedures
Before starting the study, each delivery unit obtained approval from their
local research ethics committee. As different units received ethical
permission at slightly varying times, the spread of data collection was three
years, although it was two years for each individual centre. Cases were
enrolled at the time of post mortem request by the clinician responsible for
the care of the infant during life. A detailed clinical dataset was collected on
all infants regardless of post mortem authorisation. The purpose of the study
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was explained to parents. Signed consent was obtained for autopsy, and on a
separate consent form if authorised, for extended neuropathological research
studies on the brain.
Classification
a) Maturity
Full term infants (FT) were those of 37 weeks gestation and above. All
others were preterm (PT).
b) Definition of asphyxia
Infants were defined as having suffered 'birth asphyxia' (BA) if they had any
one of the following features:
• an Apgar score at 5 minutes of < 5.0
• a cord or initial blood pH of <7.1
• the presence of grade 2/3 neonatal encephalopathy. The grading of
encephalopathy used was that of Sarnat and Sarnat41.
Because of the diverse clinical circumstances not all criteria were available
for assessment in each case. Infants who displayed at least one of these
criteria were classified as showing clinical evidence of birth asphyxia (BA).
If none of these criteria were present the infant was included in the non-
asphyxiated group (noBA). This definition is deliberately liberal to include
as many cases as possible where an element of intrapartum asphyxia may
have been present. The reasons for this and the criteria chosen are discussed
in the discussion of chapter 3. It is accepted that this definition may also
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include infants who were acidotic or depressed at birth due to other factors
such as prematurity or acidosis. The contribution of these factors to the study
definition of birth asphyxia and the presence of prelabour brain damage are
discussed in chapters 3 and 5. It is recognised that by current definitions, the
presence of hypoxic-ischemic encephalopathy in the presence of acidosis is a
more conservative definition and the neuropathological features of this
subgroup were analysed separately.
Pathological Examination
a) Autopsies
Autopsies were conducted in six Scottish centres and the brain was retained
in fixative for later examination. In the South East of Scotland the fixed
brains were examined in the Department of Neuropathology at the Western
General Hospital, Edinburgh. Elsewhere the fixed brains were sampled
locally according to a previously agreed protocol (Appendix 3). Up to 20
representative paraffin embedded blocks were prepared in each case from all
areas of the cerebrum (including temporal hippocampus), and from the basal
ganglia and thalami, midbrain, pons, medulla, vermis and cerebellar
hemispheres. These blocks were collected centrally for review and further
investigation in Edinburgh. Paraffin sections were stained routinely with
haematoxylin and eosin and luxol fast blue/cresyl violet (myelin). Selected
sections were investigated immunocytochemically for astrocytic status, using
an antibody to glial fibrillary acidic protein (GFAP) and for
microglia/macrophages (antibodies to CD68 and MHCII) or stained with
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Perls Prussian blue stain (haemosiderin). The neuropathological
appearances in grey and white matter were assessed independently in all
cases by two observers (Professor Jeanne Bell and Mrs Betty Wyatt) who
were initially blind to the clinical history. Selected cases were also reviewed
by Dr Jean Keeling. Recorded neuropathological features included neuronal
eosinophilia and karyorrhexis, astrocytic hyperplasia, activated microglia
and accumulation of macrophages, haemorrhage (recent and older), vascular
responses, and foci of mineralisation and of infarction. The
neuropathological features were then correlated with the gestational and
postnatal age of the infant and with the criteria of birth asphyxia, in
combination and individually.
A judgement of whether the damage dated from before the onset of labour
(prelabour brain damage, PBD), was based in part on the presence of patently
mature lesions such as established infarcts, previous haemorrhage or
extensive mineralisation. However these features were present in the
minority of brain damaged infants. More diffuse features such as definite
macrophage infiltration/accumulation and/or prominent reactive astrocytic
hyperplasia in white matter are thought to develop over a period greater than
3 days (Tables 5.2 and 5.3). It was estimated that the presence of prelabour
brain damage (PBD) or absence (noPBD) could only be determined reliably
in infants dying < 3 days from the onset of labour.
b) Placenta
The placenta, cord and membranes were examined macroscopically and cord
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length, placental measurements and trimmed weight were recorded. Any
abnormality was described. Histological samples were taken to include a
cross section of the umbilical cord, one strip of membranes (adjacent to the
hole through which the baby was delivered, if identifiable), and two blocks
of placenta with both fetal and maternal surfaces. Blocks and slides from the
placenta and adnexa were submitted for central review in Edinburgh by a
paediatric pathologist (Dr Jean Keeling). Histological evidence of infection,
specifically chorioamnionitis in the extraplacental membranes, chorionic
plate and funisitis were recorded, as was villitis if generalised.
Statistics
Descriptive statistics were used to examine the prevalence of clinical
variables. The Chi square test and Yates correction (or Fisher's exact test
where sample size was less than 20) was used to compare categorical
variables and the unpaired t-test or Mann Whitney U test to compare the
difference in continuous variables. Significance was assumed at the p<0.05
level.
The population
Of the 692 deaths in the 2 years of the study, 221 were early neonatal deaths
corresponding with the estimated early neonatal death rate of 2.5/1000 live
births in Scotland42.
Figure 1 lists how the cohort of 692 qualifying perinatal deaths was reduced
by various exclusions through the 221 liveborn infants to the 70 infants from
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whom the brain was available for examination in this study.
Of the 221 liveborn infants, 47 met the exclusion criteria leaving 174 infants
of whom 37 were not notified to the clinical coordinator until the end of the
study period. There were 137 infants who met the study criteria and had full
clinical detail. Of these, 90 were classified as BA and 47 as noBA according
to the definition. Table 1 shows how they met the criteria for birth asphyxia.
Of the 137 eligible infants with a full clinical dataset, 88 had consent for
post mortem and 70 of these had additional consent for the neuropathological
samples required for the study. These 70 infants were divided according to
whether they displayed birth asphyxia or not. Analysis of those 59 infants
who died at 3 days or less after the onset of labour allowed identification of
pathological features likely to have predated labour and birth. Damage seen
could not be reliably ascertained as occurring 'prelabour' when the infant
had lived for more than three days. Placentas were available for histological
examination from 41 of the 70 infants.
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Table 1. Clinical features of birth asphyxia in 137 early neonatal
deaths.
Full term Preterm
Total infants 38 99
Single feature only
Apgar <5 at 5 mins 9 35
Cord pH < 7.1 0 1
1st pH < 7.1 1 8
Encephalopathy (NNE) 1 0
Two features of asphyxia
Low Apgar and low pH 7 9
Low Apgar and NNE 2 1
Low pH and NNE 0 1
Three features of asphyxia
Low pH, low Apgar and NNE 11 4
Total with some indication of asphyxia 31 (82%) 59 (60%)
[Note - All infants had a 5 minute Apgar score measured. Only 12 full term infants
and 11 preterm infants had a cord pH measured. An additional 22 full term infants
and 35 preterm infants had a pH done on arrival in the local neonatal unit. Sixteen
full term infants at 12 hours of age were not paralysed, and 14 of these had features
of an encephalopathy. 19 preterm infants remained alive and had not receive muscle
relaxants at 12 hours, 6 had an encephalopathy]
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Figure 1. The Scottish Perinatal Deaths Cohort
692 Perinatal deaths
1 471 Stillbirths
221 Early neonatal deaths
47 with exclusion criteria (16 chromosome abnormality, 25
cardiovascular malformation, 6 CNS malformation, 0 CNS infection)
174 Early neonatal deaths meeting inclusion criteria
37 excluded as missed, these included - 24 (gestation 24-28 weeks) died
from extreme prematurity, severe RDS or severe IVH; 3 others (gestation
29,30,35 weeks) died from complications of prematurity and 5 FT (3 BA, 1
MAS, 1 sudden collapse on ward); 5 infants of unknown gestation, 2 dying
of cardiorespiratory, 2 of renal and 1 of cardiovascular failure.
137 Early neonatal deaths with clinical detail
\ 38 FT (31 BA, 7noBA); 99 PT (59BA, 40noBA)
88 Consented for autopsy
18 with no additional samples -some without consent and some samples
proving unsuitable for comprehensive neuropathological analysis. Only
50% of these 18 had 'BA' compared to 75% of the remaining 70: 16 of the
70 had grade 3 FHIE compared with none of the 18 who didn't having
extended neuropathology. Otherwise these 18 infants did not differ in any
significant way from the 70 when considering social class, maternal age,
complications of pregnancy, type of delivery, admission to NNU, Apgar
scores, pH, age at death, resuscitation, gestation and birthweight
70 Consented for additional study samples
i
53 BA







21 FT 25 PT
/ I I
2 FT 11 PT
/ I IX
PBD noPBD PBD noPBD PBD noPBD PBD noPBD
13(62%) 8(38%) 13(52%) 12(48%) 11 0 11
Key: FT= full term; PT= preterm; BA= birth asphyxia; noBA= no birth asphyxia; PBD=
prelabour brain damage; noPBD= no prelabour brain damage; RDS= respiratory distress
syndrome; IVH= intraventricular haemorrhage; MAS= meconium aspiration syndrome; FHIE=
hypoxic/ischaemic encephalopathy; CVS= cardiovascular system; CNS= central nervous




1. Trends in perinatal mortality
The last sixty years have seen a dramatic reduction in perinatal mortality
rates throughout the developed world. In the 1940s in Europe the stillbirth
rate was around 20/1000 births and the early neonatal death rate around
22/1000 livebirths. Over the first thirty years the rate declined by 20-25%
and subsequently in the latter half of this period by 55-60%43. Current
Scottish mortality figures are 5.4/1000 total births for stillbirths and
2.2/1 OOOLBs for early neonatal deaths. The figure below shows national
trends in Scotland since 197444.
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The overall background frequency of congenital malformations in the
newborn population, about 3%, has not changed much over 50 years but the
contribution that malformations make to the perinatal mortality rate have
increased by a factor of 5 due to reduction in other causes of death. This is
true particularly for the late neonatal death rate where deaths due to
malformations comprise around 40-50% of such mortality44. In contrast the
proportion of malformations amongst stillbirths has increased only slightly
despite the decrease in the overall stillbirth rate. The reason for this is in
large part due to the reduction in neural tube defects (in particular
anencephaly which is invariable fatal and is amongst the commonest defect
in stillbirths), which has resulted in a decreasing stillbirth rate since the
1960s. This decline can only be partly accounted for by early termination of
affected fetuses and the periconceptual use of folic acid. In fact the incidence
of neural tube defects had begun to fall before such factors came into play
and is still not fully understood. As many malformations occur sporadically
and to low-risk women it is expected that the burden of malformations to the
stillbirth rate will continue largely unchanged. However in contrast it can be
expected that improved prognosis for congenitally malformed live births will
continue to lead to decreases in the neonatal death rate at least until a core of
unpreventable and uncorrectable congenital defects is approached.
The concept of 'preventable mortality' in perinatal mortality statistics is
sometimes used to evaluate the effectiveness of care and distinguishes deaths
from congenital abnormality ('unpreventable') from deaths due to other
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causes ('preventable'). Deaths of infants weighing less than 500g are also
generally thought to be unavoidable. Although there have been substantial
reductions in deaths due to congenital abnormality and extreme low birth
weight over the last ten years the 'preventable' perinatal mortality rate,
inclusive of late neonatal deaths, is maintained around 5.7/1000 total births.
The cause of 'preventable mortality' amongst stillbirths is still largely
unexplained with around 65% of all cases in this category. Antepartum
haemorrhage and hypertension of pregnancy contribute to the remainder of
non-malformed stillbirths.
Among all early neonatal deaths, nearly 40% are due to problems of
prematurity and over a quarter are due to congenital anomalies, with anoxia
and/or birth trauma accounting for 17% and infection 10%. Amongst
multiple births, prematurity as a cause soars to around 75% and congenital
anomalies are responsible for about 10% of deaths. Although the relative risk
of death from any cause is greater in multiple births, this increase in risk is
greatest for deaths due to the problems of prematurity. In fact amongst
neonatal deaths in multiples there is a ten fold increase in the rate of
neonatal death due to lung immaturity and hyaline membrane disease44.
Despite this, birthweight specific perinatal mortality has continued to fall
over the last twenty years against a background of steady or even increasing
preterm birth rate. This reduction is secondary to advances in neonatal care
of the premature infant, in particular the use of antenatal steroids and
surfactant in extremely low birth weight infants45.
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2. Trends in birth asphyxia and cerebral palsy
Birth prevalence of 'birth asphyxia' ranges from 1.8-7.7 per 1000 term live
births7;46"51 and contributes to around 10% of neonatal mortality. The rate is
somewhat dependent on definition of the term 'birth asphyxia' and this may
be defined purely on the basis of a low Apgar score52'53 acidosis during or at
delivery, prolonged depression of respiration54, need for mechanical
ventilation55, neonatal encephalopathy47'56 or a combination of these. The
definition of the term 'birth asphyxia' has been repeatedly modified over the
years in response to increasing obstetric litigation and assignment of blame,
and the diminishing association between cerebral palsy and best indicators of
intrapartum hypoxia. A consensus has evolved that for damaging intrapartum
hypoxia to have occurred there must be documented evidence of ischemia in
the form of a low pH and accompanying neonatal depression in the form of
an encephalopathy15. In the longitudinal study of birth asphyxia in the
Swedish population between 1985 and 1991 the incidence of 'birth asphyxia'
as defined by an Apgar score of <7 at 5 mins (excluding congenital
malformations, opioid related depression and intracranial haemorrhage) was
6.9/1000. When only those who developed encephalopathy were included the
incidence of clinically significant birth asphyxia dropped to 1.8/1000 LBs49.
Many studies of 'birth asphyxia' pre-1990 suggest that this rate has not
changed appreciably over the last 30 years47'49'56. However, a recently
published study of over 5 million births from California observed a 91%
decrease in 'birth asphyxia' over the decade of the 1990s. This trend applied
to all birthweight groups51. Similarly perinatal mortality in the USA due to
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intrapartum asphyxia fell by 85% from 1970 to 198157. However, because the
clinical syndrome of birth asphyxia is not specific for hypoxic-ischemic
brain injury or any other single cause, authors of more recent studies of birth
asphyxia have based estimates solely on what they describe as post-asphyxial
encephalopathy58 where a classical neurological syndrome develops
following evidence of intrapartum asphyxia as defined by reasonably
stringent criteria.
The incidence of post-asphyxial or hypoxic-ischemic encephalopathy (HIE)
ranges from 3-6/1000 livebirths47;56;59;60. Although the incidence of "birth
asphyxia" is reported to have reduced only latterly, there appears to have
been a more long-standing reduction in the incidence of HIE. A Canadian
study 61 showed a halving in seizures secondary to severe encephalopathy
over a twenty year period between 1960 and 1980. A British study62 found a
decline in the incidence of HIE from 7.7/1000 LBs to 1.9/1000 LBs in the
period between two cohorts from the late 1970s and mid-1990s and Sheth
and colleagues60 in the USA showed a halving of the admission rate for HIE
in the decade 1986-1995.
Cerebral palsy is a descriptive term for a heterogeneous collection of non¬
progressive disorders of movement and posture that become manifest early in
life and are not the result of a recognised cerebral malformation, but the
result of an insult or repeated insult to the developing brain. Interest in the
incidence of cerebral palsy arises because it is often somewhat erroneously
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used as an outcome measure for obstetric care.
The total prevalence of cerebral palsy in developed countries is around
2.5/1 OOOLBs. This has not changed over the last forty years despite the more
widespread use of obstetric interventions aimed at detecting and reducing
intrapartum morbidity and neonatal management of the complications of
extreme prematurity63. Moreover in underdeveloped and developing
countries without such interventions, the cerebral palsy rate is remarkably
similar to that of the rest of the world64. During the course of a Swedish
study extending over nearly thirty years there were substantial reductions in
perinatal mortality but disappointingly no parallel reduction in the rate of
cerebral palsy65. In fact, a recent study from the USA showed a modest
increase in cerebral palsy in infants with normal birthweight between 1975
and 1 99166 and data from the Western Australia cerebral palsy register
suggests that the percentage of term children with severe forms of cerebral
palsy is increasing (www.ichr.uwa.edu.au). Other studies from Western
Australia67, Ireland68 and Northern England69'70 have shown a small
decreasing trend in heavier infants and steady or increasing rates amongst
low birth weight infants that makes the overall rate harder to interpret. As
birthweight specific mortality has continued to fall on a background of a
steady preterm birth rate it is tempting to think that the increase in
prevalence of cerebral palsy in preterm low birthweight babies has resulted
from the development of neonatal intensive care and to think of them as
'casualties of technological development'71. There are three possible
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explanations for this adverse side effect of special care: one that the
immature brain of an intact preterm infant is susceptible to haemorrhage and
ischemia and the subsequent neurological deficit. Another explanation is that
an increasing number of preterm infants are surviving, this has generated
more interest in routine follow up and has led to an improvement in the
completeness of ascertainment especially in milder cases which previously
may have been missed. Finally, cerebral palsy and preterm delivery may
have similar origins in pregnancy and more of these children, who were
compromised before birth, are now surviving72. The classical form of
cerebral palsy associated with prematurity is spastic diplegia with
preservation of intelligence. However the rise in cerebral palsy is in all
spastic types and many are associated with other severe handicaps. This
supports the hypothesis that modern technological advances have allowed the
survival of preterm infant with established neurological damage.
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3. Trends in neonatal post mortem rates
Despite increased confidence in new diagnostic techniques, the usefulness of
autopsy in establishing cause of death and determining unrelated diagnoses is
well-documented73"76. Autopsy has other recognised benefits in assisting the
grieving process77 and providing information for genetic counselling or the
7 R
management of future pregnancies . Nevertheless the autopsy consent rate
has been declining worldwide over the last three decades79 and there has
been much concern about public confidence in the process since well-
publicised criticisms in the media surrounding organ retention. Within the
United Kingdom there was a continuous decrease in neonatal post mortems
throughout the 1990s and early 2000 (Figure 2.2).
In the late 1990s, the Bristol Royal Infirmary inquiry80 into deaths of babies
having heart surgery caused widespread public concern about the quality of
information delivered to families about post mortem examinations, in
particular the retention of whole organs for detailed laboratory examination.
In January of 2001 the Redfern report81 was published and followed an
intensive inquiry into the removal, retention and disposal of human organs
and tissues following post-mortem examinations in the Royal Liverpool
Children's Hospital NHS Trust. The report criticised the 'systematic'
removal of tissues at post mortem, often without consent and often without
later histological examination.
The Human Tissue Act of 1961 which recommended that tissues or organs
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* Welsh data from the All Wales Perinatal Survey, personal communication
# English and Welsh data from the 5th-8lh Confidential Enquiry into Stillbirths and Deaths
in Infancy reports 17-19:82
A Scottish data from Information and Statistics Division ofNHS Scotland 83, personal
communication
could be removed from bodies at autopsy as long as there was no objection
raised to retention is now seen as paternalistic and new systems based on the
recommendations of the report have subsequently been put in place to ensure
no such repetition84.
However the sensationalistic media handling of these two episodes almost
certainly damaged the public's confidence in the post mortem process and
consent rates fell substantially throughout the country over the next two
years
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The Scottish Neuropathology Study took place during the years 1996-1999
when the Scottish neonatal post mortem rate fell below 50%. Our study was
concerned with stillborn infants and early neonatal deaths and the combined
post mortem rate for these groups was 64%. The study excluded late neonatal
8 5
deaths, a group that is associated with a lower autopsy consent rate and
those with known congenital malformations or chromosomal abnormalities
where, if the diagnosis is already established clinically, there may be less
endeavour to obtain autopsy consent.
The consent process during the study period was less unambiguous and
explicit than it is required to be today and of note is the discrepancy between
the neonatal post mortem rate of 64% for brain retention and study consent
rate of 51% where the only difference in protocol was centralisation of brain
blocks for detailed neuropathology.
Since the time period of the study, post mortem rates have continued to fall
around the United Kingdom, although in Edinburgh where the research team
are based, there has been recent optimism over current rates approaching
those seen at the beginning of the 1990s86.
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Chapter 3
Clinical characteristics of pregnancies resulting in
asphyxia-related neonatal death
Introduction
Considerable improvements in antenatal care have resulted in a dramatic fall
in maternal and perinatal mortality since the 1940s. However despite
significant advances in fetal surveillance over the last twenty years there has
8 2
been little further gain in the perinatal death rate within the UK . The
increasing ability to monitor the fetus in a high-risk pregnancy with
ultrasound, Doppler studies and fetal blood sampling means that delivery can
be expedited when a fetus appears compromised and as a result the caesarean
section rate within the UK is now approaching 25%.
Despite such intensive supervision and intervention some babies continue to
be born in a depressed condition. A small proportion of these children may
show neurological symptoms in the neonatal period and some of these
encephalopathic infants may go on to develop cerebral palsy. However most
children with cerebral palsy have no identifiable problem at birth87.
Over the last hundred years there has been increasing interest in the
aetiology of cerebral palsy. Legal action against health authorities on behalf
of neurologically handicapped children has escalated in the last few decades
under the general supposition that negligence in the care of the mother and
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fetus during labour has led to irreversible brain damage in the child .
However the measures put in place over that time to monitor the fetus in
labour have not led to the expected decrease in the cerebral palsy rate
(Chapter 2). Furthermore, continued research into the antecedents of long
term neurological morbidity shows that a minority of such damage is
attributable to intrapartum hypoxia. Instead epidemiological evidence
suggests that intrauterine insult is more likely to be responsible89"91, and this
is supported by neuropathological confirmation of antenatal brain damage in
the fetus and newborn23'32. Thus, although prevention of intrapartum
asphyxia remains essential, limitation of much childhood neurodisability may
depend on our ability to understand the fetal environment and its hazards.
There is little doubt that labour and delivery can be hazardous to the fetus
and that intrapartum asphyxia does occur. It is also true that such infants
may subsequently die or develop neurological impairment consequent to this
injury. What is unclear is whether all such infants have been normal up until
the onset of labour or whether they may already have been subjected to a
earlier insult. What does seem apparent is that not all asphyxial injury is the
same. Indeed, depending on the mechanism, duration and intensity of the
insult, the distribution of brain injury varies dramatically and the condition
of the newborn may differ accordingly92"94. It is likely that chronic or
intermittent forms of asphyxia are far more common than the catastrophic
asphyxiation of the experimental animal model, although less is known about
subsequent adaptation at birth.
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Although many children who later develop cerebral palsy have no adverse
intrapartum features89, it is possible that a fetus who has already sustained
damage in utero may tolerate even the hypoxia of a normal labour poorly.
Non-specific signs of fetal distress may herald such an infant who may be
born in an 'asphyxiated' condition95. Obstetric intervention may not alter the
prognosis in such cases, but the stress of a prolonged or even normal labour
may put such a fetus at risk of further damage.
The first part of this chapter describes some of the difficulties in the
definition of birth asphyxia and details the literature on the clinical
associations of asphyxia and neonatal encephalopathy. The second part
presents and discusses the clinical features of asphyxia-related neonatal
deaths from the Scottish Perinatal Neuropathology Study.
Defining 'birth asphyxia'
Birth asphyxia refers to the end result of oxygen and nutrient deprivation to
the fetal brain during labour. A normal fetus is well adapted to the inevitable
process of intermittent 'asphyxia' that occurs during normal labour. These
adaptations include switching to anaerobic metabolism during periods of
relative hypoxia and redirecting blood flow to vital organs such as the brain
and myocardium. If the adverse factors persist, the physiological adaptations
become attenuated, with eventual decompensation resulting in increasing
acidosis and a fall in cerebral blood flow. Hypoxic-ischemic damage to the
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brain may occur as a result of these persistent abnormalities. No direct
measures of asphyxia are available and various definitions, including fetal
heart rate abnormalities, acidosis and low Apgar scores, have historically
been used. However attempts to relate these measures to subsequent
neurological impairment have consistently failed as they do not reliably
predict which children will develop cerebral palsy.
Fetal cardiotocography was introduced in the 1960s in the hope that early
identification of fetal compromise would lead to prompt delivery and
avoidance of irreversible damage. The Dublin randomised trial of electronic
fetal monitoring versus intermittent auscultation in 13,000 women led to a
halving of the incidence of neonatal seizures in term infants, suggesting
differential exposure to preventable intrapartum asphyxia. Disappointingly
however follow up of this cohort to the age of four years did not reveal any
differences in the rate of cerebral palsy96. Keegan and colleagues identified
a group of full term and preterm newborns with convulsions and found a
much higher incidence of CTG abnormalities compared to a control group.
However when determining the obstetrical response to the abnormal heart
rate patterns they found in all cases that it was entirely appropriate.
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Eventually many of the cases with neonatal seizures developed CP . Some
abnormality of the CTG has been described in as many as 40-80% of labours
yet neonatal encephalopathy only occurs in 1-6/1000 98. Fetal heart rate
abnormalities may not always equate with the presence of damaging asphyxia
but instead may be the manifestation of pre-existing damage or
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maldevelopment of the fetal brain. An abnormal CTG tracing can be the
result of chromosomal abnormalities or congenital malformations". Changes
in fetal heart rate variability occur with increasing CNS maturation and
conditions which result in delayed or disordered maturation may affect the
CTG.
Correlation of the CTG with other markers of asphyxia is poor. Acidosis,
said to be the hallmark of intrapartum hypoxic-ischemia6 is only found in
about one third of cases where the CTG is deemed to be abnormal but only
one in six infants with severe acidosis may exhibit a normal fetal heart
tracing during labour100. There have been attempts to refine interpretation of
the CTG by using simultaneous electrocardiographic analysis of the ST
segment and T wave which reflect the ability of the myocardium to respond
to the stresses of labour. A Swedish randomised controlled trial of around
5000 maternities showed a reduction in neonatal encephalopathy and
metabolic acidosis when fetal ECG analysis was performed in conjunction
with cardiotocography1 1,1 2.
Fetal blood sampling was developed to add precision to electronic fetal heart
rate monitoring and to recognise those infants developing acidosis during
labour. Although a low pH has been considered the best widely available
measure for identification of asphyxia during labour, the level and duration
of acidosis at which irreversible damage may occur has been notoriously
difficult to define and may well vary between infants. The definition of a low
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pH has been debated by many5'103"105 and remains the subject of controversy.
Although profound acidosis is found in many infants with neonatal
encephalopathy, the vast majority of infants with acidosis are normal in the
neonatal period and subsequently106"109. The association of pH with long-
term outcome is even weaker. Ruth and Raivio conducted a prospective study
of the predictive value of metabolic acidosis and Apgar score on perinatal
brain damage5. Nine hundred and eight-two infants were studied and
followed to one year of age. The sensitivity of a low pH for adverse outcome
was 21% with a positive predictive value of only 8%. Only 4 of the cohort
had any indicator of CP at 1 year of age and none of the four had a pH < 7.0
at birth. Low found that only 13% of newborns with moderate acidosis had a
major deficit at 1 year but that the incidence of any deficit increased to 80%
the more severe and the longer the duration of the acidosis110. Neonatal
acidosis is not necessarily specific to intrapartum asphyxia: it is found more
commonly in fetuses who are growth restricted111, those with sepsis112 and
amongst those with rare inborn errors of metabolism. Acidosis has also been
113
reported more commonly in the preterm fetus . It remains to be proven
whether metabolic acidosis when present in a fetal, cord or early neonatal
blood sample, is attributable to chronic or intermittent hypoxia of
longstanding duration or whether de novo acute hypoxia has occurred during
labour in a previously healthy fetus.
The Apgar score, first developed in 1952 by Dr Virginia Apgar, is a quick
method of assessing the state of the newborn infant114. It is observer
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dependent and usually performed retrospectively. As a tool for predicting
outcome it performs poorly, especially amongst preterm infants115. The
National Collaborative Perinatal Project (NCPP) found that only 8% of
infants >2500g with a 5 minute Apgar score of three or less died in the first
year and only 0.7% developed cerebral palsy. Among low birthweight infants
the risk of death was far higher, 55%, but again only a small number, 7%,
suffered from cerebral palsy on follow-up. In fact the risk of cerebral palsy
amongst term infants only became significant when the Apgar score
remained severely depressed by 20 minutes of age. It is important to note
that seventy-five percent of all children with cerebral palsy within the NCPP
had 5 minute Apgar scores of 7 or higher52 and this is consistent across
studies107. Although Levene found a depressed Apgar score at 10 minutes to
be the most sensitive predictor of outcome9, Naeye found that a low 10
minute Apgar score was more likely to be due to congenital abnormalities
than birth asphyxia in children with cerebral palsy91. In fact the Apgar score
may be adversely affected by a number of factors other than asphyxia. Drugs
such as maternal opiates, infection, hypovolemia, congenital disorders and
antenatal brain damage may all cause depressed respiration at birth and some
of the components of the Apgar score are notoriously difficult to assess in
lower gestations54 who are far more likely to be attributed low scores
compared to their mature counterparts.
The term 'birth asphyxia' is now considered to be imprecise and its
implications are of dubious validity and seldom applied to problems of gas
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exchange. In 1999 an international consensus statement was issued by the
International Cerebral Palsy Task Force defining intrapartum asphyxia
sufficient to cause death or neurological damage. Essential criteria include
early onset of moderate or severe encephalopathy in infants > 34 weeks
gestation as well as evidence of acidosis in a fetal or early neonatal blood
gas (pH<7.0 and base deficit > 12mmol/l). Other non-specific criteria that
together may be suggestive of damaging intrapartum asphyxia include Apgar
scores of 6 or less for longer than 5 minutes, a sentinel hypoxic event
occurring immediately before or during labour and evidence of neonatal
multiorgan dysfunction15.
The relative contribution of birth asphyxia to cerebral palsy
Controversy exists about the relative contributions of pre- and intrapartum
factors on long-term adverse outcome. There is little doubt that intrapartum
asphyxia occurs and that it can lead to death or cerebral palsy in survivors.
The question is what proportion of neurological impairment in children can
be attributed to birth asphyxia, and whether these infants have significant
predisposing factors. That the majority of children with cerebral palsy have
been damaged during labour and delivery has now been refuted on the basis
of several studies. The National Collaborative Perinatal Study (NCPP)
followed the course of 60,000 pregnancies in 12 medical-school affiliated
hospitals from 1959 to 1966 prospectively. Many had no intrapartum risk
factors for asphyxia and the majority of those who did had co-existing
antenatal risk factors or stigmata which meant that either brain damage or an
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increased vulnerability to such damage had occurred well before labour
began. In fact Nelson and Ellenberg suggest that only 9% of all cerebral
palsy cases within this cohort were damaged perinatally89. Naeye and
colleagues analysed a sub-group of 43,000 full term infants to determine the
role of intrapartum hypoxic-ischemia in the development of cerebral palsy in
mature infants91. Although the newer methods of determining fetal well-
being were not in use during that period, surrogate indicators of intrapartum
asphyxia such as delayed onset of respirations, fetal bradycardia and
neonatal seizures were collected. This study found that only 6% of cerebral
palsy could be attributed to birth asphyxia. The authors suggested that even
state-of-the art intrapartum management was unlikely to prevent cerebral
palsy in these full term infants as congenital disorders were responsible for
many more cases of cerebral palsy than birth asphyxia.
More recent data collected after the introduction of neonatal intensive care
and more sophisticated intrapartum monitoring techniques, support this early
data. Blair and Stanley in the Western Australian series, a time-ordered
multivariate analysis of 183 cases and 549 matched controls, found that birth
asphyxia was only likely in around 8% of cases of cerebral palsy90. Stanley
and English report data on low birthweight infants within this cohort, 13% of
whom were reported to have significant perinatal asphyxia. Only 10% of
these infants, around 1% of the total cohort, later developed cerebral
palsy116. Results from a British study reported a similar proportion: only 10%
of full term infants who developed CP showed evidence of BA117. On the
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other hand the Swedish longitudinal survey of cerebral palsy, reports
intrapartum factors as being responsible for 52% of preterm and 28% of term
infants with CP118. In this study however one of the criteria suggestive of
intrapartum asphyxia was the requirement for mechanical ventilation after
birth, a necessity which may be related to lung pathology and maternal
sedation as well as birth asphyxia.
Supportive of a pre-partum origin of brain damage is the increased frequency
of minor malformations, abnormal dermatoglyphics and developmental tooth
enamel abnormalities in children with cerebral palsy89'91'119"121. Affected
siblings are more common in children with cerebral palsy122 and autosomal
recessive and X-linked modes of inheritance have been reported123. Others
have also found an increased incidence of birth defects amongst infants born
with birth asphyxia and neonatal encephalopathy124'125.
Imaging studies of the brain in children with cerebral palsy show that white
matter damage predominates126"128 even in term infants. White matter damage
preferentially occurs in the second and early third trimesters24 and its
occurrence among term children with cerebral palsy emphasises that such
damage frequently occurs prenatally.
Risk factors for birth asphyxia and hypoxic-ischemic
encephalopathy (HIE)
Clinical studies of severe birth asphyxia show that most children who survive
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with sequelae have clinical signs of encephalopathy during the neonatal
period129. Similarly between a quarter and a half of children with
encephalopathy following intrapartum asphyxia may go on to develop
neurological deficits. It has been shown that damaging intrapartum asphyxia
1 30is regularly followed by neurological symptoms in the neonatal period
However, indicators of intrapartum asphyxia are often absent in infants with
so-called hypoxic-ischemic encephalopathy. Volpe noted that a third of
infants described as having HIE had no recognised adverse features during
labour131. Nelson and Ellenberg found that three quarters of term infants said
to have HIE had meconium stained liquor or fetal bradycardia but this was
also true of 61% of those infants without HIE. Among those infants without
features of fetal distress during labour, 2.9% developed an encephalopathy
compared to 3.3% of those with fetal distress130.
Thus the contribution of intrapartum events to newborn encephalopathy
remains unclear. Although neonatal encephalopathy may follow severe
intrapartum asphyxia, it may be in some instances the manifestation of a
problem originating before the onset of labour.
Finer and Robertson examined the perinatal risk factors of 95 full term
infants with hypoxic-ischemic encephalopathy and found a high incidence of
maternal complications and fetal growth restriction. Although abnormal
cardiotocography was common amongst those mothers monitored, around
40% of encephalopathic infants had a five minute Apgar score of 8 or
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more46. Gaffney and colleagues found that children with CP who had
exhibited NNE were more likely to have had evidence of intrapartum
complications than those who were asymptomatic in the newborn period but
who later developed CP117. The authors inferred that NNE was a marker of
intrapartum injury but did not rule out the possibility that encephalopathy
may represent a more longstanding neurological disorder. Westgate and
colleagues showed that nearly a quarter of full term infants with hypoxic-
ischemic encephalopathy experienced a severe obstetric catastrophe during
1 32labour but that a further quarter only had evidence of antenatal hypoxia . It
was unclear in the remaining 50% when fetal compromise began.
One of the largest studies of risk factors in encephalopathy is the Western
Australian case-control study which described the relative contributions of
intrapartum and antenatal factors to full term newborn encephalopathy
(NNE)58'59. One hundred and sixty four infants with moderate or severe
encephalopathy were matched with 400 controls. The definition of
encephalopathy was broad and not dependent on asphyxia criteria.
Intrapartum factors alone were found in only 5% of cases, in 24% both
antepartum and intrapartum factors were identified, and in 69% only
antepartum factors. Two percent had no identifiable factors.
Among maternal features examined in this study, lower socio-economic
status, increasing maternal age and a family history of neurological disease
or seizures were positively associated with NNE. Risk factors during
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pregnancy included infertility treatment, maternal thyroid disease, severe
pre-eclampsia, bleeding, and a diagnosed viral infection. Maternal pyrexia in
labour, an acute intrapartum event and a persistent occipitoposterior position
were all associated with the development of NNE. Although there was no
difference in overall caesarean section rate, elective caesarean section alone
was found to be protective against NNE (OR 0.17). Babies who were below
the tenth centile were far more likely to develop NNE than controls. Many of
these results support data from a more historical cohort reported by this
group50 and other studies.
Small for gestational age infants are over-represented compared to controls
in many studies of birth asphyxia and proportions range from 7.5% to
29%41'49. Many studies report an excess of growth restricted infants in cases
of newborn encephalopathy ranging from 25-33%46'47'58,133-135 suggesting an
antepartum onset of fetal compromise. It has been shown that for a given
gestational age, a higher proportion of those with cerebral palsy are growth
restricted particularly those with diplegia and quadriplegia10'136'137.
Bleeding in pregnancy and placental abruption have consistently been found
to be associated with neonatal depression in the Western Australian study
and others138"140.
The association of pregnancy-induced hypertension (PIH) with
encephalopathy is unclear: Haddad showed that PIH was commoner in
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infants who had an Apgar of 0 at birth and were subsequently resuscitated139
and others have found that PIH is strongly associated with neonatal
encephalopathy46^41. On the other hand PIH has been associated with a
reduced incidence of intrapartum asphyxia and intraventricular haemorrhage
amongst extremely low birth weight infants25. Murphy et al showed a
reduced risk of cerebral palsy in very preterm survivors when pre-eclampsia
had complicated the pregnancy142. The reasons for these conflicting results
are unclear but may be due to two factors. Because of its effect on fetal
growth, PIH may appear protective against adverse outcome in birthweight
analyses, if gestational age is not accounted for. Additionally many studies
of the effects of PIH on neonatal morbidity and later handicap do not take
into consideration the potential beneficial effects of any maternal
antihypertensive treatment such as magnesium, mode of delivery or antenatal
steroids.
The association of maternal thyroid disease with neonatal encephalopathy
has also been reported50'138'140 as has an association with cerebral palsy89'143.
It has been postulated that thyroid dysfunction, its underlying cause or
treatment may disrupt normal neuronal development.
A further Australian case-control study published in 2001 sought to
determine obstetric antecedents in 83 full term infants ventilated because of
perinatal asphyxia138. Again, there was a higher incidence of maternal
thyroid disease as well as antenatal complications among case infants
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compared to controls. In labour, prolonged rupture of membranes, maternal
pyrexia and haemorrhage were all more common among cases who were also
more likely to be growth restricted and male. Cases were more likely to show
signs of fetal distress during labour and have severely depressed Apgar
scores at birth.
In a Swedish cohort of over 42,000 infants, 75 developed hypoxic-ischemic
encephalopathy. Both antenatal and intrapartum complications were more
common in hypoxic-ischemic encephalopathy infants compared to the rest of
the population. Specific predictive factors such as thyroid disease,
pregnancy-induced hypertension, placental abruption, meconium and
cardiotocograph abnormalities were consistent with previous literature.
There was a non-significant trend for a protective effect of elective caesarean
section140.
The role of maternal infection and pyrexia has received increasing interest as
it has emerged that infants of mothers with such features are more likely to
show evidence of brain injury on imaging144"146, neuropathological evidence
of brain injury at post mortem, and are at greater risk of developing cerebral
palsy147. Maternal pyrexia in labour has been found to be a strong predictor
in many studies of adverse neonatal depression and
encephalopathy50;59;138;148"150 and it has been postulated that the production of
148maternal cytokines due to infection may be an important factor . In these
studies distinction is not made between infectious and non-infectious pyrexia
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and other surrogates of infection, such as prolonged rupture of the
membranes, have been variably associated. Lieberman investigated the role
of pyrexia of a non-infectious origin on neonatal outcome. In a study of over
1200 non-infected women, 10% had intrapartum pyrexia and this was
associated with depressed Apgar scores, hypotonia at delivery, need for bag
and mask resuscitation and neonatal seizures. All these complications
increased in frequency as the degree of maternal fever increased151. The
mechanism of fetal damage in maternal pyrexia is not known and may
involve cerebral infection, hyperthermia or the action of inflammatory
mediators such as interleukin-6 and tumour necrosis factor-a which damage
oligodendroglial cells in the developing brain.
In summary it appears that while the role of intrapartum factors may be
important in the development of clinically significant asphyxia, many of
these infants have pre-existing features which may either be directly
responsible for damage occurring before the onset of labour or make an
infant more vulnerable to the normal asphyxiating events during delivery.
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Aims
1. to describe the sociodemographic, pregnancy, labour and delivery
characteristics of a population of early neonatal deaths and describe the
features of their life in the first week.
2. to determine any differences in the above characteristics between
asphyxiated infants and those born in a good condition.
Methods
Refer to chapter 1 for methods.
Note
Throughout the results section, cross-reference is made to table 5.7 where an
infant went on to have neuropathological examination. The maternal,
pregnancy, labour and postnatal details of these cases are listed. Where case





174 infants greater than or equal to 24 weeks gestation and less than 7 full
days of age met the inclusion criteria for the study.
137 infants had a full dataset available. 37 infants were not notified to the
study coordinator until after the end of the study period. Retrospective
collection of demographic data from most of these 37 infants showed that
proportion of preterm infants was similar to the 137 infants with a full
dataset.
There were 134 mothers in the study who gave birth to 137 infants. Twenty
infants were multiple births, including two pairs where both twins died and
two infants from a set of triplets who both died.
a) Sociodemographic characteristics (Table 3.1)
Thirty-seven percent of the cohort were primigravida and had an average age
at booking of 27.6 years. A history of infertility or previous pregnancy loss
was common affecting 29% of the population. Over one third of mothers
were smokers at booking. Only one mother had known thyroid dysfunction
(case 28) but required no medication. When the cohort was divided into those
with asphyxia at delivery and those without, the mothers were comparable
for all sociodemographic details.
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Maternal age at booking 27.6(6.1) 28.2(5.9) 26.8(6.5) 0.192
Body Mass Index at
booking (kg/m2)*
25.3(4.8) 25.4(4.2) 24.7(3.6) 0.504
Social class 1,2" 55(42) 41(46) 17(37) 0.311
Unemployed* 16(12) 8(9) 8(18) 0.180
Married* 38(28) 21(23) 17(36) 0.111
Smoker at booking" 49(37) 35(39) 16(35) 0.606
Primigravida* 49(37) 30(33) 20(43) 0.287
No of pregnancies" 1(0,2) 1(0,2) 1(0,2) 0.308
'Relative infertility* 39(29) 31(34) 9(19) 0.468
Previous termination of
pregnancy*
23(17) 14(16) 10(21) 0.403
2Previous uterine
instrumentation*
32(24) 24(27) 9(19) 0.329
*
mean, standard deviation and p value (independent samples t-test)
# number, percentage and 2-tailed significance (Chi-square test)
A median, interquartile range and asymptotic 2-tailed significance (Mann-Whitney U test)
'history of infertility, previous neonatal death, stillbirth or miscarriage
including suction termination of pregnancy, cervical cone biopsy, previous caesarean
section and fibroid surgery
b) Antenatal characteristics (Table 3.2)
Thirteen percent of all pregnancies were unbooked or booked after 16 weeks.
Seventeen of 134 mothers (13%) had multiple pregnancies, 16 of which were
twin and 1 triplet. Two mothers were known to have conceived following
ovulation induction, and one by in vitro fertilisation. Although abnormal
serum screening for AFP and HCG occurred in 14 pregnancies, only five of
these went on to have amniocentesis. Five other amniocenteses were
performed for amnioreduction (4) or at maternal request (1). Fifty-eight
mothers had a fetal anomaly scan, either routinely or because of clinical
concern. Twenty scans were abnormal and findings included
oligohydramnios, polyhydramnios, intrauterine growth restriction, fetal
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Unbooked or booked >15
weeks*
18(13) 12(13) 6(13) 0.926
Systolic BP at booking 115(15) 117(16) 112(13) 0.075
Diastolic BP at booking 68(12) 68(13) 68(10) 0.970
Multiple pregnancy* 17(13) 12(13) 8(17) 0.562
Assisted conception* 3(2) 3(3) 1(2) 1.000
Abnormal serum
screening*
14(16) 7(12) 7(24) 0.212
Amniocentesis
performed*
10(8) 6(7) 5(11) 0.509
Abnormal fetal anomaly
scan*
20(34) 16(38) 5(25) 0.308
Antibiotics in pregnancy* 21(16) 12(13) 10(21) 0.229
Steroids in pregnancy* 33(25) 18(20) 17(36) 0.039
Hyperemesis* 17(13) 7(8) 11(23) 0.010
Placenta praevia
>grade 1 *
7(5) 1(1) 6(13) 0.006
Pyrexia >38°C/flu-like
illness during pregnancy*
13(10) 5(6) 8(17) 0.061
Oligohydramnios 25(19) 13(15) 14(30) 0.032
Poor fetal growth* 19(14) 9(10) 10(22) 0.066
Anemia <11g/dl* 43(32) 27(30) 17(37) 0.437
Polyhydramnios* 11(8) 10(11) 1(2) 0.097
Loss of fetal movements
reported*
14(11) 8(9) 6(13) 0.554
Premature rupture of
membranes*
29(22) 20(23) 11(24) 0.850
Intrauterine or urinary
tract infection*
16(12) 10(11) 8(17) 0.331
Pregnancy-induced
hypertension*
14(11) 7(8) 7(15) 0.235
Antepartum haemorrhage
in 2/3 trimesters*
38(28) 22(24) 18(38) 0.090
Any of the above
complications of
pregnancy*
109(81) 71(79) 41(87) 0.230
*
mean, standard deviation and p value (independent samples t-test)
# number, percentage and 2-tailed significance (Chi-square test)
A median, interquartile range and asymptotic 2-tailed significance (Mann-Whitney U test)
ascites, duodenal atresia and hydrops. Complications of pregnancy were
common affecting 81% of the entire cohort, in particular oligohydramnios
(19%), anemia (32%), suspected intrauterine growth restriction (IUGR,
14%), premature rupture of membranes (PROM, 22%) and second or third
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trimester antepartum haemorrhage (APH, 28%).
Comparison of the asphyxiated and non-asphyxiated cohorts showed that
mothers of the non-asphyxiated (noBA) cohort were more likely to have
received steroids during pregnancy (p=0.039), were more likely to have
suffered from hyperemesis requiring inpatient management or outpatient
medical treatment (p=0.01) and were more likely to have a low lying
placenta (p=0.06). The mothers of the non-asphyxiated cohort were also
more likely to have had oligohydramnios diagnosed on antenatal scan
(p=0.032). Antenatal concerns about fetal growth restriction were common
and were more common in the noBA cohort (p=0.066). Polyhydramnios was
present in 8% of the asphyxiated cohort.
c) Intrapartum characteristics (Table 3.3)
Markers of fetal distress, such as meconium staining and CTG abnormalities
were significantly more prevalent amongst the BA cohort (26% vs 11%,
p=0.04; 59% vs 33%, p=0.004) in particular a terminal fetal bradycardia
(p=0.002). Intrapartum infection, indicated by positive vaginal swabs and
maternal pyrexia, increased white cell count or increased C reactive protein,
occurred in 12 cases (E Coli and other coliforms, group B Streptococcus and
Staphylococcus aureus) but was not more common in the BA group. Only
5/44 women with an epidural had a temperature of >38°C in labour.
Malpresentation was less frequent in the BA cohort (29% vs 47%, p=0.037).
Fifty percent of all early neonatal deaths had instrumental or operative
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Induction of labour" 13(10) 8(9) 5(11) 0.764
No labour" 29(22) 21(23) 8(17) 0.391
General anaesthetic in labour" 26(19) 19(21) 7(15) 0.378
Epidural in labour" 44(33) 32(36) 12(26) 0.233
Opiates in labour" 45(34) 28(31) 19(40) 0.276
Pyrexia in labour >38°C" 11(8) 7(8) 4(9) 1.000
Documented intrapartum infection" 12(9) 7(8) 5(11) 0.533








Cord prolapse" 9(7) 7(8) 2(4) 0.718
Meconium staining" 28(20) 23(26) 5(11) 0.040
Bradycardia" 20/98(20) 20/72(28) 0 0.002
CTG abnormality reported" 51/98(52) 41/71(59) 10/27(33) 0.004
1st stage duration (h)" 2.1(0,6.6) 2.5(0, 6.8) 1.7(0,6.3) 0.726
2na stage duration (m)" 5(0,0.5) 4(0,27) 7(0,30) 0.472
Time of ruptured membranes (h)" 2(0,14) 3(0,17) 1(0,7) 0.314
Malpresentation of fetus" 48(35) 26(29) 22(47) 0.037
Ruptured membranes >24h" 28(21) 19(22) 9(19) 0.691
Forceps/Ventouse delivery" 10(7) 7(8) 3(6) 1.000
Emergency caesarean section" 57(42) 41(46) 16(34) 0.194
Delivery out of hours
(21:00-08:59 and weekends)"
83(61) 57(63) 26(55) 0.362
Sentinel hypoxic event" 34(25) 26(29) 8(17) 0.092
*
mean, standard deviation and p value (independent samples t-test)
# number, percentage and 2-tailed significance (Chi-square test)
A median, interquartile range and asymptotic 2-tailed significance (Mann-Whitney U test)
deliveries and 22% were delivered before the onset of labour for fetal
distress or maternal emergency. Two babies were delivered by elective
caesarean section pre-labour: one for a twin pregnancy in a primigravida
(case 32) and the other for a previous caesarean section: the poor condition
of both babies was unexpected at delivery.
There were 34 instances where a sentinel hypoxic event was evident such as
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Male sex* 84 (61) 55 (61) 29 (62) 0.946
Gestation 31 (6.4) 31.7 (6.7) 29.2(5.4) 0.017
< 37 weeks gestation* 99 (72) 58 (64) 41 (87) 0.005
Weight (g) 1779 (1193) 1971(1268) 1411 (944) 0.004
Weight < 3rd centile for
gestational age*
12(9) 9(10) 3(6) 0.545
Occipitofrontal
circumference (cm)
27.8 (6) 28.9(5.9) 26.1(4.3) 0.015
Apgar 0 at 1 minute* 18 (13) 18 (20) 0 0.001
1 minute Apgar" 2(1,5) 1(1,2) 5(4,9) <0.001
5 minute Apgar" 4(2,8) 3(1,4) 8(7,9) <0.001
10 minute Apgar" 5(1,8) 2(0,5) 9(8,9) <0.001
Time to establish regular
respirations (m)"
1 (0,5) 3(0,14) 0 (0,2) <0.001
Cardiac massage required* 40 (29) 37 (41) 3(6) <0.001
Intubation required* 113 (83) 81 (90) 32(68) 0.001
Age at death (h)" 15 (1,51) 10.3 (1,35) 41.6 (10,55) 0.002
Admitted to SCBU * 106 (77) 65(72) 41(87) 0.046
*
mean, standard deviation and p value (independent samples t-test)
# number, percentage and 2-tailed significance (Chi-square test)
A median, interquartile range and asymptotic 2-tailed significance (Mann-Whitney U test)
massive abruption (10, cases 46, 50, 55, 69), cord accident (9, cases 8, 9, 31,
38, 41), ruptured uterus (3, cases 1, 5, 14) and others (12 in total, including
delivery into a toilet, cases 59 and 67; fetomaternal bleed, cases 11 and 13;
and severe difficulty in delivery, cases 57, 62, 65). This was no more
common in asphyxiated babies.
d) Infant characteristics at birth (Table 3.4)
There were 38 infants who fulfilled criteria for birth asphyxia and 99 who
were born in a good condition (see Chapter 1, Table 1). The two cohorts of
infants were different with respect to gestation. The non-asphyxiated cohort
were of younger gestation (29 vs 32, p=0.002) and consequently lighter in
weight and with a smaller head circumference.
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Despite antenatal concerns about fetal growth, only 9% of all infants proved
to be small for gestational age at birth. The BA cohort was more likely to
have lower Apgar scores, and require more resuscitation as a result. Eighteen
(20%) of BA infants were asystolic at birth but showed signs of life after
extensive resuscitation. The BA cohort died earlier compared with the non-
asphyxiated infants (10.7h vs 39.lh, p=0.006). Of 137 infants, only 106
survived to be admitted to a neonatal unit. Six of the original 47 non-
asphyxiated cohort were never admitted to a neonatal unit: three were found
dead in their cots (cases 33, 35) and 3 suffered a sudden acute deterioration
in the labour ward following a normal delivery (case 2) and resuscitation was
subsequently unsuccessful, one a preterm triplet who was alive and in good
condition for gestation following initial resuscitation. Twenty-five infants
with birth asphyxia, though with signs of life at or shortly after birth could
not be resuscitated sufficiently to get them to their local neonatal unit.
e) Infant characteristics in the first week (Table 3.5)
Details of infants admitted to a neonatal unit were often incomplete because
of early death. There remained a preponderance of immature infants amongst
the noBA cohort and this group had a lower first mean arterial blood pressure
(34 vs 41, p=0.004).
Within the first hour of birth, those infants with BA had a markedly lower
initial arterial blood pH (6.96 vs 7.27, p= <0.001). Infants with BA were
more likely to have renal dysfunction (26% vs 15%, p=0.015), to require
assisted ventilation for poor respiratory drive (33% vs 3%, p=<0.001) and to
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< 37 weeks gestation" 80 (76) 42(65) 38 (93) 0.001
Initial pH within 1st hour* 7.12 (0.25) 6.96 (0.23) 7.25 (0.15) <0.001
Time to reach pH >7.25
(h)A
4 (2,7) 5(3,8) 3(1,6) 0.048
First mean arterial
pressure*
38(15) 40(15) 36(13) 0.207
Hematuria in first 24h" 32 (74) 19 (76) 13(72) 1.000
Creatinine >120" 23 (41) 17 (55) 6(24) 0.020
Inotrope required" 35 (36) 20 (34) 15 (39) 0.644
Colloid required" 82 (84) 51 (86) 31(80) 0.362
Surfactant given" 56 (53) 26(40) 30(73) 0.001
Respiratory distress
syndrome
46 (46) 20(32) 26(67) 0.001
Ventilated for poor
respiratory drive"
21 (21) 20 (33) 1(3) <0.001
Abnormal coagulation" 46(80) 28 (80) 18 (78) 1.000
Abnormal infection
screen"
15 (18) 9 (18) 6(17) 0.839
Abnormal liver function
tests"
7(29) 7(47) 0 0.022
Hypoglycemia <2.6
mmol/l
40 (43) 22 (40) 18 (47) 0.480
Hyperglycemia >8 mmol/l" 36 (39) 22(40) 14 (37) 0.759
Necrotising enterocolitis" 5(5) 4(7) 1 (3) 0.645
Seizures" 12 (11) 11 (17) 1 (2) 0.027
Muscle relaxant" 22 (23) 8 (14) 14 (36) 0.011
Abnormal neurology" 22/30 (73) 19/21(90%) 3/9 (33%) <0.001
Abnormal cranial USS" 48/68(71) 31/40 (83) 17/28(61) 0.135
Age at death (h)" 36 (9,69) 25 (8,70) 43 (13,68) 0.250
*
mean, standard deviation and p value (independent samples t-test)
# number, percentage and 2-tailed significance (Chi-square test)
A median, interquartile range and asymptotic 2-tailed significance (Mann-Whitney U test)
1. alive >12hours, not receiving sedation, paralysis, anticonvulsants
have biochemical evidence of liver dysfunction (47% vs 0, p=0.022). In
keeping with their shorter gestation the noBA cohort had a greater incidence
of respiratory distress syndrome and were more likely to receive exogenous
surfactant and muscular paralysis. In those infants who survived longer than
twelve hours and who had not received sedation, paralysis or prophylactic
anticonvulsants, abnormal neurology was documented more commonly in the
BA cohort (p<0.001). Overt clinical seizures occurred almost exclusively in
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asphyxiated infants. Twelve infants had an EEG performed; all were
abnormal ranging from isoelectric trace in the majority to bilateral seizure
activity. An abnormal infection screen was found in 15 of the total group, of
which 12 were thought to have died of overwhelming sepsis. Pathogens
included Group B streptococcus (7), staphylococcus aureus (2), Escherichia
Coli (2) and others (4). The groups were comparable for other systemic
dysfunction, in particular coagulopathy, necrotising enterocolitis,
cardiovascular instability and glucose homeostasis. Cranial USS was
performed in 48 babies: intraventricular haemorrhage was found in 27
infants, appearances suggestive of parenchymal damage in 8, and a mixture
of these appearances in 4. Nine infants were reported as having slit-like
ventricles and one infant had ventricular calcification. Most infants in the
BA cohort died within the 24hrs while the NoBA cohort survived longer.





Intrapartum hypoxic-ischemic injury 35 (39%)
Respiratory disease in preterm infant 25 (28%) 23 (49%)
Intracranial bleed 7 (8%) 7 (21%)
Infection 7 (8%) 5 (11%)
Congenital anomaly 4 (4%) 2 (4%)
Other: meconium aspiration, hydrops, pulmonary
hypoplasia
3 (3%) 1 (2%)
Unexplained 9 (10%) 9 (20%)
No infants in the NoBA group died from supposed intrapartum hypoxia.
Rates of infection and congenital anomaly were similar, and more infants in
the NoBA group died from complications of prematurity. At the time of data
collection, 13% of deaths remained unexplained (cases 2,4, 7, 9, 18, 19, 29,
32, 35, 61, 62).
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Discussion
The aim of this study was to describe the maternal, pregnancy and delivery
characteristics of a population where pregnancy ended in an early neonatal
death and to ascertain whether any of these parameters were different in
asphyxiated infants. Asphyxia-related death is generally regarded as
avoidable mortality particularly when occurring in full term normally formed
infants, and although new fetal monitoring techniques and intrapartum care
have reduced the number of such deaths, longterm neuromorbidity, which is
often attributed to 'birth asphyxia', has remained unchanged for decades.
This geographically-defined population-based study included all normally
formed infants equal to or greater than 24 weeks gestation who died within
the first week of life in all of the 22 delivery units within Scotland. Forty-
seven infants had malformations which excluded them from the study. This
was equivalent to 21% of the population, and does not include those 6 babies
suitable for inclusion who died of malformations outwith the exclusion
criteria, such as bilateral renal agenesis and laryngeal atresia. Ethical
approval at local level allowed collection of anonymised clinical data in 137
infants irrespective of enrolment into the neuropathology arm of the study.
The risk factors for perinatal mortality, asphyxia and perinatal brain damage
are heterogeneous and likely to involve complex interactions between the
mother, the fetus, and their respective environments. It was therefore
essential to study the risk factors within a population rather than individuals
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or small cohorts. Although Scotland has different demographics to those of
the entire United Kingdom, especially with regard to social deprivation
scores and female smoking patterns, the population is generally
representative of the developed world. Hospital-based studies may suffer
from selection-bias and this is especially true of those conducted in specialist
centres or tertiary neonatal units where there may be an excess of extreme
prematurity or surgical conditions. Regional studies may not be truly
representative of the entire population and may emphasise the role of
particular risk factors or conditions found more commonly within that area.
Population-based studies of larger numbers may reduce such statistical
variation.
Definition of birth asphyxia
The study definition of 'birth asphyxia' may nowadays be criticised as overly
liberal and not sufficiently discriminatory to detect infants who have suffered
damaging asphyxia. One of the principle aims of the base study was to
determine whether infants with antenatal brain damage might be predisposed
to neurological depression at birth which might be labelled as birth asphyxia.
Although evidence shows that Apgar scores and pH may be relatively poor
predictors of long term neuromorbidity, these features, when present at birth,
are often understood by the public and medicolegal profession to indicate
fetal compromise during labour. An Apgar score at 5 minutes of <5.0 is the
traditional assessment of birth asphyxia and it is widely recognised that a
low 5 minute Apgar score has an association, though weak, with both
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neonatal death and morbidity in surviving infants107'137. Although
prematurity is known to affect assignment of the Apgar score and the
classical signs of hypoxic-ischemic encephalopathy, this effect is less
marked as gestation increases. Many infants of 34-36 weeks gestation are
able to achieve normal Apgar scores while those of lower gestations may
exhibit reduced tone and decreased respiratory drive under normal
conditions. Prematurity was significantly commoner within the noBA cohort
although two thirds of those who were asphyxiated were also preterm.
Among those preterm infants who were classified as having birth asphyxia, a
5 minute Apgar score of < 5 alone was found in 35 of 59 cases. Although
some might argue that depressed scores are more common in lower
gestations, a score this low is unlikely to be due to prematurity alone
especially as 22 of these infants died before reaching the neonatal unit.
Other conditions such as infection and neuromuscular conditions may also
result in a low Apgar score and although there was no obvious clinical
evidence of the latter among this population, infection may certainly have
been common and may have contributed to depression at birth. Infection can
also result in acidosis at birth, as can rarer congenital metabolic disorders.
None of the infants who died were felt to have a primary metabolic acidosis.
Obstetric epidemiology has shown that a scalp pH of less than 7.25 is
abnormal and delivery is indicated if less than 7.2152. The relationship
between scalp and cord pH is good with a sensitivity of 93%153. However the
neonate is rarely difficult to resuscitate unless the cord pH is less than 7.0. In
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a large study of full term infants a pH of 7.1 represented 2SDs below the
mean103. This value was chosen as indicating some degree of birth asphyxia
within this project. Recognising the limitations (in the absence of a cord pH)
a first blood gas with a pH less than 7.1 was also taken to indicate asphyxia.
This was, in all cases, taken before an hour of age. A value for base deficit or
plasma bicarbonate was rarely recorded and it was thus not possible to be
certain that the cause of the acidosis was entirely ischemic in origin. As
some of the infants went on to develop respiratory disease it is possible that
in some cases carbon dioxide retention compounded the acidosis. The
presence of acidosis is also not specific for asphyxia and may occur in the
presence of infection, which affected at least 15 infants in the cohort.
The presence of grade 2/3 neonatal encephalopathy is now widely accepted
as having a closer association with significant birth asphyxia and long term
neurodevelopmental disability919'107. Although many infants in the study were
classified as having abnormal neurology, in only a few was a diagnosis of
hypoxic-ischemic encephalopathy possible. The main reason was that many
infants died within a few hours of birth and a proportion of the remainder
were treated with paralytic agents, sedation or prophylactic anticonvulsants.
Some infants had neurological symptoms which did not fit the diagnosis of
hypoxic-ischemic encephalopathy: for example preterm infants who had a
normal neurological examination in the first days of life, followed by
seizures related to an intraventricular haemorrhage thereafter. Other preterm
infants were described as being very lethargic or abnormally jittery but
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without progression of symptoms or associated neurological signs. One term
infant had hypoxic-ischemic encephalopathy and multi-organ dysfunction but
with an Apgar score at 5 mins of 6 and a cord pH of 7.11 with normal
cardiotocograph monitoring. This baby had a CT scan in the first few days of
life which showed widespread severe cerebral oedema with absent
supratentorial perfusion and haemorrhage. This infant was thought to have
suffered a recent antenatal hypoxic-ischemic insult.
Clinical data and ascertainment
Review of the relevant literature about perinatal mortality, birth asphyxia
and asphyxia-related neuromorbidity highlighted many risk factors which the
study sought to examine. Although many data points needed to be collected
for each case, ascertainment of accurate and complete data was ensured by
individual review of maternal and neonatal notes for each death. Where
appropriate, data points carried a definition derived from well-recognised
texts to ensure standardisation of responses. A meeting between myself, the
link midwife, obstetrician and paediatrician in each case within two weeks of
the death of the infant allowed accuracy of data collection to be verified.
Each unit was awarded a small fee for the time invested by midwives in
completing each form. Although the Information and Statistics Division of
the National Health Service in Scotland collects national annual perinatal
mortality statistics, direct validation of study numbers with these statistics
could not be performed, as the date that each delivery unit started recruiting
cases was different for each centre. However, study numbers did approximate
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national statistics. The study only included deaths within neonatal or
delivery units. Those infants who died in the first week of life at home, in a
surgical unit or in a paediatric hospital were not included. Such infants may
have died from infective causes or for surgical reasons but almost certainly
not from intrapartum asphyxia. The number of these infants is likely to be
very small.
Inclusion and exclusion criteria
All early neonatal deaths equal to or over 24 weeks gestation and equal to or
less than 7 days of age included in the study. Enrolment in the study
involved detailed neuropathological examination for evidence of antenatal
hypoxic damage. Cellular reaction to hypoxia is increasingly difficult to
substantiate in progressively immature brains and a minimum of 24 weeks
was chosen. There were a few liveborn infants of twenty-three weeks
gestation who died during the study period but these were not included. With
increasing duration of survival, superimposed recent damage may complicate
interpretation of more longstanding damage and only infants less than 7 days
were included for this reason.
Infants with CNS malformations and chromosomal abnormalities were
excluded from enrolment as these are often accompanied by disordered brain
architecture. CNS infections may result in widespread infiltration of
inflammatory cells and these changes may be difficult to distinguish from the
cellular reaction seen following hypoxia. Infants with cardiothoracic
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malformations were also excluded as circulatory disturbance in these
conditions may itself result in hypoxic or ischemic damage in the brain.
Discussion of results
The epidemiological background of this cohort is similar to other recent
studies from the developed world50'58;59. Mothers in the study had similar
demographics to those of all Scottish maternities resulting in a stillbirth or
live birth in 1996-1998, in particular maternal age, height, marital status and
parity83. The proportion of pregnancies where booking women were smokers
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was considerably higher than that of all Scottish maternities (37% vs 29%) .
Around a third of women had experienced pregnancy loss or infertility in
previous pregnancies and this is in agreement with previous studies which
have shown increased perinatal mortality154'155 and neonatal
S 8
encephalopathy in subsequent pregnancies. Lilienfield and Parkhurst found
an association between previous infant loss and cerebral palsy and postulated
the existence of a 'continuum of reproductive wastage' with lethal
(pregnancy loss) and sublethal manifestations (cerebral palsy)156. A more
recent study showed an increase in cerebral palsy in children born after in
vitro fertilisation 157.
Most complications studied in this cohort were more common than those
found in all Scottish maternities. For example, antepartum haemorrhage,
intrauterine infection, intrauterine growth retardation, polyhydramnios,
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hyperemesis and oligohydramnios each affected less than 4% of all
maternities over the study period. Premature rupture of the membranes
affected around 5%, and anaemia, 14% of Scottish maternities over the study
O T
time period . Pregnancies with antenatal complications are known to be at
high risk of neonatal morbidity and mortality138;142;158"161 and high risk
obstetric clinics are in place in many centres to identify a fetus at risk of
compromise and pre-empt poor outcome. In deciding the best option for a
fetus at risk, a balance has to be met between expeditious delivery from a
hostile uterine environment and the hazards of premature existence. Both
options may have disadvantages for the fetus and may result in mortality.
Eight-one percent of study mothers had pregnancy complications identified
and despite such surveillance, the pregnancy ended in neonatal death. Death
may have resulted due to late presentation, inadequate surveillance or
iatrogenic prematurity. Although not significantly different (statistically),
most complications were commoner in non-asphyxiated infants suggesting
that identification of these infants may have led to improved condition at
birth. Despite having no recognised antenatal complications, nineteen
percent of study infants died. This is consistent with other data which show
that the absence of maternal complications does not protect the infant from a
neonatal complication or death161"163.
Analysis of the detailed data from the mother and her pregnancy did not
identify any reliable predictors for birth asphyxia. Significant placenta
praevia, oligohydramnios and hyperemesis were protective against asphyxia
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in general, possibly because these mothers were more intensively monitored.
Similarly those mothers who received steroids were less likely to produce an
infant with signs of asphyxia, perhaps because they were under medical care
before and after steroid administration. A history of viral illness in
5 8
pregnancy has previously been found to be associated with NNE . Our series
did not show this association and pyrexial illness in pregnancy was more
common in those pregnancies resulting in non-asphyxiated infants.
Intrauterine growth restriction has previously been strongly associated with
NNE50'58'132'134;139 and affected 9% of our population most of whom were
non-asphyxiated infants.
Around 20% of the cohort were delivered before the onset of labour for
reasons of fetal or maternal compromise. Many of these infants had signs of
asphyxia at birth despite avoidance of labour suggesting that they may have
been subject to a hypoxic-ischemic process antenatally. The incidence of
meconium staining in all Scottish deliveries of that time period was 7%
compared to the 20% seen in the neonatal deaths of this study. Although
meconium staining alone has a high false positive rate164 it is associated with
increased perinatal mortality and morbidity165. It has been hypothesized that
intra-amniotic meconium may cause vasoconstriction of the umbilical vessels
inducing fetal hypoxia/ischemia166. This is difficult to substantiate after
delivery. Although meconium stained liquor affected mostly term deliveries,
it also complicated around 10% of preterm deliveries. Although historically,
preterm in utero passage of meconium was thought to be pathognomic of
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Listeria infection, a recent study has shown meconium staining to affect
around 5% of all deliveries less than 33 weeks gestation and is associated
with prolonged rupture of the membranes but not listeriosis. These infants
were found to be at an increased risk of intraventricular hemorrhage167.
Within our cohort, only two of the 13 preterm infants with meconium
staining had ruptured membranes for more than 24 hours. Listeria was not
isolated in any infant. Ten of these infants were classified as having birth
asphyxia. Only two infants survived long enough for a head USS to be
performed and in both intraventricular haemorrhages were present.
The need for induction of labour was low and reflects the high number of
preterm deliveries that were spontaneous in onset. It has been postulated that
spontaneous preterm labour is an adaptive response initiated by the fetus to
escape an unfavourable uterine environment. Emergency caesarean section
for fetal compromise was common and more than double the national
caesarean section rate. Abnormal presentation which is associated with birth
asphyxia in term infants in the literature140 was almost exclusively confined
to infants <32 weeks gestation and was in fact less common in the
asphyxiated cohort.
Intrapartum infection and pyrexia have strong associations with both 'birth
asphyxia' and neonatal encephalopathy59'148'149'151. Incidence of documented
intrapartum infection in Scottish maternities is reported as 0.16%. This is
likely to be an underestimate as recording of data takes place soon after
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delivery and before culture results may be available. Despite this, the
incidence of intrapartum infection within this study is considerable. All cases
had isolation of organism in the mother associated with pyrexia in labour,
histological chorioamnionitis or maternal white cell changes with clinical
suspicion of infection. However there was no evidence within the cohort that
maternal infection or pyrexia were commoner within the asphyxiated group.
Epidural analgesia may result in maternal pyrexia but this association was
not seen in this study where epidurals were common. Prolonged rupture of
membranes for more than 24 hours before delivery (PROM) has been
associated with neonatal encephalopathy50 but not in other series149'151. There
was a high incidence of PROM within our cohort but not more so within the
BA group. PROM was associated with prematurity, documented intrapartum
infection and pyrexia in labour.
Perinatal mortality is associated with delivery at night or at weekends168"170.
This study did not show an excess of deaths following delivery at these
times. However, 80% of infants who were the most severely depressed at
birth (stillborn but showed some signs of life following prolonged
resuscitation) were delivered out of normal working hours. In only one case
was a consultant obstetrician present at delivery. Although intrapartum
asphyxia is often attributed to an acute catastrophe during labour, a sentinel
event such as this was only present in a quarter of all deaths and not
significantly more so in infants with signs of asphyxia. Seventeen percent of
non-asphyxiated infants had an acute perinatal event which had the potential
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to result in hypoxia-ischemia. These cases were all preterm infants who had
normal Apgar scores and no evidence of acidosis.
Examination of intrapartum factors revealed no significant differences
between BA and noBA cohorts apart from meconium staining of the liquor
and CTG abnormalities. Both these features are well known associations of
birth asphyxia. The fact that there is more intensive monitoring during labour
than at any other time during pregnancy means that any injuries sustained
antenatally may not become manifest until the commencement of labour or
until the normal stresses of labour uncover signs of a compromised fetus.
This leads to the assumption that the fetus was healthy until labour and it
was only at this point that problems occurred. If a fetus has experienced
neurological insult or maldevelopment during pregnancy, this damage may
affect parts of the brain responsible for autonomic control of activities such
as heart rate and respiration171. Thus the classical signs of intrapartum stress
such as reduced heart rate variability, and meconium passage in utero and
low Apgar scores may all represent the first recognised signs of a previously
compromised fetus. It is not possible to recognise the point at which brain
damage becomes irreversible in such chronic compromise. It is possible that
this point may be reached during a labour if the fetus has been able to
compensate until that time. It could then be argued that if delivery were to be
expedited by caesarean section for example, further irreversible damage
could be prevented.
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There was a preponderance of male infants at birth in keeping with the
increased mortality for boys at all ages172. The majority of deaths were in
preterm infants who made up three quarters of the study cohort. Non-
asphyxiated infants were more likely to be preterm and this might reflect the
fact that immature and more simple brain may be more resistant to an
asphyxial environment. Asphyxiated infants were in poorer condition,
required more extensive resuscitation and were less likely to survive long
enough to be admitted to a neonatal unit. Neonatal deaths are concentrated
increasingly at the start of the neonatal period and one third of infant deaths
occur within the first 24 hours of life173. Most infants in the study died
within the first day of life and asphyxiated infants died earlier.
Many infants received sedation or paralysis so the true incidence of
neurological symptoms is likely to be underestimated. In addition preterm
infants may not exhibit the classical signs of encephalopathy as often as
mature infants. Neurological examinations were performed by the clinician
in charge of the infant's care and were not standardised. However, review of
the infant's examination took place between the clinician and the author
following the death of the infant. Neurological abnormalities were defined as
profound hypotonia, prolonged jitteriness, brainstem release phenomena, lip
smacking, prolonged clonus, hypertonia, seizures, coma. Feeding difficulty
was common to most infants within the study and was not included as a
neurological symptom. Infants admitted to a unit who survived less than 12
hours of age were generally obtunded throughout their short life and in most
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cases this was due to severe cardiorespiratory insufficiency. Although only
12 of our cohort exhibited seizures, recent work suggests that many subtle
clinical seizures may be missed174 without a full electroencephalographic
record. This may be especially true among preterm infants or where seizures
are brief or focal. Similarly, abnormalities of neurological examination may
not be appreciated in the sick preterm infant especially if their condition
prohibits much handling. Most units do not have easy access to EEG
monitoring and at the time of the study only one neonatal unit had cerebral
function monitoring in use. All infants who had seizures had an EEG
performed and in all cases this was profoundly abnormal.
This study reports the maternal and pregnancy characteristics of a population
of early neonatal deaths and describes the condition of these infants at birth
and their progress over the first week of life. Attempt was made to identify
features in the mothers, pregnancies and labours which might predict the
delivery of an asphyxiated infant. Despite 66% of infants born in an
asphyxiated state, no reliable indicator could be found to identify such
infants apart from abnormal CTG monitoring and meconium staining in
labour. This might suggest that the processes leading to neonatal death are
similar for the two groups or that other factors not examined might be more
definitive. It is possible for example that genetic or environmental influences
may be involved. Infertility was common among our cohort as was a
previous pregnancy loss. Family history of seizures, learning disability or
cerebral palsy was sought among mothers in the study but many midwives
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and clinicians felt unable to approach mothers for this information at a time
of great distress. Similarly a detailed dietary, smoking, alcohol and
recreational drug history was not possible.
Despite the identification and surveillance of high risk pregnancies many
infants continue to be born in a depressed condition and eventually die.
Although many infants in this study did not respond to resuscitative
measures over the first day of life, many others had sustained neurological
damage manifest as hypoxic-ischemic encephalopathy and intraventricular
haemorrhage which was so severe that it was thought to be incompatible with
any meaningful existence. In these cases a decision was made involving the
parents to withdraw life-prolonging treatment. Although the majority of
neonatal deaths occur in premature infants or in infants with congenital
anomalies which are incompatible with life, many others may be preventable.
Both perinatal infection and asphyxial injury remain important potentially
avoidable causes of neonatal death. Identification of such infants can be
difficult and neonatal management of infection and asphyxia have changed
little over the last thirty years. Accurate detection of maternal infection is
difficult and routine screening results in many mothers and babies treated
unnecessarily. Detection of fetal hypoxia during labour depends largely on
non-specific signs none of which inform of damage to the fetus. Fetal injury
during pregnancy is even more difficult to ascertain. Newer rescue strategies
such as immunoglobulin for neonatal sepsis and hypothermia for hypoxic-
ischemic encephalopathy are being researched currently.
76
This study has demonstrated that the current battery of pregnancy and
labour-associated investigations remain blunt instruments in accurately
predicting the arrival of an asphyxiated infant. Current evidence suggests
that neonatal encephalopathy may be the manifestation of a number of
different morbidities, some occurring antenatally, others during labour and
still others as chronic or repeated insults spanning both periods. It is highly
unlikely that one causal pathway will be determined and instead there is
likely to be considerable heterogeneity among aetiologies. Future work must
address the development of methods for detecting fetuses at risk so that
optimal intrapartum and postnatal management can be planned.
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Chapter 4
Apolipoprotein E genotyping and brain damage
in early neonatal deaths*
Introduction and background
Apolipoprotein E polymorphism and genetics
Apolipoprotein E (apoE) is a 299 amino acid glycosylated protein which has
17 5 i •
a major role in cholesterol and lipoprotein metabolism . The major
isoforms of apoE (apoE2, apoE3 and apoE4) are products of three alleles (s2,
e3 and s4) located on the long arm of chromosome I9l76. Expression of these
alleles result in six APOE genotypes: s2/s2, s3/s2, s3/e3, s4/s2, s4/s3, s4/s4.
Although the isoforms differ only by single amino acid substitutions, this
distinction has profound functional implications at a cellular level.
In all populations the s3 allele is the most frequent, ranging from 50-90%,
with the frequency of s4 and s2 ranging from 5-35% and 1-15% respectively.
Within the UK the relative frequencies of the APOE alleles are
approximately as follows: s3 77%, s4 15% and s2 8%177. s3 seems to be the
normal isoform in all known functions, and is also the most common
isoform. s2 and s4 can be dysfunctional and have a definite impact on lipid
and lipoprotein levels.
*
This chapter contains some text from published work reproduced with consent from co-authors and
publishers347'348.
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ApoE and lipid metabolism
ApoE is an intracellular cholesterol and fatty acid transport protein that plays
an important role in lipid metabolism. It is synthesised and secreted by many
tissues throughout the body but particularly by tissue macrophages in the
liver, brain and skin. The principal role of apoE is to transport lipids from
one tissue to another. ApoE is a component of VLDL particles as they are
excreted from the liver and is acquired by chylomicrons on synthesis by the
small intestine.
Much of the early clinical interest in apoE related to hyperlipidemia,
atherosclerosis and the risk of coronary heart disease177. Isoform-specific
differences include the association of s2 with type III hyperlipidemia and
with both increased and decreased risk for atherosclerosis and the association
of s4 with an increased risk of high cholesterol levels and atherosclerosis.
Apolipoprotein E and the nervous system
By the middle of the 1980s, evidence began to emerge that apoE played an
important role in neurological diseases. It is unique among lipoproteins in
that it is involved in the recovery response of injured nerve tissue.
The brain is the second major site of apoE messenger RNA expression in
humans and contains one third of the levels found in the liver. ApoE is
synthesised by the central nervous system glia and in particular by
astrocytes178. ApoE is the principal lipid transport vehicle in cerebrospinal
fluid and appears to play a key role in neuronal repair by distributing lipids
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to regenerating axons and to Schwann cells during remyelination. This lipid
transport system provides injured neurons with cholesterol and phospholipids
allowing the potential for repair of cell membranes, growth of neurites,
dendritic remodelling and synaptogenesis. From the study of animal models
of acute nerve injury it is proposed that degenerating cellular components are
taken up by astrocytes and packaged together with apoE into lipoprotein
complexes179. These complexes are secreted into the extracellular space and
bind to specific receptors on neurons and oligodendroglial cells and are
subsequently internalised. The lipids obtained in this way may be used for
cellular repair. Following injury there is a coordinated increase in expression
of apoE by astrocytes and LDL receptors by neurons, which facilitates
transport of lipids by this system. For example, apoE synthesis is induced
dramatically (250-350-fold) following neuronal injury, in particular
38 180 181
following injury to peripheral nerves , optic nerves and spinal cord . In
cerebral ischemia, apoE has been found in neurons in both rat and gerbil
models182'183 where it is thought to have been internalised following
secretion by astrocytes. However, apoE appears to also have more complex
roles than that of lipid transport in traumatic or ischaemic nerve injury: it has
been found localised in the cytoplasm of cortical hippocampal neurons in
patients with Alzheimer's and Parkinson's disease, and in epilepsy184;185.
There is growing evidence that apoE, lipid metabolism and immune
responses are related not only systemically but also in the central nervous
system186. ApoE appears to suppress the production of various pro¬
inflammatory cytokines, including TNFa, IL113 and IL-6, in neural cells37'187.
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Accumulating evidence supports a role for APOE isoform-related effects on
the neuronal repair mechanism and the maintenance of synapses and
dendrites. In vitro work shows that s3 enhances neurite outgrowth whereas
s4 decreases neurite outgrowth39. This effect is mediated by changes in
microtubule assembly affecting the neuronal cytoskeleton. Such observations
raise the possibility that individuals may vary in their susceptibility to the
effects of acute brain injury according to their APOE phenotype (Figure 4.1).





(Modified from Weisgraber and Mahley188and reproduced with permission of the
Federal Academy of Experimental Biology)
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In 1993, Corder and colleagues discovered that APOE is a major
susceptibility gene associated with over half of cases of sporadic and familial
Alzheimer's disease. s4 was the isoform responsible for this effect,
1 RQ
increasing the occurrence and lowering the age of onset of the disease
More recent work has shown that individuals have a genetic predisposition to
amyloid p-protein deposition following head injury conferred by s4190.
Deposition of P-amyloid protein in the brain plays a key role in the
pathogenesis of Alzheimer's disease suggesting a possible association
between APOE genotype and head injury in the development of Alzheimer's
disease. Research on mice has shown APOE isoform-specific effects on
learning and memory191 and in humans evidence is beginning to emerge that
s4 expression may negatively affect cognitive function in middle aged adults
before any symptoms of Alzheimer's disease are present192'193. A higher
frequency of s4 has also been reported in patients who do not recover from
post-traumatic coma compared to those who recover consciousness194. In
another study, patients who died after spontaneous intracerebral haemorrhage
had an excess of e4, and of the survivors those with s4 had poorer
neurological function195. Head injury in an s4 carrier is more likely to lead
to death196 and s4 carriers undergoing cardiac bypass recover
neuropsychological functions less efficiently than those without an s4
allele197.
Although often supposed to be the 'good allele' a link has been established
between e2 and amyloid angiopathy198, sporadic Parkinson's disease199 and
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argyrophilic grain dementia200. Little is known about the function of the
APOE gene on the brain in childhood.
The most likely time to sustain a neurological insult is before or during birth.
At least 60% of term and 20% of preterm10 infants with subsequent cerebral
palsy are probably disabled by antepartum factors. Although many
etiological factors, including metabolic, mitochondrial and genetic factors,
play a role, intrapartum hypoxic-ischemic encephalopathy remains an
important cause of childhood cerebral palsy in the term infant. Many infants
201who suffer a brain insult recover with no long-term effects . However, a
proportion die in the neonatal period due to the severity of their injury, and
others survive but with a range of permanent neurological abnormalities
which manifest as cerebral palsy and/or cognitive deficits. There are few
markers to predict the degree of neurological sequelae after such an insult.
Much of what is known of the role of apoE in the central nervous system
relates to mature brain tissue. There have been no studies looking at the
effect of APOE genotype on the developing infant or its nervous system. In
this study we examined the distribution of APOE genotype in healthy infants
and perinatal deaths and hypothesised that isoform-related differences in
APOE might predispose to brain injury in the perinatal period. We also
sought to determine whether the APOE genotype was associated with




The aims of the study were
1. To compare the relative frequencies of the Apolipoprotein E allele in 3
Scottish populations:
Group 1: healthy newborn infants
Group 2: perinatal deaths (early neonatal deaths and stillborn infants)
Group 3: healthy middle aged adults202
2. To investigate the relationship of Apolipoprotein E genotype of perinatal
deaths with neuropathology
3. To compare the Apolipoprotein E genotype of perinatal deaths with
clinical features
Design
This study was a retrospective cross-sectional cohort analysis.
Subjects
Adults: 400 healthy late middle aged men and women who were randomly
selected from General Practitioner lists in the North East of Scotland . No
other demographic information regarding this population has been published.
Healthy newborn infants: dried blood spots were collected anonymously
and randomly from the placentas of 371 healthy infants born in the Simpson
Memorial Maternity Pavilion, Royal Infirmary of Edinburgh. All infants
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were >35 weeks gestation and had a birthweight greater than 2 kg. All
infants were healthy at birth and all left hospital when due to do so. The
blood was sampled anonymously and no other demographic information was
collected.
Perinatal deaths: DNA was extracted from formalin-fixed paraffin
embedded brain blocks of 252 perinatal deaths enrolled in the population-
based Scottish Perinatal Neuropathology Study (Chapter 1). APOE
genotyping was performed in 68 early neonatal deaths and 186 stillbirths.
Two pairs of twins were enrolled in this study, one pair liveborn and one
stillborn. For the purposes of this study, the second twin was excluded from
analysis. In other multiple pregnancies occurring in the study, only one
infant of the siblings had died. No other sibling pregnancies were entered in
this two year study. Therefore this study investigated 261 perinatal deaths
(67 early neonatal deaths and 185 stillbirths), each in a different family.
Ethics
This study was approved by the Lothian Research Ethics Committee (LREC
1998/6/53).
Funding
This study was funded by the Scottish Office K/MRS/50/C2739 £63,972.
Role of apolipoprotein E genotype in perinatal hypoxic/ischaemic
encephalopathy. Principal grant holder: Professor Jeanne E Bell. Other grant
holders: Professor Neil Mcintosh, Dr Julie-Clare Becher, Dr Jean W Keeling.
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Sample analysis
The hot start polymerase chain reaction (PCR) method for APOE genotyping
was based on that described by Hixson and Vernier203 and was adapted for
analysis of formalin fixed, paraffin embedded tissue. DNA was extracted in
each case from two or three 5pm sections using the Qiagen's DNeasy tissue
kit (Catalogue No: 69506). The sections were placed in Qiagen tissue lysis
buffer and vortex mixed before incubating with proteinase K at 50°C in a
water bath for 48 hours. After further vortex mixing incubation was
performed at 70°C for 10 minutes before mixing with absolute alcohol. The
mixture was subjected to centrifugation at 13,000rpm in Qiagen DNeasy spin
columns. Finally the eluted DNA solution was added to a master mix
solution containing customised primers (MWG Biotech) as follows:
Downstream primer: ACA GAA TTC GCC CCG GCC TGG TAC ACT GCC A
Upstream primer: TCC AAG GAG CTG CAG GCG GCG CA
The master mix also contained 5pi of x 10 PCR buffer, 8pl of 5mM
nucleotides, 1.5pi 50mM Mg Chloride and 1.25pl Taq polymerase
(Invitrogen) as well as 20pmol of each primer.
DNA cycling was run on a Techne Flexigene Thermocycler at 95°C for 3
minutes followed by 45 cycles at 94°C for 1 minute, 62°C for 1 minute and
72°C for 2 minutes with a final extension of 72°C for 8 minutes. lOpl of
each PCR reaction was run on a 3% agarose gel and visualised with ethidium
bromide under ultraviolet light. This revealed the PCR product of 227 base
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pairs. PCR product was mixed with lpl Hhal restriction digest enzyme
(New England Biolabs) at 37°C overnight. Samples were then run on a 4%
Metaphor gel and again visualised with ethidium bromide under ultraviolet
light for photography.
The genotype for each sample was determined from the migration pattern of
bands in the gel. PCR was repeated for cases in which the band pattern was
faint or equivocal until a definite result was obtained. In the small number
of cases in which paraffin embedded brain tissue failed to yield a result
despite repeat investigation, further attempts to extract DNA switched to
non-brain tissue blocks and these occasionally provided a result when the
brain had proved negative. Paraffin blocks of spleen were used for this
purpose.
This work was performed by Ian Croy and Ian Anthony in the Molecular
Biology Department of the Western General Hospital, Edinburgh.
Statistics
Descriptive statistics were used to examine the prevalence of the different
alleles. Hardy-Weinberg expectation was calculated for each cohort to
ascertain population equilibrium. The Chi square test for trend was used to
compare allele frequencies between groups and to compare allele frequency




Unequivocal results with clear APOE banding patterns were obtained for 67
of 70 liveborn infants who died at 7 days of age or less and 186 of 191
stillborn fetuses of at least 24 weeks gestation. Of the two pairs of twins in
this study, all four infants proved to be APOE 2/3. The second twin of each
pair was excluded from further analysis. APOE genotypes of 371 healthy
newborns were performed. Spleen blocks were used in 8 cases all other
results were from brain tissue.
1. Comparison of allele frequencies between cohorts
The distribution of APOE alleles and genotypes for these groups is shown in
Tables 4.1.A-C which also include previously published data for 400 Scottish
adults202. Table 4.1.C shows the Hardy-Weinberg expectation for each
population and shows that departure from this expectation is trivial. Table
4.2 compares the different groups and shows significance values as
calculated by the chi-square test for trend.
APOE £2
There is an over-representation of s2 in perinatal deaths (13%) compared
with healthy newborns (8%, p=0.012) and with adults (8%, p=0.007).
Taking the stillbirths alone, the increased prevalence of the s2 allele remains
significant compared with healthy newborns (p=0.019) and with adults
(p=0.011). The prevalence of all genotypes possessing one or more s2 alleles
(2/2, 2/3 and 2/4) was higher among perinatal deaths than among healthy
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liveborns and adults (Table 4.1.B).
APOE £3
The prevalence of the s3 allele is higher in adults than in healthy newborn
infants (p=0.042) and early neonatal deaths (p=0.023).
APOE £4
The prevalence of s4 is higher in healthy liveborns than in both normal
adults (p=0.026) and stillbirths (p=0.012). Review of Table 4.1.A suggests
that liveborn infants who die in the perinatal period have over-representation
of both e2 and s4 alleles compared with normal adults but the number of
cases (n=67) is too small to place reliance on statistical analysis.
Table 4.1. Comparison of Apolipoprotein E Alleles and Genotype
4.1.A. Distribution of APOE Alleles
Cohort e2 e3 e4 Total alleles
Adults 66 (8%) 616 (77%) 118 (15%) 800
Healthy Newborn 63 (8%) 538 (72%) 141 (19%) 742
Perinatal Deaths 65 (13%) 365 (72%) 74 (15%) 504
Early neonatal deaths 17(13%) 91(68%) 26(19%) 134
Stillbirths 48(13%) 274(74%) 48(13%) 370
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4.1.B. Distribution of APOE genotypes
Cohort 2/2 3/3 4/4 2/3 2/4 3/4
Adults 2 233 4 51 11 99
(n=400) (0.5%) (58.2%) (1%) (12.8%) (2.7%) (24.8%)
Healthy Newborns 2 199 15 44 15 96
(n=371) (0.5%) (53.6%) (4%) (11.9%) (4%) (25.9%)
Perinatal deaths 5 138 3 38 17 51
(n=252) (2%) (54.8%) (1.2%) (15.1%) (6.7%) (20.2%)
Early neonatal deaths 2 28 0 11 2 24
(n=67) (3%) (41.8%) (16.4%) (3%) (35.8%)
Stillbirths 3 110 3 27 15 27
(n=185) (1.6%) (59.5%) (1.6%) (14.6%) (8.1%) (14.6%)
4.1.C. Distribution of alleles with Hardy-Weinberg expectation
s3/s3 s3/- Others Total p value
(homozygotes) (heterozygotes) (s3 null)
Adults
Observed 232 152 16 400 0.63
Expected 237 142 21 400
Healthy
Newborns
Observed 192 139 31 362 0.58
Expected 188 146 28 362
Perinatal deaths
Observed
133 85 24 242 0.55
Expected 129 95 18 242
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Table 4.2. Comparison of APOE allele frequencies and
significance values
Groups compared e2 e3 e4
Adults vs all infants 0.127 0.022 0.134
Adults vs healthy newborns 0.865 0.042 0.026
Adults vs perinatal deaths 0.007 0.062 0.973
Adults vs early neonatal deaths 0.095 0.023 0.167
Adults vs stillbirths 0.011 0.272 0.418
Healthy newborns vs perinatal deaths 0.012 0.973 0.048
Healthy newborns vs early neonatal deaths 0.121 0.276 0.914
Healthy newborns vs stillbirths 0.019 0.584 0.012
Early neonatal deaths vs stillbirths 0.932 0.173 0.072
2. APOE genotype and neuropathology
Detailed neuropathology was available for 66/67 neonatal deaths and all 185
stillborn infants where the genotype was known. Because of the low numbers
of infants with the genotypes s2/s2, s4/s4, and s2/s4 (see table 4.1.B),
subjects with the s2 allele (s2/s2 and s2/b3) were combined into one group,
s3/s3 homozygotes made up another group, while the final group was
comprised of subjects with the s4 allele (s4/s4, s3/s4, and e2/s4), as is the
convention177. Tables 4.3 and 4.4 show the distribution of APOE genotype
according to the presence or absence of brain damage in these cohorts. No
correlation was detected between APOE status and hypoxic brain damage in
live born or stillborn babies. However among the stillborn cohort with
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Healthy newborns 199(54%) 46(12%) 126(34%)










76 (62%) 17 (14%) 30 (24%)
No brain damage
(n=62)
34 (55%) 13 (21%) 15 (24%)
Healthy newborns 199(54%) 46(12%) 126(34%)
evidence of brain haemorrhage there was a significant excess in s3
homozygotes (72% compared with 53% of stillbirths with no haemorrhage,
p=0.025 and with 54% of healthy newborns, p=0.001, table 4.6). This was
not observed in the neonatal death cohort (table 4.5).
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Healthy newborns 199(54%) 46(12%) 126(34%)














Healthy newborns 199(54%) 46(12%) 126(34%)
*p=0.025 compared to stillbirths with no haemorrhage and p=0.01 compared to healthy
newborns
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3. APOE genotype and clinical features amongst perinatal deaths
A full clinical dataset was available for 66/67 of the neonatal deaths and all
185 stillborn infants where the genotype was known. Table 4.7 shows the
variation in allele distribution across gestational groups. Although there
appears to be an increase in genotypes containing s2 in extremely preterm
gestations this difference is not statistically significant. Comparison of other
clinical detail (eg birthweight centile, baby:placenta ratios etc) between
different alleles revealed no significant differences in either cohort.






e2/s2, e3/e2 s4/s4, e4/e3, e4/e2
24-26 weeks (n=46) 23(50%) 12(26%) 11(24%)
27-29 weeks (n=31) 18(58%) 6(19%) 7(23%)
30-32 weeks (n=28) 15(54%) " 13(46%)
33-35 weeks (n=38) 24(63%) 9(24%) 5(13%)






Allele frequencies in the Scottish population
This study sought to determine the APOE allele and genotype distribution in
Scottish perinatal populations and compare these to published Scottish adult
data. In the case of perinatal death, a relationship was sought between APOE
genotype and both neuropathology and clinical features. The results of the
study showed significant differences in allele distribution between adults,
healthy newborns and perinatal deaths and an association between genotype
and brain haemorrhage in stillborn infants.
The relative frequency of different alleles of APOE has been calculated for
many population groups. The s3 allele is the commonest in all published
studies. In most populations the next commonest is e4. Amongst Caucasian
populations, whose allele frequency has been studied in many countries, the
relative frequency of alleles is remarkably similar, apart from Finnish
subjects. All studies in Caucasians have shown an s3 frequency of <0.79,
lower than the frequency amongst American Indians, Chinese and Japanese
(>0.82). There are however, differences in s4 and s2 distribution between
geographically separated Caucasian groups, most notably a significant
reduction of s2 frequency with an excess of s4 in the Finnish population177.
Few investigators have examined the effect of age on APOE allele frequency.
Ordovas et al found no difference in the distribution of APOE alleles
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between young and older adults204 although Schachter et al found that
centenarians had a lower incidence of s4 and higher incidence of e2
compared to young and middle aged adults205. No differences have been
found between parents and their offspring206. Herrmann at al examined 199
newborns and found an excess of APOE c3 and e2 with reduced prevalence
of s4, a result that contrasts with the present findings207.
The adult population was selected randomly in the mid 1980s and was
composed of late middle-aged men and women. Although this is a historical
cohort, the distribution of allele frequencies is similar to that of other
Caucasian populations in the literature. In the review of all published data by
Davignon and colleagues, it was found that in 5,805 Caucasians the APOE
allele frequency was 0.08 for e2, 0.77 for s3 and 0.15 for s4, a distribution
which is precisely the same as that reported for the Scottish adult population
used in this study177. The perinatal subjects were born a decade later than the
adults reported, effectively a difference of 60-70 years.
The Hardy-Weinberg Law states that gene frequencies and genotype ratios in
a randomly breeding population remain constant from generation to
generation. Evolution involves changes in the gene pool but a population in
Hardy-Weinberg equilibrium shows no change from generation to generation.
The study data show that each population was in Hardy-Weinberg
equilibrium and therefore the results cannot be explained by evolutionary
change.
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The study data showed an excess of the s4 allele and a corresponding
decrease in the e3 allele amongst healthy babies at birth when compared to
healthy middle-aged Scottish adults. The differences observed cannot have
occurred by evolutionary forces as both populations are in Hardy-Weinberg
equilibrium. While it is possible that these differences have occurred by
chance it is unlikely as the numbers in the study are not small. Other reasons
for the differences observed may include sampling bias: the Scottish adults
were from the North of Scotland and the healthy newborns from Edinburgh.
As the relative frequencies of the APOE alleles remain fairly constant
throughout most Caucasian populations it is unlikely that two populations
within a limited geographical area such as Scotland would exhibit such
differences. However the adult cohort did have to consent to participation in
the study which involved venepuncture whereas the newborns were truly
sampled randomly by a method which did not involve consent or a noxious
procedure. It is possible therefore that the results may represent differences
in education or social class between populations, with the adult cohort better
educated and more able to make an informed choice about participation.
Although such differences between APOE genotypes have not been
extensively explored in the literature there are studies which show an
association between e4 and both higher educational achievement and
cognitive function in early to mid adulthood208'209. This is in contrast to the
decline in cognitive function associated with s4 in elderly subjects210. This
study however shows a decreased frequency of s4 among the middle-aged
consenting cohort compared with infancy and therefore would not be
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consistent with this theory. However, the results of this study are supported
by research that centenarians have been found to have a lower frequency of
the s4 allele and a higher frequency of the s2 allele205.
The decline in s4 between birth and middle age in the Scottish population
may reflect an increased mortality or morbidity of e4 carriers between these
ages. The s4 allele is known to be strongly associated with
hypercholesterolemia and atherosclerosis177. Both these conditions may lead
to ischemic heart disease which is a leading cause of premature mortality in
the Scottish population211.
Comparison of both perinatal cohorts reveal that there is an excess of s2 and
a corresponding decrease in s4 in perinatal deaths compared to those infants
who are born healthy and survive. Infants who are born alive but who die in
the first week of life appear to have the lowest prevalence of e3, with over-
representation both of s2 (resembling stillbirths) and of s4 (resembling
healthy newborns).
Support in the literature for a developmental association with different
APOE alleles comes from two studies in children and spontaneous abortions.
Zetterberg and colleagues found a decreased prevalence of e4 in early
pregnancy loss in Crete, 87% of which were in the first trimester40. They
proposed that e4 might have a protective effect in pregnancy. This suggestion
would be consistent with the study findings in healthy newborns. In addition
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the excess of s2 in extremely preterm perinatal deaths compared to s4
suggests that s4 may promote normal pregnancy outcome. Wright and
colleagues showed that infants with e4 have a better mental developmental
index at 2 years of age suggesting that the effects of e4 at an early age may
be beneficial rather than detrimental212. A similar effect of s4 on cognitive
function has also been shown in young children with chronic diarrhoea in
South America213 and in young adults where s4 has been associated with
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higher educational attainment and improved mental arithmetic scores
In contrast in this study, possession of one or more s2 alleles appears to be
detrimental to pregnancy outcome. s2 has historically been regarded as the
"good" gene with respect to Alzheimer's disease and ischaemic heart disease.
e2 was reported in an early study to be associated with pre-eclampsia214 but
this was not upheld in a subsequent study215. Although maternal genotyping
was not possible in the context of this study, no association between
offspring genotype and maternal pregnancy-induced hypertension was found.
The allele s2 is less often transmitted to babies who are small for gestational
age216 and such infants are more likely to develop cardiovascular disease
later in life217. This study however did not find any association between
birthweight centile and genotype among perinatal deaths.
The deleterious effects of s4 present late in life when the effects of natural
selection are weak. The negative effects of s4 at older ages may be
counterbalanced by beneficial influences during embryogenesis, infancy and
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the reproductive years in order to explain the relatively stable frequency in
adult populations. According to the antagonistic pleiotropic theory of ageing,
natural selection favours genes which confer short term benefits at the
expense of deterioration in later life218. Such opposing effects of the s4 allele
may result in beneficial effects in early development but detrimental effects
in adulthood.
The nature of this early protective mechanism is unknown. APOE appears to
have a wider relevance than simply its influence on lipid and cholesterol
metabolism. Mahley and Rail have speculated about a role for s4 in reducing
susceptibility to infection175. APOE knockout mice have an impaired immune
response and display a susceptibility to bacterial infections, in particular
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Listera and Klebsiella . s4 may also have an anti-infective role against
viruses, protozoa and fungi. It is well recognised that infection of the
chorioamnion is a common cause of spontaneous onset of labour in the
second and third trimester of pregnancy although fetal infection is a lesser
but nevertheless important cause of intrauterine death.
ApoE is critical to synaptogenesis in the developing brain and genetic
variants of APOE may therefore be associated with differential effects on
neurodevelopment. Although it has been shown that s4 may have detrimental
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effects on the maintenance of healthy neurites and neuronal cells
compared to e3, other studies have shown potentially beneficial effects on
neuronal survival. In a recent study by Ohkubo and colleagues, s4 and not e3
too
was responsible for the induction of many genes including the cell-protective
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gene, Bcl-2 . In addition, the appreciation that APOE is involved in some
intracellular signalling pathways and may have a role in apoptosis presents a
wide range of opportunity for influencing embryonic development175.
During the past two decades the role of essential fatty acids and cholesterol
in the developing brain has received increasing interest175. Although work
has concentrated mainly on the role of polyunsaturated fatty acids in growth
and myelination, there is mounting evidence to suggest that cholesterol is
essential to neurodevelopment. Apolipoprotein E is a key regulator of
lipoproteins and cholesterol. Isoform-related effects of APOE on cholesterol
may influence myelination and synaptogenesis in the developing brain.
This study has found an excess of s3 homozygosity among stillborn infants
who showed brain haemorrhage at autopsy. The relationship of APOE
genotype and haemorrhage and ischemic brain injury in adults appears to be
complex: e2 predisposes to haemorrhage in cerebral amyloid angiopathy but
this condition is commoner in carriers of the s4 allele224. Other forms of
intracranial haemorrhage do not share the same association. Transgenic adult
mice expressing human s3 have smaller cerebral infarcts after ischemia than
9 9^ 99 f\
mice expressing s4 . In humans, s4 is a risk factor for ischemic stroke
and results in a larger ischemic lesion on MRI227. Much of the isoform-
related risk in both ischemic and haemorrhagic stroke is thought to be related
to chronic disease processes, such as atherosclerosis and microangiopathic
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changes within the cerebral circulation. The association between APOE
genotype in the fetus and haemorrhage is more difficult to explain. A Finnish
study found that adolescent boys with the s4 genotype demonstrated less
evidence of cardiovascular stress, such as heart rate variability, when
subjected to a series of mental stressors228. Genotype-specific effects on
cardiovascular stability may predispose to haemorrhage within the
developing brain. However, it is important to note that grouping of APOE
genotypes may be an artificial approach and there may be confounding or
synergistic effects depending on the combination of alleles. Moreover the
assignment of s2/s4 to either s2 or e4 groups may be misleading.
Although the results of this study show differences between the studied
populations these differences in general are not large. It is highly possible
that these findings have occurred by chance. It is also impossible to exclude
confounding effects of neighbouring genes without performing whole
genome and linkage disequilibrium studies. In addition the causes of
perinatal mortality are notoriously heterogeneous and it is fanciful to
presume that a single genotype might hold the answer to all perinatal death.
A recent review in the Lancet has highlighted the thousands of genetic
polymorphisms which are tested for disease associations each week around
the world and that it would be expected for many associations that are
229
significant at 5% or less to have arisen by chance . These authors suggest a
much lower threshold of significance for such studies. It is emphasised that
genes act through complex networks involving gene-gene and gene-
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environment interactions and not in an additive manner and argue that
association studies will always be 'hopelessly simplistic and reductionist'.
Accepting that this may be true, the results of this study are however
consistent with others that show protective effects of s4 in early development
and these findings may warrant further investigation. It is increasingly
recognised that genetic factors that alter the host response to its environment
may be important during critical developmental windows that occur during
early life230. Both cholesterol and fatty acids are critical to nervous system
growth and maintenance, and genetic factors that regulate their metabolism
may influence this development. However the mechanism by which the
APOE gene influences survival in early development remains unclear and
future studies should address this. One approach may be to study the APOE
status at different gestations in the presence or absence of specific
pathological disorders, both generalised and organ-specific. Such studies




The neuropathology of a population of earl^
neonatal deaths *
Introduction
The origins of childhood neurological deficits are still poorly understood.
Complications of pregnancy and adverse peripartum events are common and
of uncertain but poor predictive value. Perinatal asphyxia in the majority of
cases is not followed either by neonatal encephalopathy or by cerebral
palsy7'10"14 and there is international consensus that encephalopathy and
cerebral palsy are infrequently caused by perinatal asphyxia (the
International Cerebral Palsy Task Force)15'231. Despite the clinical and
medicolegal significance attached to perinatal asphyxia, the
neuropathological basis of this condition remains obscure.
Major published cohort studies of neonatal encephalopathies and related
clinical conditions have shown that the associated factors are surprisingly
diverse58'59 but these studies seldom include neuropathological findings of
the deceased infants. On the other hand, reported perinatal neuropathological
studies usually represent the collected experience of specialist referral
centres20"24;232;233, or focus on particular age groups such as preterm infants26"
29. Only a small number of studies have investigated the clinical correlates of
identified neuropathological features30"32'234'235. Although in recent years
*
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neuroimaging has proved to be a powerful tool for studying the extent and
location of lesions in the perinatal brain33, neuropathological examination
may be better at defining the nature of lesions. There is a complete dearth of
studies designed to match detailed neuropathology with equally detailed
demographic data in unselected groups of neonates.
Perinatal neuropathology
Brain development is a continuum which starts at about three weeks after
conception with the formation and closure of the neural tube continuing into
the third decade. Damage may occur at any point during this period. The
fetal brain appears to be particularly vulnerable to injury and the patterns of
injury seen are quite distinct from those seen in adults and older infants. A
range of damage has been extensively documented over the last thirty years
and haemorrhage and damage to both white and grey matter are well-
described. Influential perinatal studies are described in table 5.1 and the
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What has emerged from both human and animal descriptive studies has been
the differential vulnerability of the developing brain to hypoxia and in
particular maturational, structural and functional differences. The brain of
the immature newborn has a greater susceptibility to subependymal/
intraventricular haemorrhage and white matter damage compared to the full
term infants in whom the grey matter of the cortex is preferentially affected.
Differences in the development of the brain blood supply means that the
germinal matrix with its rich network of fragile, poorly supported blood
vessels is a prime area for haemorrhage in the preterm infant whereas the
thin, compact, relatively poorly vascularised cortical ribbon is protected.
Reduced effectiveness of the cerebral autoregulation mechanism in infants,
particularly in the face of immaturity, systemic hypoxaemia and hypercarbia,
means that the watershed areas of the brain's arterial supply are particularly
susceptible to ischemic damage.
In addition to vascular factors, the metabolic activity and differentiation of
cells within an area affect the propensity for damage. For example, the
immature periventricular white matter exists on relatively active anaerobic
glycolysis. With ischemia, the relatively high glucose demand readily
outstrips the substrate supplies. The regional distribution of synapses using
excitatory amino acids plays a critical role in the distribution of hypoxic
injury throughout gestation. Glutamate is a major mediator of fast excitatory
neurotransmission and acts at various receptors, including the NMDA
receptor. The NMDA receptor is especially abundant in the developing brain,
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particularly in the striatum, hippocampus and neocortex. When this receptor
is stimulated in the rat brain with exogenous NMDA, the toxicity varies
according to the developmental stage of the brain. Damage proved to be most
severe when concentration of NMDA receptors is at its highest256. Not only
increased receptor density but receptor sensitivity or differences in the
compensatory or modulatory mechanisms may be important in glutamate-
induced toxicity.
Undoubtedly the response of the developing brain to injury is complex and
depends not only on individual vulnerability and ontogenetic differences but
also on the nature of the insult. Variation in the nature and severity of insult
can result in a spectrum of damage. In particular, classic experiments have
shown acute total anoxia results in severe injury to the brain stem nuclei
whereas partial anoxia causes parasagittal cortical damage93'257'258. These
experiments showed that animals may survive short periods of total anoxia
without histological change, but that damage increases with increasing
O r n. i rn
duration of insult ' . Others have shown that frequent brief episodes of
ischemia may result in more neuronal loss than one single insult of the same
total duration94.
Consequently, results of experiments which use a standardised insult may not
be easily extrapolated to the real life situation. In human gestation, an
isolated injury to a fetus may occur acutely at delivery, or at an early stage
of gestation. On the other hand injury may occur chronically or intermittently
ill
throughout gestation. Such a chronically compromised fetus may also sustain
an acute injury at delivery. The range of neuropathological changes may be
complex as a result, with lesions of different ages superimposed in one
region or co-existing in different areas in the brain. In addition, secondary
degenerative processes occurring from the time of damage until death may
complicate the neuropathological picture further.
Post-hypoxic cellular changes in the developing brain
A well-described sequence of events occurs within neurones and central
nervous system glia of the developing brain following a hypoxic insult. This
sequence has been documented in both human infants and animal models and
the merits and limitations of both situations are discussed.
The difficulty of relating pathological change to a hypoxic-ischemic injury in
the human infant is the uncertainty of knowing when exactly the insult
occurred and although many of studies of human infants have attempted to
document the sequence of cellular change following a clinical incident or
sentinel event, it is recognised that it is impossible to say whether the brain
was normal up until that point, when exactly during the peripartum period an
insult occurred and the exact nature, of the insult. As a result the response to
such heterogeneous injury observed may vary considerably.
Animal studies, on the other hand, have the advantage of a known timing and
severity of insult and presuppose normal brain development until the point of
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injury. Animal models should be expected to mimic the aetiological basis
through which such injury occurs, reflect the histopathological spectrum of
injury to the developing brain and ideally express the functional outcomes
seen in the newborn infant and child.
Since the classic experimental work of Windle in the late 1950s261'262 and
Myers in the 1970s 263 a variety of animal models have been studied
including sheep, pigs, rodents and non-human primates. A variety of insults
have been studied, from pure hypoxia-ischemia (HI) to experiments where
induction of seizures and hypotension have been introduced to more closely
mimic the human condition. The duration of insult has varied from acute to
chronic and intermittent insults.
Through such experiments, some difficulties in working with the animal
model have been encountered. The various stages in brain development occur
at different times across species. Myelination is complete by term in the fetal
sheep whereas in the human it begins midgestation and progresses until early
adolescence. In the rat, myelination only commences postnatally.
Proliferation, migration and the development of subplate neurons occur
earlier in humans than in most animal models. There are also ontogenetic
differences in neurotransmitters with development of the NMDA receptor
peaking at around 24 weeks in the human and 1-2 weeks postnatally in the
rat 264. In addition, rodent models of HI show wide interstrain variation in
susceptibility to HI damage after an identical insult suggesting genetic
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factors may be important 265. Piglets and sheep generally mature quickly and
therefore there may be difficulty in establishing relevance to the full term
newborn. Non-human primates may be more similar to humans but there
remain unresolved issues about scarcity, ethical issues and the relative
maturity of their brain at birth266. Many have found difficulty in keeping
animals alive long enough after a sustained hypoxic-ischemic insult to
investigate the cellular response and clinical outcomes.
Despite these reservations about the use of animals to study HI injury, there
has been tremendous progress over the last forty years enhancing our
understanding of the mechanisms of perinatal brain injury particularly at
biochemical and molecular levels and many experimental models have
contributed to this progress.
Over two decades of investigation into various degrees of intrauterine
asphyxia in Rhesus monkeys, Myers et al described 4 patterns of brain injury
closely resembling the changes observed in perinatally damaged humans. 263:
total hypoxic-ischemia with acidosis produced damage predominantly in the
brainstem; partial asphyxia with acidosis resulted in widespread cortical
necrosis; partial asphyxia without acidosis produced selective white matter
injury and partial prolonged asphyxia culminating in terminal total asphyxia
resulted in damage in the basal ganglia and thalamus. The non-human
primate model has also been studied in relation to white matter damage in the
immature brain. Inder et al have developed a premature baboon model which
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shows diffuse white matter damage and haemorrhage in the absence of an
experimental interventional insult and correlates well with human
findings267.
The sheep has also been used to study both grey and white matter damage.
Gunn et al subjected fetal sheep to repetitive and brief occlusion of the
umbilical cord of and showed that intermittent asphyxia resulted in greater
grey matter damage than a single asphyxial insult of the same duration.
When the episodes were repeated at much shorter intervals the damage
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became more diffuse and extensive . Others have shown maturational
differences in response to asphyxia in the white matter in the sheep which
parallels that seen in humans270'271.
Following the introduction of the Rice-Vannucci 7 day old rat model in the
1980s, this animal has become the most commonly used model for perinatal
272*
asphyxia . Histologically a gradation of injury is observed that correlates
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m a linear fashion with the duration/severity of the insult ' . This model
has been used extensively to study cerebral metabolism and the
proinflammatory response occurring secondary to asphyxia. Work in the
rodent white matter injury model has identified the oligodendrocyte
progenitor cell as the major target and as such has correlated the 2nd-5th
postnatal day in rats with 24-32 weeks gestation in the human as being the
most vulnerable for such injury 275.
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More recently interest has focussed on mechanisms of white matter injury
and the sheep has been used to investigate the role of infection and
inflammation in brain injury ' by injecting bacterial endotoxin into the
fetal sheep leading to preferential damage of white matter and in particular
oligodendrocytes. On the other hand, umbilical cord occlusion alone resulted
in neuronal necrosis in the hippocampus and striatum. More recently there
has been evidence of a synergistic effect between infection and hypoxia.
Mallard et al in the immature rat model showed that a combination of
intraperitoneal endotoxin and a mild asphyxial insult resulted in extensive
white matter damage, which could not be explained by simple additive
effects of infection and hypoxia278.
Other animal models have proved useful in studying the effect of fetal
growth retardation and placental insufficiency on the developing brain. In
both guinea pigs and lambs, chronic intrauterine hypoxia results in poor
brain growth and myelination with reduced neuronal numbers in the cortex
cerebellum279;280
The reactions detected in fetal animal brains in response to a variety of
insults including acute and chronic hypoxia, ionizing radiation, glutamate
analogues and ischaemic injury all lead to a similar sequence of responses
suggesting that the fetal brain responds to injury in a stereotyped fashion. It
is likely that a variety of insults trigger a final common pathway of damage
in the perinatal brain. The initial trigger event is more difficult to identify in
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the human fetus. Despite the limitations of the animal model, the sequence
and timing of post-hypoxic cellular changes are remarkably similar to those
of the human infant brain and have been documented comprehensively by
Ellis et al 281. The spectrum and evolution of post-hypoxic histopathological
changes are documented in tables 5.2 and summarised in table 5.3. Both
tables have been derived from the literature on human infants and key
cellular changes are elaborated below.
117




Banker(1967)describedcystsapp aringi e sofdamagedwhitett rt oe kafh insult. Ellisetal(1988)drewonth irwnexperie ceconcludt at4dayswr quired. Squier(2001)q otesthliteratureandheownexperi cesuggestingpe iodf14-42 days. Kinney&Armstrong(2002)describedaelaof"f wweeks".
ReactiveGliosis(whit matter)
3-11days
Roessman&Gambetti(1986)thoughta4dayswererequir dfohpp a ancef hypertrophiedastrocytesid ntifieca egoricallybGFAPimmu ocytoch mistry;s met me presentinsolatiobutstakeevid ncefaidamage).Astrocytichyperplas ac uld detectedasearly20weeksg stationbutth remo epron uncedre po ewi h increasinggestationalage.Th yr portedfocanddiffupatter s.et r commonlyaffectsthcerebral/cerebellarwhim tt rret yft ns wssivprolif atio ofastrocytes. Lowetal(1989)indicatedth t3-5d yswererequire . BankerndL rrochedescribedthearli stast ocytepr liferation12hou Gilles&Murphy(1969)thoughthathypert ophicast ocy esrequired3d yppearndw abletottributebraindamagheprena alriodt ssis,ovidedast ocyto is wasaccompaniedbyotherevidencefitmatterd gsuchgli lpykno is. Ellisetal(1988)xaminedveryc refullyseri soinf ntwhomastrocytosisagrad early,st blishedola e.Subtlrlyastrocytosiscoulbdetec enft rin t whereasenla gedandhypertrophicas cytesrequir3-5d ys. Norenberg(1994)concentrat dastrocyticeac ionsdth ughtsw rm ximalb4d ys afterinju yhumanscomparedwith24rr tod l-emphasiseth o situationswerenotcompa ableithehu nbr ilik yff rm reid sp ad damageandrequiredtocov rbefountingcell larreactions. Theconsensusithatreactiveastro ytosisr quireund3d yndib ,amagh beenascribedinseverale i stohpr natalr o . 119
ReactiveGliosis(greymatt r)
3-5days
Friede(1972)describ dagl alr sponseoccurringinpontos biculare ro is3-5dayft rth insult.Ifi fan swithpontosubicularnecro iss rvivednly1-2d y ,thgma tl al responsewaveryslight. DelBigio&ecker(1994)des ribedthl alresponseindamagednt tyrus"l g ingb hind" amicroglialresponsewhichitse frequired1-4d ys. Marin-Padilla(1999)emphas sedth tgr ytt rda gew srep irbylio is,unlikt matterwhichcavi ates,bufo ndth sphenomenono lyicomp rativelyl ng rs rvivo(w eks andmonthsfterthinsul ).DescribesbpialGMAA/Mgliosia dp st-injurytrans ormat on ofuninjuredadjacentGM. Kinney&Armstrong(2002)suggestedthat3-5dayswerrequifogrtt rlio isol w onneuronalc sisib thpre erma dmatureinfa ts.
MicroglialUpregulation
3hours -3days
Banker(1967)observedmicroglialinfilt ate8h ursaft rthons tfcoagulativeecros s. Norman(1978)foundrocellsinecroticwhitematterfo lyaf2-3d yf ll w ngnox episode. Ellisetal(1988),quotingnimalst diescomparedw hthe rownhustudi s,observ microglia1-3daysfterninsult. Lowetal(1989)bservedrodcel s36-72h ufterypoxicepiso e. DelBigio&ecker(1994)observedanincr asenumb rfodc l slywh ns rvi al exceeded4daysfollowingninsultwhichhproducedgr ymatt ri farc s.Thtquo s resultsinanimalexperimentswheremic oglialu regul tionaobservedtcom ence approximately1dayfterthinsult,becomingm xi alt4ys.
MacrophageInfiltration
3-7days
Banker(1967)observedmacrophagesnlyw kaft rdocumentedinsult. Friede(1972)observ dmacrophagere p nses(f amyc llinr lationtpontosubicularda g 4-5daysfterthonsetfpresumedclinicalinsult. Ellisetal(1988)documentedarly,midd endl tst g sfromth irwnobserva ionsf macrophagefor ationndrelatedthisan malstudi s. Squier(2001)observedmacrophagesnly4-5d ysaft rinj y. Kinney&Armstrong(2002)suggest d3-5daywerequirfoacrophageresponsi relationtopontosubicularnecr sis,resumablybasednth irwexper ence. 120
HaemosiderinD posits
2-3days
Ellisetal(1988)foundthathaemosiderinst iningacrophagesaccom an dt ppear cef macrophageswit inndar undhaemorr giclesi nsthatisch ereq ir d3d y appear. Squier&Keeling(1991)s ggestthatpr s nceofigme tedmacrophagesar u haemorrhagesrequiratl ast2d ys. Vanesis(2001)stateth thaemosid rinc n ai ingacrophagesafou dwitbr in3-4 daysfterinju yndthislateanomeothetis s.V n sisempha storel a ce shouldbeplaceonanimaltudi sith sregarincerv ryco s erableintersp i s variation.
Mineralisation
3-14days
Norman(1978)believedthatferruginationfn uro scouloccur3daysp stins lt.H weve otheraut orsh vllssumedlonginter a . Ellisetal(1988)observedthatperiodf4d yw srequirf ppea ance perivascularminera isingfocithkitt nodel.T e ,a dmphophi icgl bules,yb foundinassociationwithhi emattergliosis(Gille&M rp y,1969)h vbeenstd t theonsetfdamageiprenataleriod. Ellisetal(1988)thoughtatneuronalferruginationr quiredmo4d y . Squier(2001)tho ghtatmineralisationrequ red8-14day .Amphophilicglobul si ndr n thewallsofsmallvesselsm yrepr sentleak dplasmarot in . 121
Table 5.3. Timing of CNS Injury after cerebral insult
Pathological Feature Timing of Onset
after Injury
References
Neuronal eosinophilia 6-24 hours 282-284
Neuronal karyorrhexis 12-48 hours 283:285-287
Infarcts - necrosis 3-8 hours 281 ;282;287;288
Infarcts - cavitation 14- 42 days 32;289-291
White matter gliosis 3-11 days 26:27;232;248;292;291 ;293;294
Grey matter gliosis 3-5 days 22;239;291;295
Microglial upregulation 3 hours - 3 days 32;248:289:292;295
Macrophage infiltration 3-7 days 32:239:289-291
Fresh haemorrhage minutes 32
Haemosiderin deposits 2-3 days 23;32;296
Mineralisation 3-14 days 32:232:292:297
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Neuronal eosinophilia and nuclear karyorrhexis
Following neuronal ischemia, vulnerable neurons undergo a sequence of
characteristic morphological changes. Neurons show microvacuolation in the
first hours followed by marked cytoplasmic eosinophilia from around 6
hours. Nuclear karyorrhexis ensues from 12 hours onwards. Karyorrhexis is
the process by which the nucleus of a dying cell breaks up into a number of
rounded particles. Primary cell necrosis may result in nuclear karyorrhexis as
well as nuclear karyolysis, or pyknosis. Karyorrhexis may also occur as the
end stage of apoptosis, a form of active cell death mediated by a cascade of
intracellular enzymes. The nucleus initially becomes round and shrinks with
intense nuclear basophilia. Breakdown of nuclear chromatin ensues at around
12-24 hours and membrane-bound fragments of the cell are subsequently
phagocytosed by adjacent cells. Apoptosis is the mechanism of programmed
cell death by which cell numbers in the brain are regulated. Although most
cell death following hypoxic-ischemic insult occurs by primary necrosis, it is
increasingly recognised that cell death also occurs due to activation of
apoptosis. This is especially true of immature, less differentiated cell types
but may also occur within the context of milder injury.
Astrocytic change
Astrocytes are the most numerous cell element of the brain, outnumbering
neurons 10 to 1 and occupying one third of the cerebral cortex294. They are
not structurally independent but organised in a network interconnected by
gap junctions. They are not morphologically static as their shape may be
123
influenced by interactions with neurons, neurotransmitters and by state of
hydration. They have important roles in neuronal migration, neurite
outgrowth, synaptogenesis and synaptic plasticity, maintenance of the blood
brain barrier, provision of energy and nutrient support of neurons, regulation
of water ion and neurotransmitter metabolism, modulation of immune and
inflammatory responses and phagocytic functions. There are also specific
enzyme systems which enable astrocytes to metabolise ammonia, glutamate
and free radicals, protecting the brain from the toxicity of these agents.
Astrocyte swelling is very common and is probably the earliest response to
CNS injury, occurring in response to a wide variety of insults294. This is
followed by enlargement and proliferation of astrocytes a process which is
thought to require between 3 and 5 days. The nucleus is often enlarged and
irregular with multiple small nucleoli and an increase in chromatin. Although
astrocytic hyperplasia has been detected in brains of fetuses as early as 20
weeks gestation, the magnitude of the response increases with increasing
90"?.
maturity and postnatal age . (Prior to 20 weeks, the predominant reactive
cell is the macrophage). Protrusions of long astrocytic cytoplasmic processes
that will later form the 'glial scar' subsequently occur. Distinction must be
made between reactive astrocytic proliferation and immature glia, immature
migrating neurons and 'myelination gliosis' (oligodendroglia
2 3•292
precursors) ' . Myelination glia have a rim of pale basophilic cytoplasm
and the cells may be arranged in rows. Reactive astrocytes on the other hand
are less orderly in their arrangement, have abundant eosinophilic cytoplasm
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and characteristically have long cytoplasmic processes24'32'293. In addition,
reactive astrocytosis is usually accompanied by macrophage reaction,
haemorrhage, coagulation necrosis and the presence of amphophilic globules.
Amphophilic globules are small deposits seen most commonly in vessel walls
but also in the parenchyma, and are most frequently seen in more mature
infants who have survived longer26'27. They are thought to represent
mineralising plasma proteins which have leaked through damaged blood
vessel endothelium. However accurate identification of reactive astrocytes is
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best done using immunocytochemistry for glial fibrillary acidic protein
which is the main biochemical constituent of the glial filaments found in
astrocytes.
Microglial proliferation
The microglia are derived from blood monocytes that migrate into the brain
tissue during fetal development and subsequently remain after complete
formation of the blood-brain barrier. In the fetal brain they are present from
the twenty-first embryonic day and increase steadily in number through
gestation and postnatally. In addition to astrocytes and oligodendrocytes,
microglia represent the third major population of glial cells within the CNS.
They form a network of resident macrophages with a capacity for immune
surveillance and control. Microglia are distributed ubiquitously throughout
the brain and spinal cord, and a key function is to monitor and sustain
neuronal health. Microglia are extremely sensitive to virtually any insult
within the CNS and proliferate accordingly within hours32'236'248'295. When
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activated they are small elongated rod shaped cells with two or three
branches emanating from each end. In most pathological settings the
microglia are aided by infiltrating haematogenous macrophages which are
evident within the CNS 4-5 days following injury239'290. Activated microglia
are mainly scavenger cells, ingesting cell debris and contributing to cyst
formation. Phagocytosis can be observed at 4-6 days and the accumulation of
lipid material within these cells gives them a 'foamy' appearance. They take
up and break down red cells, and the resulting haemosiderin-laden
macrophages may persist for years after injury as a lasting record of previous
haemorrhage.
Capillary proliferation
The endothelial cells of capillaries become swollen in the first few days
following an injury, they show evidence of reduplication and their nuclei
become more rounded. There is subsequent proliferation of capillaries at 5-8
days.
Mineralisation
Mineralisation is identified as basophilic granules within macrophages,
neurones and processes and is first seen around 7 days of injury32;290.
Although classically associated with viral infections, it is also seen in the
thalamus and in areas of old infarction secondary to hypoxic-ischemic
damage.
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Incidence of prenatal brain damage
Studies determining the incidence of prenatal brain damage have applied the
literature on post-hypoxic cellular changes to establish the duration of injury
observed (table 5.1). Injury occurring in utero prior to the death of a fetus
has been frequently seen in studies of stillborn infants, manifest as ischemic
white matter damage, established infarcts, widespread cystic change and old
haemorrhage23;30;237;248;252;253. In fact, any neuropathological changes
observable in the brains of stillborn infants must have predated death by
some hours. The exception to this is haemorrhage which may occur acutely
as a terminal event. The incidence of such established damage ranges from 1-
44% 23>234 of all stillbirths and up to 85% of macerated stillbirths252.
Among studies of neuropathological abnormality in neonatal death there is
much heterogeneity of subjects. Some studies have focussed only on preterm
or low birth weight infants 26-27'254,298^ 0thers have restricted examination to
all early NNDs32'245. Some researchers have selected deaths related to
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particular conditions such as asphyxia ' , respiratory distress
syndrome237'242 or intraventricular haemorrhage245'299. Timing of damage
however may be difficult to ascertain where the infant has survived for many
days or weeks and where duration of labour is unknown. Incidence of
damage occurring prior to the delivery has been found in these studies in up
to 75% of preterm neonatal deaths245 and in up to 48% of full term neonatal
deaths32.
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There are three neuropathological studies dedicated to asphyxia-related death
in the literature. Nakamura et al studied 26 preterm and full term infants
dying from severe asphyxia at less than a week of age. Five infants had
evidence of periventricular leucomalacia, and 13 infants who had survived
for 2 days or less had pathological astrocytosis in the white matter as
observed with GFAP staining. Macrophages were present in three of these
infants243. Low et al studied 120 asphyxia-related stillbirths and early
neonatal deaths. 'Asphyxia' was not defined but the authors allude to acid-
base studies. In all cases the duration of labour was known and clinical
antepartum detail recorded. Sixteen cases had evidence of CNS injury other
than haemorrhage. Seven (6%) infants had evidence of established brain
injury characterised by histopathological changes which predated the onset
of labour . A Dutch study attempted to correlate neuropathological
observations with USS251 and subsequently with MRI findings33. Three out
of 21 (14%) infants dying from severe HIE showed evidence of antenatal
brain damage.
Antenatal brain damage as detected by fetal imaging has been widely
reported. In particular, ultrasound has demonstrated the presence of fetal
intraventricular haemorrhage and parenchymal echodensities300. A large
French study of antenatal magnetic resonance imaging in 400 patients
demonstrated the presence of ischemic and haemorrhagic lesions as well as
the more subtle disorders of neuronal migration301. Postnatal MRI and
ultrasound have also identified the presence of established antenatal brain
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injury in newborn infants, confirmed subsequently at post mortem33'146'255.
Some studies have attempted to correlate radiological diagnoses made during
life with post mortem neuropathological features33'251'302"304. Newer
technology and increased user experience has led to improved detection of
perinatal brain damage during life. It is accepted that MRI has superior
sensitivity for neuropathological damage than ultrasound examination305'3
which may miss up to 72% of parenchymal abnormalities. With newer MR
modalities such as diffusion-weighted imaging (DWI), acute disturbances
within brain tissue can be observed. However post mortem remains the gold
standard in the diagnosis of brain injury. In particular, histological changes
such as inflammatory cell infiltration and increased cell death are easily
missed by MRI302. Even with T2 sequencing and DWI around half of all
histologically ascertained damage may be underestimated or overlooked by
mri303;304.
Clinical correlation of neuropathological change
The fact that brain damage can occur in utero is undisputed. Both
neuropathological and imaging studies have clearly demonstrated this. In
addition, the majority of full term children with cerebral palsy have a normal
perinatal history but investigation into their mother's pregnancy often
reveals adverse features89. The aetiology of this damage, however, is less
well understood. The fetus within the womb is relatively protected from the
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investigative eye and though our ability to monitor the fetus with
cardiotocograph monitoring, acid-base studies, ultrasound and Doppler
studies has advanced significantly over the last quarter of a century, many
adverse events occur unnoticed. Although obstetricians are adept at
identifying high risk pregnancies, many stillbirths occur in pregnancies
deemed to be low risk or uncomplicated161,307.
Few researchers have sought to correlate neuropathological findings with
antenatal clinical features. Larroche categorised lesions depending on
whether maternal, fetal or placental/cord factors were responsible. In
particular she discusses the contribution of twinning to disrupted
morphogenesis early in gestation and to ischemic lesions in the second and
third trimesters308'309. Necrosis of the cerebral white matter is well described
in multiple gestations and is far commoner in monozygous twins310. In a
review of the 53 surviving monozygotic twins whose pair had died in utero,
72% had an abnormality of the central nervous system311. This predilection
for poor neurodevelopmental outcome in the surviving twin persists when
one twin dies in infancy312. Placental anastamoses may lead to imbalance of
flow between twins throughout gestation, resulting in single or recurrent
episodes of hypoperfusion. Ischemic damage to the brain and other organs or
even death may subsequently occur.
Sims and co-workers examined the histories of 25 stillborn infants found to
have evidence of gliosis with or without haemorrhage and found that 36% of
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these had evidence of chorioamnionitis compared to 20% of the 408 stillborn
infants without any brain damage234. One infant with haemorrhage was found
to have cerebral artery emboli and the authors suggest that these could have
originated in association with placental vasculitis. Leviton found that 85% of
infants who had evidence of antenatal white matter necrosis at post mortem,
had had a terminal gram negative bacteraemia313.
Murphy and colleagues reviewed the histories of 83 very preterm infants who
died in the first six months of life254. They could find no clinical associations
with antenatal ischemic white matter brain damage but neonatal sepsis,
necrotising enterocolitis, pre-eclampsia and IUGR were all associated with
the development of postnatal damage (ORs 4.6, 25, 11 and 5 respectively).
This association with pre-eclampsia is in contrast to studies that show an
inverse association with intraventricular haemorrhage314 and with the later
development of cerebral palsy142'315. Studies examining the association of
pre-eclampsia with brain injury often fail to consider treatment effects of
drugs such as magnesium sulphate. In addition, studies analysing risk by
birthweight may overlook the effect of pre-eclampsia on fetal growth.
Gaffney and colleagues investigated the clinical association of prenatal white
matter injury in 274 cases of perinatal death. Twenty percent of this cohort
had evidence of prenatal brain damage. The mothers of these infants were
more likely to be unmarried (OR 2.5) and to have had an antenatal diagnosis
of intrauterine growth retardation (OR 2.7) or oligohydramnios (OR 2.9).
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Indicators of fetal distress such as meconium staining and abnormal
cardiotocograph were more common in infants with antenatal brain injury
(ORs 6.8 and 12.4 respectively) as was a severely depressed 5 minute Apgar
score (OR 3.2)30.
Ellis and co-workers studied 89 early neonatal deaths and found prenatal
brain damage to be more common in full term infants compared to preterm
infants (48% vs 16%). Oligohydramnios appeared protective while
polyhydramnios predisposed to prenatal brain damage among the full term
cohort. The group found no other clinical associations with prenatal brain
damage32.
These studies show that despite the relatively high prevalence of antenatal
brain damage in infants dying around the time of birth there are conflicting
and inconsistent reports of factors responsible for this damage. Imaging
studies of brain injury diagnosed during life suggest that infection and
multiple gestations are important risk factors. Bejar et al classified 18% of
preterm infants as having sustained antenatal white matter necrosis as
diagnosed by postnatal ultrasound scan. Clinical associations were low birth
weight, placental anastamoses in multiple gestations, purulent amniotic fluid
and funisitis146. Others have found associations between ultrasound
abnormalities and infection parameters such as chorioamnionitis, funisitis,
increased inflammatory markers and neonatal sepsis316"318.
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As previous pathological studies have studied selected groups of infants, or
have been hospital-based, therefore representing the experience of specialist
centres, the aim of this study was to examine the prevalence of brain damage
occurring within an entire population of neonatal deaths. Previous published
literature on the clinical associations of perinatal brain damage is scarce and
this study aimed to provide additional information about the clinical
associations of brain damage within this population of perinatal deaths, with
a particular focus on the differences between asphyxiated infants and those
born in a good condition.
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Aims
1. to investigate the neuropathological status in a population of early
neonatal deaths in whom a post mortem was authorized, and to determine
whether lesions could be of prelabour origin
2. to determine whether infants who have pre-existing brain damage are more
likely to be born in an asphyxiated condition
3. to compare the antepartum and intrapartum course of early neonatal deaths
born with birth asphyxia, with and without pre-existing damage
Methods




Of 137 early neonatal deaths with a full clinical dataset, 88 (64%) had
consent for autopsy and 70 (51%) had consent for the additional
neuropathological investigations required by the study protocol. Of these 70,
53 were classified as asphyxiated (BA, including 23 mature infants > 37
weeks and 30 preterm, 24-36 weeks) and 17 did not appear to be asphyxiated
(noBA, three mature > 37 weeks, 14 preterm infants 24-36 weeks) (Figure 1,
Chapter 1). The mature infants lived for between 15 minutes and 7 days with
only three surviving for more than 3 days. The preterm infants lived between
5 minutes and 6.8 days with only eight infants surviving for more than 3
days. The ratio of asphyxiated (77%) to non-asphyxiated (23%) was slightly
skewed though not significantly in the group of autopsied infants towards
asphyxiated cases when compared with the whole cohort of liveborn infants
included in the detailed epidemiological survey (n=137, 66% asphyxiated,
34% non-asphyxiated).
2. Neuropathological findings
The prevalence of neuropathological findings of the cohort of 70 infants are
shown in table 5.4, subgrouped according to whether they showed asphyxia
or not (53 vs 17) and according to their gestation (mature vs preterm).
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Table 5.4. Histological evidence of brain damage in 70 early
neonatal deaths
Asphyxiated infants Non-asphyxiated infants
(BA) (noBA)
n= 53 n= 17
Mature Preterm Mature Preterm
n=23 oCOIIc n=3 n=14
Neuronal Eosinophilia 14 (61%) 9 (30%) 2 5 (36%)
Neuronal Karyorrhexis 11 (48%) 8 (27%) 0 0 (0%)
Grey Matter Infarcts 1 (4%) 3 (10%) 0 0 (0%)
White Matter Gliosis 11 (48%) 14 (47%) 2 0 (0%)
Grey Matter Gliosis 7 (30%) 5 (17%) 1 0 (0%)
Microglial Upregulation 9 (39%) 14 (47%) 1 1 (7%)
Macrophages 9 (39%) 14 (47%) 0 0 (0%)
Haemorrhage, Fresh 11 (48%) 19 (63%) 0 8 (57%)
Haemosiderin Deposits 0 (0%) 1 (3%) 0 0 (0%)
Mineral Deposits 2 (9%) 8 (27%) 2 1 (7%)
Assessment of neuronal damage was initially undertaken in sections stained
with haematoxylin and eosin. Recent onset hypoxic change as indicated by
neuronal eosinophilia [Fig 5.1], page 134, was seen in some or all
differentiated nerve cell bodies in the cerebral cortex, basal ganglia, brain
stem, particularly in the ventral pons and inferior olive, and in the cerebellar
dentate nuclei and Purkinje cell layer. Neuronal karyorrhexes [Fig 5.2] were
observed in a similar distribution but the dentate gyrus of the hippocampus
and the cerebellar granular layer was also affected in occasional cases. If
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neuronal karyorrhexes were only present infrequently, they were considered
indistinguishable from the normal apoptosis known to occur during brain
development and were disregarded. Even when present in large numbers, the
changes affected only a subpopulation of neurons in the neocortex but were
more numerous and concentrated in the subiculum of the temporal lobe
(spreading to involve the entorhinal cortex and the neighbouring sectors of
the cornu ammonis) and in the ventral pons. The most severely affected
cases showed loss of most Purkinje cells [Fig 5.3] within the cerebellum.
Neuronal eosinophilia was identified in 43% of the cohort and karyorrhexes
in 27%. Cortical infarction with prominent neovascularisation and
perivascular fibrosis [Fig 5.4] was observed in occasional infants. Figs 5.5-7
show focal and diffuse macrophage responses in the context of neuronal loss,
not all of which had been suspected on routine staining but which were
identified with immunocytochemistry [Fig 5.6]. A conspicuous glial
response was also seen in conjunction with cortical damage [Fig 5.8],
Evidence of white matter damage in routinely stained sections was present in
24% of cases. This ranged from widespread homogenous eosinophilia of the
neuropil to areas of clear focal infarction. In three cases of infarction, axonal
retraction bulbs [Fig 5.9] were identified with more widespread surrounding
white matter damage. Moderate numbers of karyorrhectic glial nuclei were
identified within damaged white matter, and these were accompanied by
infiltration of macrophages and astrocytic hyperplasia [Fig 5.10]. Even if
white matter appeared normal [Fig 5.11], unexpected astrocytic hyperplasia
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was sometimes revealed by GFAP immunostaining [Fig 5.12], This was
different from the normal white matter astrocytic immunoreactivity in this
age group [Fig 13], No clear foci of cystic periventricular leucomalacia were
observed.
Small foci of perivascular mineralisation were present in the central white
matter in 19% of the total cohort, more commonly in the preterm infants.
One infant displayed extensive mineralisation in the basal ganglia and
internal capsule (case 20).
In nine cases, glial nuclei in both white and grey matter were enlarged, pale
and prominent [Fig 5.14] resembling the Alzheimer type II astrocytes
observed in hepatic encephalopathy. Although the cytoplasm of such cells
was not generally prominent, they were GFAP positive [Fig 5.15] and in
most of these cases a reactive astrocytosis was confirmed in the white matter.
Some mature neonates showed prominent changes of so-called myelination
gliosis [Fig 5.16] but such cells did not prove to be GFAP reactive in
contrast to juxtaposed normal astrocytes [Fig 5.17]. Interpretation of such
cases sometimes proved difficult on routine staining especially in the
presence of incipient white matter damage and GFAP staining proved
essential for the detection of true astrocytic hyperplasia.
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3. Estimation of prelabour brain damage
In those cases where brain damage was present, a conclusion as to whether
this was likely to be of prelabour origin could be achieved only in infants
dying < 3 days from the onset of labour. This was based on the presence of
abnormalities thought to first appear approximately three days after brain
injury. There is no absolute certainty regarding the time needed for the
different responses to become visible (Table 5.3) but the presence of
accumulations of macrophages and/or prominent astrocytic hyperplasia in
human white or grey matter is generally assumed to require 3 days or more
(Table 5.2).
Fifty-nine infants died at or before 3 days from the onset of labour, 43% of
those with a full clinical dataset. Of these 59 infants, 46 were asphyxiated
(BA) and 13 were born in a good condition (noBA). Twenty-one of the BA
group and 11 of the noBA group were preterm (Figure 1, Chapter 1). Table
5.5 shows the prevalence of neuropathological abnormalities in these 59
infants. This table has been further subdivided according to whether
encephalopathy was one of the features of asphyxia or not.
Damage occurring before the onset of labour was observed in 27 (39%) of
the entire cohort and almost exclusively in those who were asphyxiated at
birth. Twenty-six (57%) of the asphyxiated group had evidence suggestive of
prelabour brain damage (PBD) compared to 1 (8%) of the non-asphyxiated
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Table 5.5. Histological evidence of brain damage, including






















8 (100%) 1 5 (38%) 4 (17%) 0 4 (36%)
Neuronal
Karyorrhexis
8 (100%) 1 1 (8%) 4 (17%) 0 0
Grey Matter
Infarcts
0 0 0 0 0 0
White Matter
Gliosis*
7 (88%) 1 4 (31%) 9 (39%) 1 0
Grey Matter
Gliosis*
5 (63%) 1 0 1 (4%) 0 0
Metabolic
astrocytosis
3(38%) 1 1 2(9%) 0 0
Microglial
Upregulation
6 (75%) 1 2 (15%) 9 (39%) 0 1 (9%)
Macrophages* 7 (88%) 1 1 (8%) 8 (35%) 0 0
Haemorrhage,
Fresh
4 (50%) 0 6 (46%) 11 (48%) 0 5 (45%)
Haemosiderin
Deposits
0 0 0 0 0 0
Mineral
Deposits*
























26 (57%) 1 (8%)
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group - a highly significant difference - p<0.005. It is important to note that
of the 27 infants judged to have suffered prelabour brain damage, only four
of them had survived for more than 2 days, six had survived between 1 and 2
days and all the rest (65%) had survived for less than 1 day from the onset of
labour.
4. Correlation of Neuropathology Findings with Clinical Features
Neuronal eosinophilia was no more common in asphyxiated infants (23/53,
43%) than in non-asphyxiated infants (7/17, 41%, p=0.87) (Table 5.4).
However this feature was detected more frequently in mature (16/26, 62%)
than preterm infants (14/44, 32%, p=0.015). In contrast with neuronal
eosinophilia, neuronal karyorrhexes were significantly increased in
asphyxiated infants (19/53, 36%) compared with non-asphyxiated infants
(0/17, 0%, p <0.01) and were also more prevalent in mature (11/26, 42%)
than in preterm infants (8/44, 18%, p=0.08) although not significantly so.
These observations remained consistent in the subgroup of 59 infants dying
less than 3 days old (Table 5.5). In both mature and preterm infants, the
asphyxiated infants were more likely to show brain damage than the non-
asphyxiated, although brain damage was not universally present in
asphyxiated infants (Tables 5.4 and 5.5, Figure 1). Some infants showed
evidence of ongoing brain damage with recent events such as neuronal
eosinophilia and fresh haemorrhage superimposed on older lesions including
established infarcts, macrophage accumulation including cells laden with
haemosiderin, extensive micromineralisation and white matter gliosis.
Infants with no evidence of asphyxia at birth (mostly preterm infants) were
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more likely than asphyxiated infants to appear virtually normal on
neuropathological examination, and such changes as were present, including
haemorrhage and neuronal eosinophilia, appeared to be recent apart from two
mature infants who displayed prominent gliosis.
Encephalopathic infants (Table 5.5) showed a particularly high prevalence of
neuronal eosinophilia and karyorrhexes (9/10, 90%). White matter damage
was significantly more common in encephalopathic (9/10, 90%) than in non-
encephalopathic asphyxiated (13/36, 36%) and non-asphyxiated (1/13, 8%)
neonates (p=0.001). Encephalopathy was significantly associated with white
matter gliosis (p=0.001), with macrophage reactions (p=0.002) and with
metabolic astrocytosis (p=0.024) but not with mineral deposits. The minor
differences in white matter micromineralisation between asphyxiated and
non-asphyxiated infants was not significant. Table 5.5 also highlights the
fact that many of the brains of non-encephalopathic asphyxiated infants were
apparently undamaged before the onset of labour and that even by the time of
death in the postnatal period, 31% of mature and 13% of preterm asphyxiated
infants in this subgroup showed no histological abnormality. Although the
non-asphyxiated infants appeared to be more prone to postnatal or
intrapartum damage, this difference was not significant (p=0.059).
Prelabour brain damage tended to be found more often in mature infants
compared to immature infants (14/23, 61% vs 13/36, 36%, p=0.063).
Unsurprisingly, the preterm infants were more susceptible to damage of
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recent and likely postnatal origin than were mature infants.
5. Prelabour brain damage and the signs of birth asphyxia
Table 5.6 shows the pathology of prelabour brain damage related to the
criteria used for birth asphyxia. Although the strongest clinical association
with the features of prelabour damage is the development of a neonatal
encephalopathy following a low pH and a poor Apgar score at 5 mins, it is of
note that of the 21 infants who had only a low Apgar score and then died and
had a post mortem, 8 showed brain damage.




Clinical PM* at PM
Preterm
Total PBD
Clinical PM* at PM
Single feature of asphyxia
Apgar <5 at 5 mins
Cord pH < 7.1


















2 features of asphyxia
Apgar and low pH
Apgar and NNE













3 features of asphyxia
Low pH, low Apgar and NNE 11 8 8 4 2 1
TOTAL 31 21 13 59 25 13
NOTE: * A total of 47 infants that died at 3days or less of age = PM, but 1 FT infant with
prenatal damage had no asphyxia
PBD- prelabour brain damage, NNE- neonatal encephalopathy, PM- post mortem
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All eight infants died within two hours of life, before acid-base studies were
performed. By this evidence, a low Apgar score was the sole clinical
indicator of PBD in 3 of 13 of mature infants and in 5 of 13 of preterm
infants. Only 16 mature and 19 preterm infants of 137 infants survived to 12
hours and remained non paralysed; of these, 14 mature and 6 preterm infants
had an encephalopathy. Looked at another way, 14 full term infants had
NNE. Eight of these had a post mortem and all had evidence of PBD. Only 6
PT infants had NNE. Of the two who had a post mortem, only 1 had PBD.
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Table 5.7. Clinical cause of death in 59 infants surviving < 3days
with signs of asphyxia* and presence of prelabour brain damage























































* Note: See page 19 for definitions of asphyxia
Infants with congenital anomalies and preterm infants who died from
respiratory complications were more likely to appear in poor condition at
birth but did not ultimately show evidence of prelabour brain damage.
6. Clinical Factors Associated with Prelabour Brain Damage (PBD)
Sociodemographic, pregnancy, delivery and postnatal characteristics of
infants with putative prelabour brain damage are described case by case in
Table 5.8. Details are given of neuropathological findings.
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1.Normal 2.AbnormalCTG,IOLover4d,rupturet us 3.Apgar45,H6.91Seizures,isoelectricEEG cerebralo demanUSS,di d32h
32hours
Cerebralo dema;n uronal eosinophilia&karyorrhexis;mic ogli l activation&fo lmacrophage infiltrationWM.
2
42(-)















1.Normal 2.Meconium,abnormalCTG,rupturedter s 3.Apgar0105,H6.8,HIE,died15hou s
28hours
Cerebralo dema;fresh microhaemorrhages,neuronal eosinophilia&karyorrhexis;micr gli l activation;WMglios s&damage.
6(E)
40(+)
1.Normal 2.PROM,meconium,abn rmalCTGinf tion 3.Apgar15,H6.86,HIEisoelect icEEG,seizures, died42h
61hours
Neuronaleosinophilia&karyorrhexis; WMdamage;microglialactivation& macrophageaccumulation;fo ally glioticWM.
7(E)
40(+)











1.Normal 2.AbnormalCTG,c rdprolapse 3.Apgar0125,H6.79HIE,cereb aloedeman USS,isoelectricEEGdi d14h
21hours
Cerebralo dema;n uronal eosinophilia;WMgl osis&amph ilic globules.
9
40(+)
1.APH6,29wks 2.Cordhaemor hage 3.Apgar05,diedat1h
2hours









1.LossFM32,39wks,essentialHT 2.Nolab ur,meconium,abCTGfetomaternalbl d 3.Apgar45,H7.06,HIEgradedie14h
14hours
Neuronaleosinophilia&karyorrhexis; greymatterliosis;ic oglialact vation andmacrophageaccumulation.
12(E)
38(+)
1.Unbooked,severePIH 2.Nolab ur,abnCTGmultipleplace talinfarctions 3.Apgar0125,H6.57seizu es,HIEgr d,bilateral echogenicityonUSS,died17h
17hours
Cerebralo dema,n uronaleosinophilia &karyorrhexis;WMgliosis macrophageaccumulation.
13(E)
38(+)
1.Lossfetalmovements38/40 2.Nolab ur,abn rmalCTGfetomate alble d 3.Apgar0105,H6.8,severeHIEdi d43h
43hours
Germinalmatrixhaemorrh ge;neu onal eosinophilia&karyorrhexis;WM damage&gliosis;icr glialact vation &macrophageac umulation.
14(E)
37(+)
1.Smoking 2.NoLab ur,a n rmalCTGute inerupt r 3.Apgar0105,H6.69isoelectricEEGHIE,di d 35h
35hours
Cerebralo dema;n uronaleosinophili &karyorrhexis;gliosisymatter microgliala tivation&macr phage accumulation.
15(E)
36(+)
1.Smoking,multiplepregna cy,APH30-36wks 2.Greenvaginaldischarge,omplexs ould r presentation,abnormalCTG 3.Apgar0135,H6.9,HIEabnormalback roundEEG, died45h
53hours



















1.PreviousSB,unbooked,massivf talasciteson USS 2.Nolab ur,meconium,abn rmalCTG 3.Apgar15,H6.81,abnormalneurology,died8h
8hours
Mineraliseduronsibasalg nglia; freshmicrohaemorrhages;neuronal karyorrhexis;WMgliosis& macrophages.
19
32(+)
1.Knownduodenalatresia,amnioreduction, polyhydramnios,anten talst roidseverePIH2 2.Nolab ur,abn rmalCTG 3.Apgar0105,H6.9died1h
1hour
Cerebralo dema;microminer lisation; focalwhitematterda ge;WMgliosis.
20
28(+)
1.Twinpreg,antenatals roids,hyd op c1stt i 2.Breech,meconium 3.Apgar15,died2h
7hours
Microhaemorrhages;basalganglia micromineralisation;WMdamage& gliosis;focalmacr phagea cumulation.
21
28(+)
1.Smoking,oligohydramnios,IUGRanten talsteroids 2.Nolabour,abn rmalCTGbreech 3.Apgar95,H7.09,Abnormaleurology,USS showedIVH,PVLdied70h
70hours
Germinalmatrixha orrhagew th thrombosedvess ls;WMinfarction& gliosis;neuronaleosin ph lia& karyorrhexis;mac ophage accumulation.
22
27(+)
1.PreviousSB25wk ,antenatalsteroids, oligohydramnios,IUGR 2.Nolab ur,meconium,abn rmalCTG 3.Apgar45,died<1h
0.5hours









1.Smoking,lowAFP,oligohydramnios,PH9/40 grade3placentavia,ROM26/40suspec ed infection,bicornuateuterus 2.PROM,breechabnormalCTG 3.Apgar75,H.02,died11h
29hours
Microhaemorrhages;f cal microglialactivation&macr phage infiltrationofWM.
24
25(+)
1.Severemate nalv ric lla,heavilysedat dnd ventilated,anten alsteroids 2.Breech,deliv redunexpectedlyiadulITU 3.Apgar0145,H6.9seizu es,sevePVHdi d51h
51hours
Neuronaleosinophilia&karyorrhexis; germinalmatrixhaemorrh ge;foca microglialactivation&ac phage accumulation.
25
25(+)
1.HighAFP,severeoligohydramnios,IUGR,PHat 16,205wks,ROM7wks 2.PROM,breech 3.Apgar15,died2h
6hours








1 .Oligohydramnios,APH3/40,ROM21anem a <9g/dl,suspectedinfection 2.PROM 3.Apgar85,H7.08,IVdied12h
13hours
Germinalmatrixhae orrh ges; neuronaleosin philia;focaWM damage&micro lialactivation;g ey mattergliosis.
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Infantswithpostnataldamage(n=21) Case (NNE=E)Gestation (asphyxiaat birth)ClinicalFeatures




1.smoker,Gravesdi easep rniciousnemia 2.induced,forcepsdeliv ry,normalCTG 3.Apgar5,fullCPR,died1hou
10
Slightpatchyhaemorr ageinbas l ganglia
29
41(+)






1.smoker,hypertension 2.forcepsdelivery,meconium 3.cordpH6.6,A gar05multiorganfailu eanNNE
34
Widespreadwhiteandg ymatt r haemorrhage,neu onaleosinophilia
31
39(+)










1.infertility,previousSBandNND 2.SVD 3.Apgar105diedincot48hrs,GBSs psi
52
Haemorrhageincentralwhita er, neuronaleosin philiaihipp campal neurones
34
36(+)





1.infertility,lossFM34and6wks 2.SVD,normalCTG 3.Apgar95 ,diedincot44hrs
48
Focal(patchy)haemorrhageincentral whitemat r,recenthypoxia(neuron l eosinophilia)
36
31(-)











1.incrtrisomyrisk,amnio,olig hydramnios,ROM 28wk 2.infection,abnCTGprelabourS 3.Apgar95,H7.2,EColisepsis,RDSpneumothorax
17
Slighthaemorr ageincentralwhit matter,occ sionalcort cneur l eosinophilia
38
29(+)
1.smoker,latebooker 2.ROM72hrs,co dpr lapse,elabourCS 3.Apg65,pH.9hy oplasticlungs
4
Smallgerminalatrixhaemorrh ges, occasionalneuro lhypoxi (eosinophilia)ihippocampalneurones
39
28(-)
1.twinpreg,anemia,PIHhy e esis,placr vi 2.EmCSprelabour 3.Apg95,pH7.5,RDS,pneumothorax
66
Recenthypoxia(n uro lsh inkagea d eosinophilia)
40
27(-)
1.twinpreg,amnioreduction,TTTS,IUGRPIH hyperemesis,flu12wklosFM26w ,ROM7 2.breechvaginal 3.Apg85,pH7.19,renalfailure,hy oplasticlungs
52
Intraventricularhaemor hagend extensivegerminalmatrixha morrh ge, neuronalshrinkagea deosi ophi ia
41 (E)
25(+)







Slightgerminalmatrixhaemorrh ge, neuronaleosin philiaihipp campusa d cerebellarort x
43
25(-)



























1.smoker,latebook ,APH2w sfluillnes20w s 2.EmCSinlabourforarmpresentation 3.Apg5,poorresp nset sus,died20mi
5





Slightgerminalmatrixhae orr ageand haemorrhagesincentralw ita t r
Infantswithnobr indamage(n=11) Case (NNE=E)Gestation (asphyxiaat birth)ClinicalFeatures
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Infantssurviving3-7d y(n=11) Case (NNE=E)Gestation (asphyxiaat birth)
ClinicalFeatures




1.lossFM24wks 2.EmCSfetald:s ress,meconium,normalCTG 3.Apgar65,cordH7.11,HIEabnheCTsc n
187
Largefreshcorticalha morr ge, neovascularisation,c rticalinf rc , macrophages,pontosubicularnecrosi hippocampuskaryorrhexis,whitem tter gliosis,basalangl ali is,po tine neuronalloss
61
41(-)
1.normal 2.induced,ventouse 3.Apgar95,sc lpH7.35,coll pse80hfulCPR NNE
116
Recenthypoxia(n uro leosinophilia), centralwhitema tergliosis,i e li ing foci(smallperivascularbutfrequent)in centralwhitema ter
62 (E)
39(+)
1.anemia 2.failedVentousex3,th nforc ps 3.Apgar45,H7.14,massiveICsubaponeurotic bleed
82
Freshhaemorrhageinge minalatrix, whitematterda age-gliosisand macrophages;pontosubicularnecrosi , cerebellarkaryorrh cticneurones,focal acutemeningitis
63 (E)
36(+)
1.multiple,amnioforIb,nemia,UGKHELLP 2.fetaldis ress,bradyd celerationsCS 3.Apgar5,H7.26,HIE
82
Neuronaleosinophiliaihippocampus, centralwhitema tergliosisa d macrophageac umulation,fresnd old(haemosiderinp sit ve) haemorrhagesinthege minalatrix, cerebellarortic lhypoplasia
64
34(-)
1.amniofortrisomyrisk,IUGRhyperemesis,G4 placentarevi ,PVdischarge 2.EmCSprelabour 3.Apgar9,cordH7.36,wt1,25kg,dieincota 86h,fullCPRunsuccessful
86









1.anemia,APFI29wks 2.assistedbreech,radyfor29mins 3.Apgar5s,FH6.7HIE,ulmh e,ICHs
82
Severeneuronalhypoxiiippocampus, freshhaemorrhageincentralwhiteat r, germinalmatrixandIVhaemorrh ge,r cent+ olderhypoxia,brainstem neurones+cerebellarc rt xen alwhit mattergliosis+ acr phages
66 (E)
27(+)
1.smoker,a nioforincrtris myriskIUGR,AEDF PIH 2.EmCSinlabourfetalbr dy 3.Apgar65,H.71,HIEpulmh eIC
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Focalcorticalinfarctionma rophage accumulation+neovascularisation,entral whitemattergliosis,larggerminala rix haemorrhage+IVH.Brainstem haemorrhage,cerebellarortic lat ophy
67
27(+)
1.unbooked,severePIH 2.SVDathomeintot ilet 3.Apgar2s,H7.06,PIEmultiorganfailu e
131
Centralwhitemat rgliosisandfoca macrophageaccumulation.M t ri gs ll haemorrhageincerebellart x
68
27(-)
1.smoker,NIDDMUTI8wks 2.SVD 3.Apgar85,H7.36,massivepulmonaryh e
73
Neuronaleosinophiliaihipp campusa d cerebellarort x
69
26(+)
1.smoker,heavyalc hol,l tebookanemia,APH 12wks,recurrentabdotr uma 2.EmCSforplacentalabrup ion,etabrady 3.Apgar,H7.23,massiveulmh eseizures
164
Germinalmatrix,cen lWMa dIVH pontosubicularnecrosis,whitematt damage+gliosis,macrophagesinpons.
70
25(-)
1.maternalv ricella25wksinICU,heavysedation 2.unexpecteddeliv ry,twins 3.Apgar9,H7.38,suspectedeizu es,RDS
111
Neuronaleosinophilia&karyorrhexis; germinalmatrixhaemorrh ge;focaicroglial &macrophageaccumulation.
Key1.pr gnancyfeatures 2.labouranddeliveryfe tures 3.resuscitationandneon talfe tures
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A careful comparison was made of the pregnancies leading to the births of
infants with features of prelabour damage (PBD, n=27) compared with those
without such damage (noPBD, n=32), table 5.8. Unmarried status was common
overall but was significantly more common in the PBD group (24 vs 21,
p=0.036). Fewer mothers in the PBD group received antibiotics in pregnancy (1
vs 8, p=0.031), more had emergency Caesarean section (17 vs 9, p=0.007) for
CTG abnormalities (18 vs 8, p=0.005) and more had meconium stained amniotic
fluid (11 vs 3, p= 0.005). The Apgar score was 0 at 1 minute of age in 33% of
those with PBD, significantly more likely than in the noPBD group (9 vs 2,
p=0.008) and the former group were heavier and more mature (2526 grams vs
1824 grams, p=0.033, and 34.6 vs 31.2 weeks gestation, p=0.051 respectively).
The PBD group was more likely to be ventilated after birth for a poor
respiratory drive (8 vs 3, p=0.037) and although both groups had initial acidosis,
this was commoner in the PBD group (6.90 vs 7.16, p=0.02). The time to
spontaneous respiration was longer (5 mins vs 1 min, p=0.009) and the 5 minute
Apgar score was correspondingly less good (2 vs 5, p=0.021) in the PBD group.
Reflecting the larger birthweight and more mature status, the PBD group had a
higher first blood pressure (46 mmHg vs 36 mmHg, p=0.019) and was less
likely to receive surfactant (4 vs 13, p=0.024). The time to death however was
similar in the two groups (12 hours vs 7 hours, p=0.416).
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Unmarried# 24(89) 21(66) 0.036
Smoker# 5(19) 13(41) 0.080
Multiple gestation# 2(7) 3(9) 1.000
Pregnancy-induced hypertension# 3(11) 3(9) 1.000
Antibiotics in pregnancy or labour# 1(4) 8(25) 0.031
Infection prior to or during labour# 2(7) 8(25) 0.092
Oligohydramnios# 6(22) 3(9) 0.275
Polyhydramnios# 2(7) 3(9) 1.000
Complicated pregnancy# 20(74) 22(69) 0.653
Caesarean section in labour# 17(63) 9(28) 0.007
CTG abnormalities# 18/23(78) 8/18(38) 0.003
Meconium stained liquor# 11(41) 3(9) 0.005
Apgar 0 at 1 minute# 9(33) 2(6) 0.008
First pHA 6.9(6.8,7.1) 7.16(6.8,7.24) 0.020
5 minute Apgar scoreA 2(0,4) 5(2,8) 0.021
T to spontaneous respirations (min) A 5(1,15) 1(0,4) 0.009
Birth asphyxia# 26(96) 20(62) 0.002
Birth weight (g) * 2526(1344) 1824(1120) 0.033
Gestation (wks) * 34.6(6.5) 31.2(6.5) 0.051
Small for gestational age# 4(15) 1(3) 0.169
Male sex# 12(44) 22(69) 0.060
First mean blood pressure (mmFIg)* 46(3) 36(27) 0.019
Poor respiratory drive# 8(44) 3(14) 0.037
Surfactant received# 4(14) 13(42) 0.024
Abnormal neurological examination
> 6 hours of age#
12(44) 4(13) 0.006
Neonatal encephalopathy >12h age# 9(33) 1(3) 0.004
Age at death (h) A 12(1,32) 7(1,26) 0.416
*
mean, standard deviation, p value (independent samples t-test)
# number, percentage, 2-tailed significance (Chi-square test)
A median, interquartile range, asymptotic 2-tailed significance(Mann-Whitney U test)
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No differences in sociodemographic or pregnancy factors were identified on
comparison of the encephalopathic and non-encephalopathic asphyxiated
groups, but CTG abnormalities were present in 80% of the former group and in
only 43% of the latter group (p=0.04).
7. The placenta
The placenta was available for examination in 41 cases (59% of those having a
post-mortem examination). In 7 cases there was histological evidence of
infection and in 33 cases there was none. All of the 7 infected placentas came
from infants delivered prematurely. In 2 (25 and 27 weeks gestation) the
inflammation was focal and in 4 it was more generalized (at 24, 24, 30 and 35
weeks gestation). The placenta of an additional baby, born at 41 weeks
gestation, showed focal acute deciduitis without inflammation of the placenta,
membranes or cord. Only 2 of these infants had evidence of prelabour brain
damage. Thus there was no concordance of placental and brain pathology.
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Discussion
This aim of this study was to describe the neuropathology in a geographically
defined cohort of early neonatal deaths and to seek associations with antepartum
and intrapartum events as well as with the infant's condition at birth and during
life. Previous studies reporting the neuropathology of perinatal death have been
hospital-based, have reflected the experience of specialist centres or have
selected patients according to gestational age or disease process. This study
aimed to provide population-based information from Scottish neonatal deaths
occurring over a two year period. The only exclusions were infants with
chromosomal abnormalities and with abnormalities of the cardiovascular and
central nervous systems because these might themselves lead to
neuropathological changes. Seventy cases were reviewed with extensive
neuropathology.
Birth asphyxia criteria
Although intrapartum hypoxia manifesting as birth asphyxia is uncommon and
in decline43, it is still viewed as a potentially preventable cause of death or
damage often with expensive medico-legal implications. Yet there is much
evidence that neurodevelopmental delay and cerebral palsy are associated with
birth asphyxia in only a minority of cases and also that the majority of birth
asphyxiated infants do not manifest developmental delay or cerebral palsy87'90.
The study definition of 'birth asphyxia' has been discussed previously (Chapter
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3). This study used broad inclusion criteria for the diagnosis of birth asphyxia to
ensure that no cases were missed. This liberal classification may have led to the
inclusion of infants whose depressed condition was due to other factors such as
extreme immaturity, sepsis or metabolic disease, including case 7 (Table 5.7)
with gangliosidosis GM1. Evaluation of the individual clinical features of
asphyxia in relation to neuropathological abnormality was performed later.
The Neuropathology
Fifty-one percent of the 137 eligible infants had detailed neuropathological
investigation. The range of neuropathological abnormalities resembles those
reported in previous studies 20-23;26-29;32;232;232;235;236;239;248;252;292;3«9although ^
prevalence of grey matter and neuronal damage is generally higher than reported
elsewhere. In general, many studies report findings of preterm infants or
stillbirths where white matter damage has predominated. Terplan alone, in a
large study of perinatal deaths from 1967, reports similar incidences of neuronal
damage among neonatal deaths (table l)320. Both necrosis and apoptosis have
been implicated in perinatal neuronal loss321. Unequivocal signs of cell death
are more easily detected in the differentiated neurons of the mature infant brain
and were particularly prevalent in asphyxiated infants who suffered seizures. In
only very few of the present cases were all neurons affected even within a single
target area of the brain. Specific cell surface receptors may confer these
differing levels of vulnerability, as well as forming the basis of perinatal
patterns of neuronal involvement, as in pontosubicular necrosis291. The reactions
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of the immature brain to hypoxic/ischaemic and other injury differ from those of
the adult brain. The white matter appears to be particularly vulnerable in the
perinatal period and both white matter infarction and the presence of axonal
9 Qfi • 9 07 •
swellings have been described previously ' although this latter feature has
not been widely recognised.
Brain injury originating before the onset of labour was observed in 46% of the
entire cohort, 57% of those with birth asphyxia and 90% of those with neonatal
encephalopathy. Such brain damage was commoner in full term than preterm
infants. These figures are higher than reported in previous studies of neonatal
deaths23;26;30;32;33;146;248;251;254. Studies of stillborn infants generally report a
99,994,99S,9S9,9^9,999
higher incidence of established brain damage" ' ' than those of live
births although this was not the case in the stillborn cohort of the Scottish
Perinatal Neuropathology Study where the percentage with pre-existing damage
was 35%323.
The higher incidence of prelabour brain damage in mature infants may result
from these infants dying from the consequences of the injury itself. Preterm
infants on the other hand, may be delivered following acute maternal conditions,
such as pre-eclampsia or infection and then succumb to injury during the
delivery or in the postnatal period due to prematurity-related problems.
Haemorrhagic lesions observed in this study were all acute and appeared to have
occurred postnatally. In no infant were haemosiderin-laden macrophages seen.
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Haemorrhage was no more common in infants with prelabour brain damage. The
classical lesions of periventricular leucomalacia were not observed in this study.
These cysts, representing focal areas of necrosis commonly clustered around the
posterior horns of the lateral ventricles, generally take around 6 days to become
apparent324, and their absence in this study may be due to the short survival time
of the infants.
Neuropathologies! considerations in interpretation of results
Judgements about neuropathological abnormalities are more difficult in the
preterm than in the brain at term. The glial response, though present, is less
marked in younger gestations and becomes more pronounced towards full term.
Although it is possible that such responses may not have been as developed
within the more immature noBA group, there were many immature infants
within the birth asphyxia cohort who exhibited marked astrocytic and microglial
changes. In fact, 30-40% of asphyxiated preterm infants showed gliosis and an
increase in inflammatory cells. This in accordance with Gilles and co-workers27
who found white matter astrocytosis in 33% of very low birth weight infants.
Abnormal proliferation of astrocytes may be difficult to differentiate from the
'myelination gliosis' of the normal developing brain. Myelination occurs in the
white matter of the cerebral hemispheres of the human brain from the end of the
second trimester and is characterised by proliferation and enlargement of
oligodendrocytes and astrocytes. Immature glia and immature migrating neurons
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may also be difficult to distinguish from reactive astrocytes. All of these cells
can be differentiated from the astrocytic hyperplasia seen in response to injury
by the demonstration of glial fibrillary acidic protein (GFAP) in the cytoplasm
of reactive glia. This immunocytochemical technique was used to avoid
confusion with myelination gliosis and other immature glia. This study also
found that some astrocytes, found to be markedly reactive on GFAP
immunocytochemistry, were not easily seen on routine staining. It is concluded
that a meaningful assessment of gliosis in the neonatal brain requires GFAP
immunocytochemistry. The significance of the apparent Alzheimer type II
astrocytosis present in a number of cases is unclear but it has been remarked
upon previously in immature brains291. It may represent the result of metabolic
upset and in this study was more prevalent in infants with brain damage.
Cell death is an integral part of the development of the central nervous system
and up to 50% of neurones die by programmed cell death (apoptosis) before
maturity, due to limiting trophic support from the target tissues they innervate.
The classical sign of apoptosis, the karyorrhectic nucleus, has been recognised
by pathologists for many years325. Apoptosis also appears to be the preferred
mode of death in the developing brain following a variety of insults. Cells at an
earlier stage of development are likely to die by apoptosis rather than primary
necrosis, which is usual in cells which are differentiated. Although our
understanding of why one type of cell death is favoured over another is limited,
it is possible that milder insults are more likely to result in apoptotic cell death
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than severe insults. For the purposes of this study, nuclear karyorrhexis was
regarded as abnormal, if large numbers of cells within a tissue were involved or
if accompanied by other post-hypoxic cellular responses.
Despite these considerations, comparison of the asphyxiated infants and those
not apparently suffering from birth asphyxia shows clear differences in terms of
neuropathological changes. Examination confined to infants who died within 3
days of the start of labour, and the separation of the asphyxiated group into
those with and without neonatal encephalopathy, identifies a spectrum of
damage. Unsurprisingly, the mature infants who died after displaying neonatal
encephalopathy are most likely to show neuropathological changes. All of the
brains in this study were carefully examined in order to determine whether any
damage could have occurred before the onset of labour. If it is accepted that
features such as focal or diffuse astrocytic hyperplasia and parenchymal
macrophage accumulation are cellular reactions which require three days to
become established, a majority of infants with features of BA sustained brain
damage prenatally, including all 8 of the FT encephalopathic group. What is
uncertain is how old such damage is, but the background of apparently normal
brain development suggests that the insult was sustained not long before labour
commenced. It is harder to draw conclusions about the preterm infants in this
study but the absence of neuropathological changes in virtually all the mature
and most of the preterm infants who did not display asphyxia is reassuring.
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The difficulties associated with interpreting these neuropathological findings
and attributing timing of onset to them is not underestimated. Every abnormality
has been included Table 5.7, whether focal or diffuse, recent or old, but it is
accepted that interpretation is subjective. Some observations on perinatal brain
necrosis have assumed that the injury has arisen from a single insult. However,
the results of this study and reports by previous authors24;237;239;240;292;308 show
that brain lesions of varying ages may occur in the same infant. Therefore the
possibility of multiple or repetitive injuries has to be taken into account when
dating lesions and ascribing pathogenesis. Difficulties with timing the
abnormalities arise from the fact that experimental studies are not possible in
human infants although classic studies were able to relate pathology findings to
major clinical incidents32'292. Some experts also comment that the results of
animal work may not be directly relevant to the human situation32 although the
timing of an insult may be far more accurate292. A number of the classic studies
were conducted before cell specific immunocytochemistry became available
although this is not the case for more recent papers. Earlier papers may not have
always included, or added, the duration of labour as a factor in timing, and
interpretation may be hampered by longer survival. It is noted that the infants
with a history of encephalopathy had survived for more than one day in most
instances. It is conceded that seizure activity might possibly induce and
accelerate some of the changes seen in the brains of such infants but the
presence of diffuse astrocytosis in other infants who had survived very few
hours and who died with no evidence of seizure activity reinforces the
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possibility of prenatal origin. A more secure evidence base for timing
neuropathological events awaits the evolution of new markers of cell damage
and irreversible cell death. The clinical significance of some lesions described
such as diffuse astrocytosis, and in particular their contribution to the cause of
death, remains uncertain.
Correlation of Clinical Factors and Neuropathology
This study identified few factors which predicted the incidence of prelabour
brain damage. Damage occurring before the onset of labour was commoner in
more mature and heavier infants, who were more likely to be delivered by
emergency caesarean section. Abnormal CTG, meconium staining of liquor,
asystole at birth, acidosis and prolonged depression of spontaneous respirations
are all common in the presence of intrapartum asphyxia yet were found to be
predictive for prelabour brain damage. Grafe studied the brains of 98 perinatal
deaths and found meconium staining of the placenta to be associated with white
matter necrosis in the brain235. It has been suggested that meconium in the
liquor may cause vasoconstriction of the umbilical vessels although this is
difficult to substantiate following delivery166.
An abnormal CTG was the only clinical factor differentiating the asphyxiated
infants who displayed encephalopathy and neuropathological abnormality from
those who did not. Abnormal heart rate recordings have previously been
described in fetuses with central nervous system lesions and malformations99'326
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and a persistent non-reactive fetal heart rate tracing has been described in
neurologically impaired infants who had clinical evidence of compromise
occurring prior to the onset of labour327. Infants with severe encephalopathy
show a lack of heart rate variability during life328.
Infants who went on to develop classical signs of hypoxic-ischemic
encephalopathy were far more likely to show signs of prelabour brain damage.
As discussed previously, it is possible that seizure activity may induce or
accelerate post-injury changes but even infants without seizures who had an
abnormal early neurological examination at 6 hours were more likely to have
established neuropathological lesions. Neurological abnormality in these infants
may be the result of previously sustained damage. In many infants, acute change
such as cerebral oedema and haemorrhage co-existed with older lesions. The
possibility arises that infants who have been damaged before the onset of
labour, may tolerate even a normal labour poorly, manifesting signs of fetal
distress and sustaining further damage at relatively ordinary levels of hypoxia.
Intrauterine growth restriction, polyhydramnios and oligohydramnios have
27'30'32'234
previously been associated with established brain damage ' ' ' but no
similar associations were found in this study. This may have been due to the
small number of cases studied with these complications. In the context of fetal
brain damage, polyhydramnios is often attributed to impairment of fetal
swallowing and oligohydramnios to renal dysfunction following the asphyxial
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insult. In this study, abnormalities of liquor volume may have gone undetected
due to the presumed short interval between brain injury and the onset of labour.
Recently the presence of prenatal infection has been linked to white matter
damagel45;146;329. This study found no support for this association and in fact
infection during labour was commoner in those infants without established
damage. The best diagnosis of intrauterine infection is the presence of
histological placental inflammation or funisitis. Chorioamnionitis usually results
in expeditious delivery of the fetus and any neuropathological changes, resulting
either directly from intrauterine infection or more probably from the ensuing
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fetal inflammatory response may take days to develop , and may exceed the
survival time of many of our infants. Despite the intention to collect placentas
from all infants who died, in practice this was poorly achieved and examination
was limited to 59% of infants undergoing post mortem. A more complete
analysis may have yielded additional information.
Implications for Surviving Infants
It is possible that the neuropathological findings reported here represent the
most severe end of a spectrum of perinatal brain damage resulting in a fatal
outcome while infants surviving perinatal asphyxia might show lesser degrees of
similar pathology. However the possibility also exists that dead infants and
survivors represent two completely different groups in terms of both causation
and pathology. It is also possible that a similar proportion of normally delivered
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infants have exactly the same changes. Recent neuroimaging studies of neonates
surviving with encephalopathy, with or without seizures, have a bearing on
these questions. A large study by Cowan and colleagues33 concluded on the
basis of MRI examination performed in the first two weeks of life that brain
damage in mature infants presenting with newborn encephalopathy was most
often acute and of perinatal onset particularly in an encephalopathic group
without seizures. Very few infants in that study displayed evidence of prenatal
brain damage on 1-1.5 Tesla sequencing. Neuropathological corroboration was
achieved in very few cases. Three of 21 infants with HIE (14%), who had
undergone detailed neuropathology designed to establish the incidence of
prenatal damage, had such changes in the brain. In the absence of
immunocytochemical investigation of gliosis and brain macrophage
accumulation in all deaths, their conclusions about the prevalence of prenatal
abnormalities may be an underestimate. Higher resolution MRI may be required
to detect early changes. The difficulties surrounding timing of lesions have been
discussed within our own study in which conclusions regarding presence or
absence of prenatal brain damage were confined to infants who died less than 3
days from the onset of labour and based on neuropathological examination
rather than imaging. Against a background of normal brain development, the
cerebral insult was likely to have been sustained only shortly before the onset of
labour, possibly even precipitating the onset of labour. Evidence of ongoing
neuronal damage was also present within this series, not dissimilar from the
findings in Cowan's study, but this was frequently in addition to the damage
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identified as occurring pre-labour within the constraints of current knowledge.
The question arises as to whether the established changes observed in our cohort
translate to significant functional consequences in survivors. There is little
doubt that some infants who exhibited widespread, severe changes may have
developed neurological sequelae if they had survived. However more localised
lesions or milder gliotic change may affect functionally unimportant parts of the
brain or may simply not result in sufficient neuronal death to cause neurological
impairment. It is well-established that abnormality of the internal capsule on
MRI has a high sensitivity and specificity for later neurological impairment
following hypoxic-ischemic encephalopathy331. Infants without such
abnormality do well. Although MRI is poorly sensitive for histological
change ' it may be that some damage undetectable by MRI has little clinical
consequence. On the other hand, MRI of the brain may appear normal in up to a
quarter of patients with cerebral palsy332. In such obvious functional
impairment, histological damage must surely exist. Newer MRI technology with
diffusion weighted imaging and higher strength magnetic fields may improve
detection of perinatal brain injury. More detailed topographical analysis may
indicate the significance of the brain injury observed within this cohort.
It might be expected that brain damage in survivors would be less extensive and
severe than in those with a fatal outcome. Whether the brain damage observed in
our study represents the result of persisting or repeated insult, or the onset of a
potentially reversible cascade accruing from a single insult, is uncertain. A
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multistep pathological process might present opportunities for intervention to
limit further brain damage.
There is increasing evidence to suggest that combined insults may have
synergistic effects in causing brain injury. Early differentiating oligodendroglia
in culture indicate a particular vulnerability to combined glucose and oxygen
deprivation but not to either alone333. Combined exposure to endotoxin and a
hypoxic-ischemic insult in a neonatal rat model results in extensive brain
damage that cannot be explained by simple additive effects and suggests
synergy between ischemia and inflammation334. This work supports the finding
that combined intrapartum infection and evidence of hypoxic-ischemia
dramatically increases the risk of spastic cerebral palsy compared to hypoxia-
ischemia alone (OR 78)164. The possibility that infants with antenatal damage
may experience further compromise during labour, suggests that the early
identification of such a group with subsequent avoidance of labour might be
neuroprotective. Studies of neonatal asphyxia and cerebral palsy have failed to
show a protective effect of Caesarean section335. This may be in part because
distinction is generally not made between elective prelabour and emergency in-
labour CS. However, Badawi and colleagues found that elective caesarean
section was associated with a odds ratio of 0.17 for neonatal encephalopathy in
the Western Australian case-control study59. Others have shown a protective
effect of prelabour CS for PVL in preterm infants in the context of
chorioamnionitis (OR 0.15)336.
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The fact that a significant proportion of clinically asphyxiated infants display no
evidence of brain damage, and that infants who are not asphyxiated at birth
frequently display only recent postnatal damage, offers hope for a good clinical
outcome if such infants could be identified and "rescued" by medical
intervention. This study has demonstrated that the current battery of pregnancy
and labour-associated investigations remain blunt instruments in accurately
predicting the arrival of a prenatally brain damaged infant. Future work must
address the development of methods for detecting antepartum damage so that
optimal management of these vulnerable fetuses can be planned. Further
evidence is also required regarding evolution of cellular reactions in the
developing brain. The findings in this study support the notion that the birth of
a compromised "asphyxiated" encephalopathic infant is not necessarily the
result of a mismanaged labour or of a lack of vigilance in pregnancy.
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Summary
In 1862, William John Little, physician to the London Orthopaedic Hospital
presented a paper describing the contribution of prolonged and difficult labour
to the condition of spastic diplegia337. From this time onwards, cerebral palsy
became synonymous with 'birth asphyxia' despite attempts by Sigmund Freud in
338the late 1890s to attribute cerebral palsy to damage occurring prior to labour
Such pervasive opinion about the intrapartum origin of cerebral palsy has
continued despite large epidemiological studies published over the last 15 years
indicating that a minority of cases of cerebral palsy are secondary to intrapartum
influences. In fact these studies suggest that the majority of childhood
neuromotor impairment originates prior to the onset of labour10'87 These
findings have been supported by observation of antenatally occurring brain
injury at post mortem and on imaging of the fetus and the newborn
32; 146;252;290;301
Despite this evidence, obstetric malpractice claims have soared over the last 50
years such that the obstetric work force is declining throughout the developed
world. In the United States of America, 76% of obstetricians report being sued
at least once and one in seven no longer practice in the field 339. In some areas
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of the country due to workforce shortages, many women are no longer under the
care of an obstetrician, but are cared for by birth attendants only. In the United
Kingdom, 1800 new cases of cerebral palsy are diagnosed each year. Of these,
one third will result in litigation and one third of these claims will be awarded
damages. Cerebral palsy constitutes 5% of all medical negligence claims within
the NHS but accounts for 60% of all payments, amounting to £451 million in the
year 2001/2 340;341.
The Scottish Perinatal Neuropathology Study was designed to investigate the
clinical factors associated with asphyxia-related death and to determine the
prevalence of antenatal brain injury occurring within a population of early
neonatal deaths and stillborn infants. It sought to investigate the clinical factors
associated with prenatal brain damage in an attempt to explain the pathogenesis.
Results from this study have shown that adverse features such as antepartum
haemorrhage, anaemia and intrauterine growth retardation often complicate
pregnancies resulting in early neonatal death. A high incidence of previous
pregnancy loss and infertility was common as were mothers to be unmarried or
to smoke. No factors predicted the birth of an infant with asphyxia apart from
CTG abnormalities and meconium staining of the liquor.
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Seventy newborn infants underwent detailed neuropathology. Evidence of
prelabour damage was observed in nearly half of a group of infants surviving for
less than three days. This damage was more common in asphyxiated infants.
Clinical associations of such established damage were few. Indicators of fetal
distress such as cardiotocograph abnormalities and meconium staining predicted
prelabour damage, as did a depressed condition at birth. Nearly all infants who
demonstrated a neonatal encephalopathy had evidence of brain damage which
had occurred prior to the onset of labour.
These results have relevance to both perinatal medicine and paediatric
neurodevelopment. Obstetricians strive to eliminate morbidity and mortality
during pregnancy and the perinatal period. Many have developed high risk
clinics for the identification and surveillance of vulnerable fetuses. General
improvements in antenatal and intrapartum care have led to important reductions
in the perinatal mortality rate. Despite this, the results of this work show that
damage may occur undetected during fetal life and without obvious warning.
Current instruments for fetal surveillance are at present not sensitive enough to
detect such fetal injury and new diagnostic techniques are needed to assess brain
development, detect early brain injury and to monitor interventions aimed at
minimizing brain injury. Although routine ultrasound imaging in pregnancy now
occurs throughout the developed world, newer technology such as 4 dimensional
(real time) fetal imaging may eventually provide in depth information about the
normality of fetal behaviour. It is possible that measurements of the quantity
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and quality of fetal movement may allow assessment of neurological damage if
present. Fetal MRI has already provided insights into normal neurodevelopment
including myelination and neuronal migration, and has documented a spectrum
of malformation and injury to the fetal brain301;342. Newer research techniques
such as functional MRI343 and MR spectroscopy344 may provide information
about metabolism at both regional and cellular levels following fetal hypoxic-
ischemic brain injury.
Identification of fetal brain injury raises both obstetric and neonatal
management issues. The counselling of a mother whose fetus has sustained such
injury must be informed by accurate prognostic information. The plasticity of
the developing brain may influence prediction of later neurodevelopmental
sequelae. Avoidance of further injury may mean avoidance of labour or
expeditious delivery, both of which may have significant morbidity for the
mother and infant.
Current neonatal neuroprotective strategies such as brain cooling rely on a
window of opportunity following primary brain injury in which to prevent
secondary cell death. A fetus who has been damaged some time before labour
may not benefit from such an intervention. Preliminary results from the
hypothermia trials suggest that hypothermia may not be beneficial to those
infants with severe encephalopathy345. Within this Scottish study, 90% of those
with severe encephalopathy showed evidence of damage occurring prior to the
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onset of labour. It is likely that secondary cell death would have been well
established within this group of infants. It is possible that the resistance of some
infants with severe encephalopathy to the neuroprotective effects of
hypothermia may be due to the advanced state of energy failure and cell death
within these damaged brains. Accurate detection of pre-existing brain injury
may influence application of such an intervention in the future.
The detection of brain injury is not sufficient. Preventative strategies can only
be developed through an understanding of the pathogenesis. Recent interest has
focused on the role of infection in white matter injury329'330'346. Evidence
suggests that the fetal response is more detrimental than the direct effect of the
pathogen330. The role of maternal pyrexia may also be significant151. Emerging
concerns about the synergistic effects of hypoxia and infection may modify
3 34
intrapartum management
This study found no support for the role of infection in fetal brain damage and
indeed identified no factors to explain the brain injury observed. Adverse
features in the maternal history were common compared to all Scottish
maternities but affected infants with damage as often as those without.
Individual vulnerability may predispose a particular infant to suffer damage at a
level of hypoxia that another infant may tolerate unharmed.
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This study found a high prevalence of antenatally occurring brain injury among
asphyxiated infants who die in the neonatal period. It is unclear whether these
results are applicable to survivors of perinatal asphyxia or whether these infants
who die represent a different group altogether. The majority of infants with
signs of birth asphyxia escape their insult unscathed as do many infants with
hypoxic-ischaemic encephalopathy. A normal neurodevelopmental examination
at 18 months was found in over half of a recent cohort of infants with moderate
or severe encephalopathy". Those infants with encephalopathy who eventually
die may be a group in whom effects of antenatal and intrapartum injury have
combined to make extrauterine life impossible while those with a less severe or
an acute brief insult may make a full recovery. It may however be simplistic to
imagine a spectrum of sequelae resulting from a spectrum of injury and
antenatal brain damage observed histologically may be of a different
pathoaetiology to that resulting in cerebral palsy.
Investigation of the pathogenesis of brain injury and disease in adults has
revealed that an individual's genetic profile may influence response and
recovery. In particular the apolipoprotein E gene has received much interest due
to its strong association with Alzheimer's disease and atherosclerosis. The s4
allele in particular is a risk factor for Alzheimer's disease and poor outcome
following traumatic brain injury and cardiac bypass surgery189'190,197. A small
number of studies in early life suggest the s4 genotype may be advantageous for
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fetal survival and childhood cognitive performance40;212;213. This project sought
to determine differences in the prevalence of APOE genotype in a population of
perinatal deaths and investigate any relationship with brain injury.
Healthy newborn infants were found to have an increase in the prevalence of the
s4 allele compared to both perinatal deaths and to adults supporting the
possibility for an advantageous role of this gene in early development.
Antagonistic pleiotropic effects of the s4 allele may be responsible for
beneficial effects in childhood but later adverse effects on cognitive decline.
Although s4 has been associated with neurological injury and deterioration in
later life, no such association was found with the presence of brain injury in
these perinatal subjects.
Further work is needed to clarify the role of APOE in perinatal mortality,
through linkage disequilibrium and/or whole genomic studies. With regard to
brain injury, ApoE has important functions in both neuronal repair and synaptic
-j q . 1 o o
remodeling ' . Although ApoE may not affect the occurrence of brain injury
as such, it may have an influence on longterm neurodevelopmental outcome.
Genetic studies of survivors of perinatal brain injury may help to establish such
an association if present.
It is the aim of all who work in perinatal medicine to prevent maternal and
181
infant mortality and morbidity. The results presented in this thesis demonstrate
that brain injury does occur in utero and responsibility must follow to prevent
such damage or at least to develop interventions to limit further injury.
Furthermore, 'fetal distress' during labour may not always represent the
presence of potentially damaging acute asphyxia but instead may signify an
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Appendix 2
Clinical Dataset for The




social class- professional, trade/clerical, unskilled manual, housewife, unemployed,
student, missing
smoker- yes, no
other recreational drug abuse- intravenous, oral, inhaled drugs
abdominal surgery- yes, no
uterine surgery- yes, no
number of previous pregnancies
number of previous pregnancy losses
number ofprevious tenninations of pregnancy
blood group- O Neg, O Pos, A Neg, A Pos, AB Neg, AB Pos, B Neg, B Pos
Antenatal Details
booking status- unbooked, booked after 16 weeks, booked at/before 16 weeks
assisted conception- ovulation induction, IVF, GIFT, AID, ICSI
weight at booking (kg)
systolic blood pressure at booking (mmHg)
diastolic blood pressure at booking (mmHg)
multiple pregnancy- yes, no
amniocentesis performed- yes, no
reason for amniocentesis performed- increased trisomy risk on screening, maternal age,
maternal request, amnioreduction
serum screening- nonnal, not performed, increased trisomy risk, increased NTD risk
rubella immune- yes, no
abnormal fetal anomaly scan- yes, no, not performed
medications in pregnancy- nil or vitamins only, antibiotics, sedatives, antihypertensives,





hyperemesis requiring hospitalisation- yes, no
Grade 3/ Grade 4 placenta praevia- yes, no
antepartum haemorrhage, first trimester- yes, no
antepartum haemorrhage, second or third trimester- yes, no
loss of fetal movements (gestation)- yes, no
pyrexial illness with flu symptoms incl urinary tract infection (gestation)- yes, no
pyrexial illness without flu symptoms, incl urinary tract infection (gestation)- yes, no
diabetes- nil, pregnancy associated diet-controlled, pregnancy associated insulin-
controlled, non-pregnancy associated insulin-dependent diabetes mellitus
premature rupture ofmembranes (gestation) <35 weeks- yes, no
intrauterine infection with isolated pathogen (gestation)- yes, no
abdominal trauma (gestation)- yes, no
essential hypertension- yes, no
pregnancy-induced hypertension- diastolic 20mmHg above booking or 90 mmHg (+/-
proteinuria, +/- oedema), eclampsia
failure to gain weight in pregnancy- nil, 2nd trimester, 3rd trimester, throughout
pregnancy
Intrapartum Details
initiation of labour- spontaneous, induced, no labour
length of first stage (h, min)
length of second stage (h, min)
duration of ruptured membranes- at delivery, < 24hours, >24 hours
delivered at home- yes, no
malpresentation of baby- yes, no
mode of delivery- spontaneous, forceps/Ventouse, emergency CS prelabour, emergency
CS in labour, elective CS
meconium stained liquor- yes, no
CTG abnormalities- yes, no
CTG abnormalities- details
epidural- yes, no
general anaesthetic- yes, no
cord prolapse- yes, no
pyrexial in labour >38C- yes, no
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intrapartum infection- details incl pathogen, white cell count, C reactive protein
excessive bleeding in labour- yes, no
baby with weight < 3rd centile- yes, no
weight of baby (kg)
occipitofrontal circumference ofbaby (cm)
gestation of baby (wks)
gestation of baby < 37 weeks- yes, no
sex ofbaby- male or female
Newborn Details
Apgar score at 1 min
Apgar score at 5mins
Apgar score at 10 mins
resuscitation required- nil, intubation only, full resuscitation including cardiac massage
and drugs
time to spontaneous respirations >10 mins- yes, no
admitted to SCBU- yes, no
initial pH
initial pH <7.1- yes, no
grade of HIE- nil, 1, 2, 3
age at death (h)
renal impairment- yes, no (defined as Creatinine >120, Hematuria, proteinuria, oliguria
>24hours)
inotropic requirement- yes, no
first mean arterial BP- mmHg
abnormal coagulation screen- yes, no
hypoglycemia- yes, no
hyperglycemia- yes, no
main respiratory problem- poor drive, RDS, PPHN, pneumothorax, pulmonary
haemorrhage, hypoplastic lungs, pleural effusions
seizures- yes, no, unsure
cranial USS results- details
EEG results-details
CT scan results- details
Medications during life- details
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Appendix 3
Protocol for Neuropathological Specimens
From 30 weeks gestation onwards (20 blocks):
R and L frontal parasagittal
R and L parietal parasagittal
R and L parietal convexity
R and L basal ganglia at level of mamillary bodies
R and L thalamus
R and L hippocampus at level of lateral geniculate body




R and L cerebellar hemispheres (including dentate nucleus) and vermis
From 24-30 weeks gestation (14 blocks):
R frontal
R and L hemispheres- level of basal ganglia









• Becher JC, Bell JE, Keeling JW, Mcintosh N, Wyatt B. The Scottish Perinatal
Neuropathology Study- clinico-pathological correlation in early neonatal deaths.
Arch Dis Child Fetal Neonatal Ed 2004;89(5):F399-407
• Becher JC, Bell JE, Mcintosh N, Keeling JW. Distribution of apolipoprotein E
alleles in a Scottish healthy newborn population. Biol Neonate. 2005; 88(3): 164-
167
• Bell JE, Becher JC, Wyatt B, Keeling JW, Mcintosh N. Brain damage and
axonal injury in a Scottish cohort of neonatal deaths. Brain. 2005;128:1070-
1081
• Becher JC, Keeling JW Mcintosh N, Wyatt B, Bell JE. The distribution of
apolipoprotein E alleles in Scottish perinatal deaths. JMed Genetics. In Press
Consent has been obtained from joint authors and from publishers of all above
journals to include copies of each paper as appended.
216
Downloaded from fn.bmjjournals.com on 21 February 2006
F399
ORIGINAL ARTICLE
The Scottish perinatal neuropathology study:
clinicopathological correlation in early neonatal deaths
J C Becher, J E Bell, J W Keeling, N Mcintosh, B Wyatt
Arch Dis Child Fetal Neonatal Ed 2004;89:F399-F407. doi: 10.1136/adc.2003.037606
Background: A proportion of neonatal deaths from asphyxia have been shown to be associated with pre¬
existing brain injury.
Objectives: (a) To compare the epidemiology of infants displaying signs of birth asphyxia with those not
showing signs; (Jb) to examine the neuropathology and determine if possible the timing of brain insult
comparing asphyxiated with non-asphyxiated infants; (c) to compare the clinical features of those born
with birth asphyxia with and without pre-labour damage.
Methods: Over a two year period, all 22 Scottish delivery units collected clinical details on early neonatal
deaths. Requests for post mortem included separate requests for detailed neuropathological examination
of the brain. Infants were classified into two groups: birth asphyxia and non-birth asphyxia.
Clinicopathological correlation was used to attempt to define the time of brain insult.
Results: Detailed clinical data were available on 1 37 of 174 early neonatal deaths that met the inclusion
criteria. Seventy of 88 parents who had agreed to post mortem examination consented to a detailed
examination of additional samples from the brain; in 53 of these cases the infant was born in an
asphyxiated condition. All asphyxiated and encephalopathic infants, 38% of mature and 52% of preterm
infants with features of birth asphyxia but without encephalopathy, and only one of 1 2 infants without any
signs of birth asphyxia showed damage consistent with onset before the start of labour.
Conclusions: In a large proportion of neonatal deaths, brain injury predates the onset of labour. This is
more common in infants born in an asphyxiated condition.
The supplementary tables
can be found at http://
adc.bmjjournals.com/
supplemental/.
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The three major causes of neonatal death are lethal mal¬formations, prematurity, and birth asphyxia.' Whereasthe general public considers major malformations and
premature birth as unavoidable mischance, birth asphyxia
implies a lack of care in labour. Although birth asphyxia is
classically linked to intrapartum hypoxia-ischaemia in full
term infants, often proceeding to a neonatal encephalopathy—
the so-called hypoxic-ischaemic encephalopathy, a proportion
of preterm babies are also born in a neurologically depressed
condition almost certainly related to poor oxygenation in
labour. Asphyxia is acknowledged to be an imprecise term, but
is still used regularly by the profession and parents. It may be
implied by one or more of the following features: a low Apgar
score2"7; a baby who is difficult to resuscitate; metabolic
acidosis in either the cord5 6 8' or early neonatal blood samples;
the development of neonatal encephalopathy.10"12 A history of
these particular features may be sought retrospectively if an
infant goes on to develop neurodevelopmental delay. None of
these indicators, when applied prospectively to infants born in
poor condition, has good sensitivity, specificity, or predictive
value for neurodevelopmental delay or disability, although in
full term infants the development of neonatal encephalopathy
is more specific." It is clear that perinatal asphyxia is not likely
to be an important factor in the development of every case of
neonatal encephalopathy or in most cases of cerebral palsy.14""
This view has been endorsed by a statement from the
International CP Task Force.20 21
Obstetric care has seen dramatic changes over the lasl few
decades. Most changes have contributed to the steadily
falling stillbirth and neonatal death rates.'22"25 However,
despite better clinical care and widespread use of fetal
monitoring and fetal blood sampling, full term infants
continue to be born in a neurologically depressed condition.
Such infants cause considerable distress to parents and staff.
They contribute both to early neonatal mortality and to the
pool of children who display later neurodevelopmental
disability with cerebral palsy. Although in some cases
obstetric risk factors can be identified, affected children also
result from pregnancies and labours that, even when
scrutinised critically, appear to be normal.
Litigation for perceived perinatal mismanagement is
increasingly common, particularly in relation to infants born
in a neurologically depressed condition—usually manifested
by a poor Apgar score—and often reflexly labelled birth
asphyxia. Some recent anecdotal reports and small series of
infants born in poor condition have shown neuropathological
abnormality at autopsy that must have preceded the onset of
labour. These generally represent the collected experience of
specialist referral centres26"'0 or focus on a particular age
group of infants—for example, those born preterm.Only
rarely do the neuropathological studies include correlation
with clinical factors.""18 Further insights into cliniconeuro-
pathological correlation in the first weeks of life are now
being achieved by neuroimaging." This Scottish study was
set up to identify neuropathological abnormalities in a
population cohort of perinatal deaths and to explore the
relation between clinical features and pathological findings.
We report here the findings in the neonatal deaths.
The specific aims of this paper are to:
• review the epidemiology (sociodemographic, antenatal,
and perinatal factors) of the early neonatal deaths overall
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and to compare infants who displayed signs of birth
asphyxia with those who did not;
• investigate the neuropathological status in those infants in
whom a post mortem was authorised, and to determine
whether lesions could be of prenatal origin;
• determine if infants who have pre-existing brain damage
are, when born alive, more likely to be born in an
asphyxiated condition;
• compare the antepartum and intrapartum course of early
neonatal deaths of infants born with birth asphyxia with
and without pre-existing damage.
METHODS
Study setting and patients
The Scottish perinatal neuropathology study was a prospec¬
tive observational and experimental study involving all 22
delivery units within Scotland. Patients were recruited during
a two year period for each centre. The study started in
January 1996, and recruitment of cases was completed by
January 1999. The base study considered all perinatal deaths
of infants who were & 24 weeks gestation al birth and
< 7 days at time of death delivered in Scotland over the two
year period. This paper concerns the epidemiology and
neuropathology of the liveborn subset of the study cohort.
The stillborn infants presented somewhat different features
and will be reported on separately.
Infants with central nervous system or cardiac malforma¬
tions, major chromosomal abnormalities, or central nervous
system infection were excluded because it was felt that the
neuropathological changes associated with such conditions
might interfere with the interpretation of any changes
superimposed by perinatal insult.
Figure 1 lists how the cohort of 692 qualifying perinatal
deaths was reduced by various exclusions through the 221
liveborn infants to the 70 infants from whom the brain was
available for examination in this study. These 70 infants were
classified according to whether they displayed birth asphyxia
(BA group) or not (noBA group). Analysis of those who died
three days or less after the onset of labour allowed
identification of pathological features likely to have predated
labour and birth. Placentas were available for histological
examination from 41 of the 70 infants.
Ethical and consent procedures
Before the start of the study, each delivery unit obtained
approval from their local research ethics committee to
approach appropriate parents. As different units received
ethical permission at slightly varying times, the spread of
data collection was three years, although it was two years for
each individual centre. Cases were enrolled at the time of
post mortem request by the clinician responsible for the care
of the infant during life. A detailed clinical dataset was
collected on all infants regardless of enrolment status. The
purpose of the study was explained to parents. Signed
consent was obtained for autopsy, and on a separate consent
form, if authorised also for extended neuropathological
research studies on the brain.
Clinical details
For each case a detailed questionnaire was completed by
specially trained midwives or other local staff who recorded a
battery of clinical information and the results of investiga¬
tions relating to each pregnancy, labour, delivery, and
neonatal course. This was entered into a central database
(SPSS) by the study clinical coordinator (JCB). information
on the intrapartum cardiotocograph (CTG) was recorded if
available.
Diagnosis of asphyxia
No test is available to accurately diagnose clinically important
intrapartum asphyxia. The CTG is notorious for its poor
predictive value."41 As one of the principle aims of the study
was to determine if infants with pre-existing brain damage
are predisposed to neurological depression at birth which
might be labelled as birth asphyxia, we used fairly broad
inclusion criteria.
• An Apgar score al five minutes of < 5.0; this is the
traditional assessment and it is widely recognised that a
low five minute Apgar score has an association, although
weak, with both neonatal death and morbidity in
surviving infants.42
• A cord or initial blood pH of < 7.1; obstetric epidemiology
has shown that a scalp pH of less than 7.25 is abnormal
and delivery is indicated if less than 7.2.4"41 The relation
between scalp and cord pH is good with a sensitivity of
93%/" However, the neonate is rarely difficult to resusci¬
tate unless the cord pll is less than 7.0. We arbitrarily
chose an intermediate level (pH < 7.1) as indicating some
degree of birth asphyxia in this group of early neonatal
deaths. Recognising the limitations, we also used (in the
absence of a cord pH) a first blood gas with a pll less than
7.1 to indicate asphyxia.
• The presence of grade 2/3 neonatal encephalopathy. This is
widely accepted as having a closer association with
significant birth asphyxia and long term neurodevelop-
mental disability." 44 The grading of encephalopathy used
was that of Sarnat and Sarnat.45
Because of the diverse clinical circumstances, not all
criteria were available for assessment in each case. Infants
who displayed at least one of these criteria were classified as
showing clinical evidence of birth asphyxia (BA group). If
none of these criteria were present, the infant was included
in the non-asphyxiated group (noBA).
Pathological examination
Autopsies
Autopsies were conducted in six Scottish centres, and the
brain was retained in fixative for later examination. In the
south east of Scotland, the fixed brains were examined in
the Department of Neuropathology at the Western General
Hospital, Edinburgh. Elsewhere they were sampled locally
according to a previously agreed protocol. Up to 20 repre¬
sentative paraffin embedded blocks were prepared in each
case from all areas of the cerebrum (including temporal
hippocampus), and from the basal ganglia and thalami,
midbrain, pons, medulla, vermis, and cerebellar hemispheres.
These blocks were collected centrally for review and further
investigation in Edinburgh. Paraffin sections were stained
routinely with haematoxylin and eosin and luxol fast blue/
cresy) violet (myelin). Selected sections were investigated
immunocytochemically for astrocytic status, using an anti¬
body to glial fibrillary acidic protein and for microglia/
macrophages (antibodies to CD68 and MHCII) or stained
with Perls Prussian blue stain (haemosiderin). The neuro¬
pathological appearances in grey and white matter were
assessed independently in all cases by two observers (JEB
and BW), who were initially blind to the clinical history.
Selected cases were also reviewed by JWK. Recorded
neuropathological features included neuronal eosinophilia
and karyorrhexis, astrocytic hyperplasia, activated microglia
and accumulation of macrophages, haemorrhage (recent and
older), vascular responses, and foci of mineralisation and of
infarction. The neuropathological features were then corre¬
lated with the gestational and postnatal age of the infant and
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221 Early neonatal deaths
47 with exclusion criteria (16 chromosome abnormality,
25 CVS malformation, 6 CNS malformation, 0 CNS infection)
174 Early neonatal deaths meeting inclusion criteria
37 excluded as missed these included:
24 (gestation 24-28 weeks) died from extreme prematurity, severe RDS,
or severe IVH; 3 others (gestation 29, 30, 35 weeks) died from
complications of prematurity; 5 FT (3 BA, 1 MAS, 1 sudden collapse on
ward); 5 infants of unknown gestation, 2 died from cardiorespiratory,
2 from renal and 1 from cardiovascular failure
137 Early neonatal deaths with clinical detail
(38 FT (31 BA, 7 noBA); 99 PT (59 BA, 40 noBA))
1 Consented to autopsy
1 8 with no additional samples - a mixture of some not consenting and
some samples proving unsuitable for comprehensive neuropathological
analysis.
Only 50% of these 1 8 had 'BA' compared with 75% of the remaining
70: 1 6 of the 70 had grade 3 HIE compared with none of the 1 8 not
having extended neuropathology. Otherwise these 1 8 infants did not
differ in any significant way from the 70 when considering social class,
maternal age, complications of pregnancy, type of delivery, admission to
NNU, Apgar scores, pH, age at death, resuscitation, gestation and birth
weight.
70 Consented to additional study samples
53 BA
23 FT 30 PT
17 noBA
3 FT 14 PT
Died < 3 days j
21 FT 25 PT 2 FT 11 PT
/ \ / \ / \ / \
PND noPND PND noPND PND noPND PND noPND
13(62%] 8(38%) 13(52%] 12(48%) 1 1 0 11
Figure 1 The Scottish perinatal deaths cohort. FT, full term; RDS, respiratory distress syndrome; PT, preterm < 37 weeks; IVH, intraventricular
haemorrhage; BA, birth asphyxia; MAS, meconium aspiration syndrome; noBA, no birth asphyxia; HIE, hypoxic-ischaemic encephalopathy; PND,
prenatal brain damage; NNU, neonatal unit; noPND, no prenatal brain damage; CVS, cardiovascular system; CNS, central nervous system.
with the criteria of birth asphyxia, in combination and
individually.
A judgment of whether the damage dated from before the
onset of labour, and was therefore prenatal, was based in part
on the presence of patently mature lesions such as
established infarcts, previous haemorrhage, or extensive
mineralisation. However, these features were present in the
minority of brain damaged infants. More diffuse features
such as definite macrophage infiltration/accumulation and/or
prominent reactive astrocytic hyperplasia in white matter are
thought to develop over a period of more than three days
(table 1). We estimated that the presence or absence of
prenatal brain damage could only be determined reliably in
infants who died at < 3 days of age (n = 59).
Placenta
The placenta, cord, and membranes were examined macro-
scopically, and cord length, placental measurements, and
trimmed weight were recorded. Any abnormality was
described. Histological samples were taken to include a
cross section of the umbilical cord, one strip of membranes
(adjacent to the hole through which the baby was delivered,
if identifiable), and two blocks of placenta with both fetal
and maternal surfaces. Blocks and slides from the placenta
and adnexa were submitted for central review in Edinburgh
(JK). Histological evidence of infection, specifically chorio-
amnionilis in the extraplacental membranes or chorio¬
nic plate and funisitis, were recorded, as was villitis if
generalised.
Statistical analysis
Data were recorded in SPSS. Descriptive statistics were used
to examine the prevalence of clinical variables. The y2 test
with Yates correction (or Fisher's exact test where sample
size was less than 20) was used to compare categorical
variables, and the unpaired t test or Mann-Whitney U test to
compare the difference in continuous variables. Significance
was assumed at p < 0.05, but we recognise that a large
number of tests were performed, and some positive results at
this level may have occurred by chance. As the epidemiology
was performed on observational data, we leave the reader to
consider the implications at this level ralher than apply a
correction such as that of Bonferroni. The statistical
comparison of the pathology of asphyxiated and non-
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Table 1 Timing of injury to the central nervous system
after cerebral insult
Timing of onset
Pathological feature after injury References
Neuronal eosinophilic 6-24 hours 60-62
Neuronal karyorrhexis 12-48 hours 61, 63-65
Infarcts—necrosis 3-8 hours 60, 65, 66
Infarcts—cavitation 14-42 days 65-68
White matter gliosis 3-11 days 31, 32, 58, 60,61,65,
67, 69, 70
Grey matter gliosis 3-5 days 30, 63, 68, 71
Microglial upregulation 3 hours-3 days 60, 61, 66, 67, 71
Macrophage infiltration 3-7 days 63, 65-68
Fresh haemorrhage Minutes 67
Haemosiderin deposits 2-3 days 27, 67, 72
Mineralisation 3-14 days 58, 60, 65, 67
RESULTS
Population and study cohort
Of ihe 692 deaths in the two years of the study, 221 were
early neonatal deaths corresponding to the estimated early
neonatal death rate of 2.5/1000 live births in Scotland.
Of the 137 deaths analysed (fig 1), 90 were classified as BA
and 47 as noBA according to our liberal definition. Table 2
shows how they met the criteria for birth asphyxia. Most
infants died from the effects of prematurity, congenital
anomalies, or "anoxia". The causes of death included one
case each of GM1 gangliosidosis, laryngeal atresia, and
diaphragmatic hernia, all of which may have conlribuled to
the clinical picture of asphyxia. Twenty out of 137 (15%)
pregnancies studied were twin (19) or triplet (one).
Complications of pregnancy were common, in particular,
oligohydramnios (20%), intrauterine growth restriction
(14%), premature rupture of membranes (23%), and second
or third trimester antepartum haemorrhage (29%). Although
abnormal serum screening for a fetoprotein and human
choriogonadotrophin occurred in 14 pregnancies, in only five
of these was amniocentesis carried out. The other six
amniocenteses were performed for amnioreduclion (five) or
at maternal request (one). Of 62 cases of fetal anomaly scan,
21 were abnormal (including multiple abnormalities). Two
infants were conceived following induction by ovulation
stimulating drugs, and two by in vitro fertilisation.
Emergency caesarean section look place in 57 (42%)
deliveries, of which 21 were performed before the onset of
labour and 36 were intrapartum. Two infants were born by
elective caesarean section, one because of a previous
caesarean section and the other because it was a twin
pregnancy. There was no excess over the expected proportion
of early neonatal deaths delivered out of hours (2100-0900
and weekends; 61%). An abnormal infection screen was
found in 15 of the total group (group B Streptococcus (seven),
coliforms (four), Staphylococcus aureus (two), others (two)), of
which eight were thought to have died from overwhelming
sepsis (three group B Streptococcus; one group A Streptococcus;
two coliforms; one Pseudomonas, and one unidentified).
Seventy neonates were fully enrolled in this study with
their parents agreeing to both an autopsy and the extended
brain sampling. Of these 70, 53 were thought to be
asphyxiated (BA group; 23 mature (> 37 weeks) and 30
preterm (24-36 weeks) infants), and 17 did not appear to be
asphyxiated (noBA group; three mature (5= 37 weeks) and 14
preterm (24-36 weeks) infants) (fig 1). The mature infants
lived for between 15 minutes and seven days, with only three
surviving for more than three days. The preterm infants lived
for between five minutes and 6.8 days, with only eight
infants surviving for more than three days. The ratio of
asphyxiated (77%) to non-asphyxiated (23%) was slightly
skewed in the group of autopsied infants towards
asphyxiated cases when compared with the whole cohort of
liveborn infants included in the detailed epidemiological
survey (n = 137; 66% asphyxiated, 34% non-asphyxiated).
Clinical comparison of BA and noBA cohorts
Detailed supplementary tables can be found at htlp;//
adc.bmjjournals.com/supplemental/. Briefly, the mothers
were comparable for age, weight, height, social class, marital
status, parity, and all other factors examined (supplementary
table 1). Mothers of infants who were bom in an asphyxiated
state were less likely to have received steroids during
pregnancy (20% v 36%, p = 0.036). Hyperemesis (8% v 23%,
p = 0.013), placenta praevia (2% v 11%, p = 0.037),
intrauterine growth retardation (10% v 23% p = 0.066), and
pyrexia or flu-like illness during pregnancy (6% v 17%,
p = 0.061) were less common in the BA cohort (supple¬
mentary table 2). Markers of fetal distress (supplementary
table 3), such as meconium staining and cardiotocograph
(CTG) abnormalities,4" were significantly more prevalent in
the BA cohort (26% v 11%, p = 0.040; 59%v33%,p = 0.004).
Intrapartum infection, indicated by positive vaginal swabs,
maternal pyrexia, increased white cell count, or increased C
reactive protein, occurred in 12 cases (Escherichia coli and
other coliforms, group B Streptococcus, and Staphylococcus
aureus) but was not more common in the BA group.
Malpresentation was less common in the BA cohort (30% v
45%, p = 0.087).
The noBA cohort were of younger gestation (29 v 32,
p = 0.017), lighter, and had a smaller head circumference
(supplementary table 4). The BA cohort, who had lower
Apgar scores, required more resuscitation as a result.
Eighteen (20%) infants in the BA group were asystolic at
birth. Infants in the BA cohort were more likely to die early
compared with those in the noBA cohort (10.3 h v 43 h,
p = 0.002). Of 137 infants, only 106 were admitted to a
neonatal unit. Of the remaining 31 infants, five were born in
good condition and died suddenly and unexpectedly: three
were found dead in their cots on the postnatal ward after
transfer from the labour ward, and two suffered a sudden
acute deterioration in the labour ward after a normal
delivery. Twenty four infants had severe birth asphyxia.
Table 2 Clinical features of birth asphyxia in
137 early neonatal deaths
Features of asphyxia Full term Preterm
Total number of infants 38 99
Single feature only
Apgar < 5 at 5 min 9 35
Cord pH < 7.1 0 1
IstpH < 7.1 1 8
NNE 1 0
Two features
Low Apgar and low pH 7 9
Low Apgar and NNE 2 1
Low pH and NNE 0 1
Three features
Low pH, low Apgar, and NNE 11 4
Total with some indication of 31 (82%) 59(60%)
asphyxia
All infants had a five minute Apgar score. Only 12 full term
infants and 11 preterm infants had cord pH measured. An
additional 22 full term infants and 35 preterm infants had the
pH measured on arrival in the local neonatal unit. 16 full
term infants at 12 hours of age were not paralysed, and 14
of these had features of an encephalopathy. 19 preterm
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and, although they had signs of life at or shortly after birth,
they could not be resuscitated sufficiently to move them to
the neonatal unit. One extremely premature infant (a triplet)
was given only compassionate care.
Clinical details of infants admitted to a neonatal unit were
often limited because of early death (supplementary table 5).
Within the first hour of birth, infants in the BA group had a
considerably lower initial arterial blood pH (6.96 v 7.25,
p < 0.001). In survivors of more than 12 hours, those in the
BA group were more likely to have renal dysfunction (55% v
24%, p = 0.029) and to require assisted ventilation for poor
respiratory drive (33% v 3%, p < 0.001). The noBA cohort, in
keeping with their shorter gestation, had a greater incidence
of respiratory distress syndrome and were more likely to have
received exogenous surfactant (73% v 40%, p = 0.001) and to
have muscular paralysis (36% v 14%, p = 0.011). In infants
who survived for longer than 12 hours, abnormal neurology
was documented in 83% of the BA cohort compared with 20%
of the noBA cohort (p < 0.001). Secures were significantly
more common (19%) in the BA than in the no BA group (3%)
(p < 0.027), but many infants (n = 30) were treated
prophylactically with anticonvulsants or paralysis, and many
(n = 61) died before seizures might have been expected. The
groups were comparable for other features of systemic
dysfunction, in particular coagulopathies, necrotising entero¬
colitis, cardiovascular instability, and glucose homoeostasis.
Neuropathological findings and identification of
prenatal brain damage
Eighty eight infants underwent autopsy, and 70 parents
authorised the additional samples required for this research
study (fig 1). Table 3 shows the prevalence of neuropatho¬
logical abnormalities in these 70 infants, classified into the
BA and noBA groups (53 v 17) and according to their
gestation (mature v preterm). Table 4 shows similar data for
the infants aged 3 days and less. A detailed table of
clinicopathological correlation for each infant in the group
of 27 with putative prenatal brain damage has been provided
for the interested reader (supplementary table 6). In table 4,
the BA group has been further subdivided according to
whether encephalopathy was one of the features of birth
asphyxia.
In both mature and preterm infants, the asphyxiated
infants were more likely to show brain damage than the non-
asphyxiated, although brain damage was not universally
present in asphyxiated infants (tables 3 and 4). Some infants
showed evidence of continuing brain damage, with recent
events such as neuronal eosinophilia and fresh haemorrhage
superimposed on older lesions including established infarcts,
macrophage accumulation including cells laden with haemo-
siderin, extensive micromineralisalion, and white matter
gliosis. Infants with no evidence of asphyxia at birth (mostly
preterm infants) were more likely than asphyxiated infants
to appear virtually normal on neuropathological examina¬
tion, and such changes as were present, including haemor¬
rhage and neuronal eosinophilia, appeared to be recent
except in two mature infants who displayed prominent
gliosis.
In cases in which brain damage was present, a conclusion
as to whether this was likely to be of prenatal origin could be
achieved only in infants who died at < 3 days of age. This
was based on the presence of abnormalities thought to first
appear about three days after brain injury. There is no
absolute certainty about the time needed for the different
responses to become visible (table 1), but the presence of
accumulations of macrophages and/or prominent astrocytic
hyperplasia in human white or grey matter is generally
assumed to require three days or more. Evidence from the
literature for this timing is presented in more detail in
supplementary table 7. It is important to note that, of the 27
infants judged to have suffered prenatal brain damage, only
four had survived for more than two days, six had survived
one to two days, and all the rest (65%) had survived for less
than one day from the onset of labour. On this basis, 26
(57%) of the asphyxiated group had evidence suggesting
prenatal brain damage compared with one (8%) of the non-
asphyxiated group, a highly significant difference (p < 0.005)
(table 4).
Table 4 also shows that infants in the BA group who were
encephalopathic displayed a particularly high prevalence of
brain damage. Nine of 10 infants in this group showed
macrophages or gliosis, or both, together with other
confirmatory signs of continuing damage such as neuronal
karyorrhexis and eosinophilia. Table 4 also highlights the fact
that many of the brains of non-encephalopathic asphyxiated
infants were apparently undamaged prenatally and that even
by the time of death in the postnatal period, 31% of mature
and 13% of preterm asphyxiated infants in this subgroup had
apparently normal brains. Although the non-asphyxiated
infants appeared to be more prone to postnatal or intrapar¬
tum damage, this difference was not significant (p < 0.059).
Unsurprisingly, the preterm infants were more susceptible to
damage of recent, and therefore probably, postnatal origin
than were mature infants.
Clinical factors associated with prenatal brain
damage
A careful comparison was made of the pregnancies leading to
the births of infants with features of pre-labour damage
(PND group, n = 27) compared with those without such
damage (noPND group, n = 32). Fewer mothers in the PND
group received antibiotics in pregnancy (1 v 8, p = 0.031),
more had caesarean section (17 v 10, p = 0.015) and
emergency caesarean section (17 v 9, p = 0.007) for CTG
abnormalities (18 v 8, p = 0.005), and more had meconium
present in the amniotic fluid (11 v 3, p = 0.005). The Apgar
score was 0 at birth in 33% of the PND group, significantly
more than in the noPND group (9 v 2, p = 0.008), and the
former group were heavier and more mature (2526 v 1824 g,
p = 0.033, and 34.6 v 31.2 weeks gestation, p = 0.051
respectively). The PND group were more likely to be
ventilated after birth for a poor respiratory drive (8 v 3,
p = 0.037), and, although both groups were acidotic, had a
more acidic first pH (6.90 v 7.08, p = 0.022). The time to
spontaneous respiration was longer (5 v 1 minute, p = 0.009),
and the five minute Apgar score was correspondingly less
good (2 v 5, p = 0.021). Reflecting the larger birth weight
and more mature status, they had a higher first blood
pressure (46 v 36 mm Hg, p = 0.019) and were less likely to
receive surfactant (4 v 13, p = 0.024). The time to death,
however, was similar in the two groups (12 v 7 hours,
p = 0.42).
No differences in sociodemographic or pregnancy factors
were identified between the encephalopathic and non-
encephalopathic asphyxiated groups, but CTG abnormalities
were present in 80% of the former group and in only 43% of
the latter group (p < 0.04).
Prenatal damage and the signs of birth asphyxia
Table 5 shows the pathology of prenatal brain damage related
to the criteria we used for birth asphyxia. Although the
strongest clinical association with the features of pre-labour
damage is the development of a neonatal encephalopathy
after a low pH and a poor Apgar score at five minutes, it is of
note that, of the 22 infants who had only a low Apgar score
and then died and had a post mortem examination, 11
showed brain damage. By this evidence, a low Apgar score
was the sole clinical indicator of prenatal damage in three of
www.archdischild.com
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Table 3 Histological evidence of brain damage in 70 neonates
NoBA group (n = 17; non-asphyxiated
BA group (n = 53; asphyxiated infants) infants)
Pathological feature Mature (n = 23) Preterm (n = 30) Mature (n = 3) Preterm (n = 14)
Neuronal eosinophilic 14 (61) 9 (30) 2 5(36)
Neuronal karyorrhexis 11 (48) 8(27) 0 0(0)
Grey matter infarcts 1 14) 3(10) 0 0(0)
White matter gliosis 11 (48) 14(47) 2 0(0)
Grey matter gliosis 7(30) 5(17) 1 0(0)
Microglial upregulation 9(39) 14 (47) 1 1 (7)
Macrophages 9(39) 14(47) 0 0(0)
Fresh haemorrhage 11 (48) 19 (63) 0 8(57)
Haemosiderin deposits 0(0) 1 (3) 0 0(0)
Mineral deposits 2(9) 8(27) 2 1 (7)
Values in parentheses are percentages.
Mature, s=37 weeks; preterm, 24-36 weeks.
13 mature infants and in eight of 13 preterm infants. Only 16
mature and 19 preterm infants in the PND group survived to
12 hours and remained non-paralysed; of these, 14 mature
and six preterm infants had an encephalopathy. Looked at
another way, 14 full term infants had clinical neonatal
encephalopathy. Eight of these had a post mortem examina¬
tion, and all had evidence of prenatal damage. Only six
preterm infants had neonatal encephalopathy. Two of these
had a post mortem, and only one had evidence of prenatal
damage.
The placenta
In 41 cases (59% of those who had a post mortem
examination), a placenta was available for examination. In
seven cases, there was histological evidence of infection, and
in 33 cases there was none. All of the seven infected placentas
came from infants delivered prematurely. In two (25 and
27 weeks gestation), the inflammation was focal, and in four
it was more generalised (at 24, 24, 30, and 35 weeks
gestation). The placenta of an additional baby, born at
41 weeks gestation, showed focal acute deciduitis without
inflammation of the placenta, membranes, or cord. Only two
of these infants had evidence of prenatal brain damage. Thus




A major aim of this study was to determine the neuropathol¬
ogy in a geographically defined cohort of early neonatal
deaths and to seek associations with events in the mother's
pregnancy, labour, and delivery, and with the infant's
condition at birth and during the period before death. We
excluded infants with chromosomal abnormalities and with
abnormalities of the cardiovascular and central nervous
systems because these might themselves lead to neuropatho-
logical changes. We were able to review 137 cases with
carefully documented clinical detail, and 70 with extensive
neuropathology.
Birth asphyxia criteria
Although intrapartum hypoxia manifesting as birth asphyxia
is uncommon and in decline,""1 it is still viewed as a
potentially preventable cause of death or damage often with
expensive medicolegal implications. Yet there is much
evidence that neurodevelopmental delay and cerebral palsy
are associated with birth asphyxia in only a minority of cases
and also that most birth asphyxiated infants do not manifest
developmental delay or cerebral palsy.'7 4* We used broad
inclusion criteria for the diagnosis of birth asphyxia to ensure
that we missed no cases and were able to evaluate the
individual clinical features of asphyxia in relation to
neuropathological abnormality. This may have led to the
inclusion of infants whose poor condition was due to other
factors such as sepsis and/or metabolic disease, including
case 10 (supplementary table 6) with gangliosidosis GM1.
Two thirds of our cohort of 137 infants were born in a poor
condition. We used the clinical finding of depression at birth
manifested by Apgar scores or letal/neonatal acidosis as a
marker of an acute intrapartum event leading to birth
asphyxia. An assessment for neonatal encephalopathy in
Table 4 Histological evidence of brain damag e, including putative prenatal damage, in 59 neonates aged 3 days or less
Encephalopathic No encephalopathy No encephalopathy
BA group (n=10; 17%) BA group (rr = 36; 61%) BA group (n = 13; 22%)
Pathological feature Mature (n = 8) Preterm (n = 2) Mature (n = 13) Preterm (n = 23) Mature (n = 2) Preterm (n= 11)
Neuronal eosinophils 8 (100) 1 5 (38) 4(17) 0 4(36)
Neuronal karyorrhexis 8 (100) 1 1 (8) 4(17) 0 0
Grey matter infarcts 0 0 0 0 0 0
White matter gliosis* 7(88) 1 4(31) 9 (39) 1 0
Grey matter gliosis* 5 (63) 1 0 1 14) 0 0
Microglial upregulation 6(75) 1 2(15) 9(39) 0 1 (9)
Macrophages* 7(88) 1 1 (8) 8 (35) 0 0
Fresh haemorrhage 4(50) 0 6 (46) 11 (48) 0 5(45)
Haemosiderin deposits 0 0 0 0 0 0
Mineral deposits 1 (13) 0 1 (8) 6(26) 1 1 (9)
*Estimated prenatal brain damage 8 (100) 1 5 (38) 12(52) 1 0
Values in parentheses are percentages.
Mature, s»37 weeks; preterm, 24-36 weeks.
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Table 5 Features of asphyxia and presence of putative prenatal damage (PND)
Full term Preterm
Total PND Total PND
Features of asphyxia Clinical PM at PM Clinical PM at PM
Single feature only
Apgar < 5 at 5 min 9 7 3 35 15 8
Cord pH < 7.1 0 0 0 1 0 0
1st pH < 7.1 1 1 1 8 5 2
NNE 1 0 0 0 0 0
Two features
Apgar and low pH 7 5 1 9 3 2
Apgar and NNE 2 0 0 1 0 0
Low pH and NNE 0 0 0 1 0 0
Three features
Low pH, low Apgar and NNE 11 8 8 4 2 1
Total 31 21 13 59 25 13
One full term infant with prenatal damage had no asphyxia.
PM, Total of 47 infants who died at 3 days or less of age. NNE, Neonatal encephalopathy.
combination with these markers would have been more
specific,21 but many of our infants died within hours of
delivery, and a record of neurological examination was not
always obtained. In addition, the administration of muscle
relaxants to a fifth of our population precluded such an
assessment. Finally, 70% of our group were preterm and thus
unlikely to exhibit the classical signs of neonatal encephalo¬
pathy.
Clinical
The epidemiological background of this cohort is similar to
other recent studies from the developed world."2 "~51 Analysis
of the maternal sociodemographic information and the
detailed data from the pregnancy did not identify any reliable
predictors for birth asphyxia or for neuropathological
abnormalities. Significant placenta praevia and hyperemesis
were protective against asphyxia in general, possibly because
these mothers were more intensively monitored. Even taking
neonatal encephalopathy in isolation as a marker for prenatal
asphyxia, no differences were identified between encephalo-
pathic and non-encephalopathic asphyxiated infants in the
pregnancy or sociodemographic factors monitored in this
study. A history of pyrexia or flu-like illness in pregnancy has
previously been found to be associated with neonatal
encephalopathy.51 Our series did not show this association,
and pyrexia was more common in pregnancies thai resulted
in non-asphyxiated infants. Intrauterine growth restriction
has previously been strongly associated with neonatal
encephalopathy'" 5"52 and affected 14% of our population,
although not just the asphyxiated infants.
CTG abnormalities are common and are poorly predictive
of fetal acidosis.5' Both CTG abnormalities and meconium
staining of liquor were more common in infants with
prenalal damage in Ihis study, and CTG abnormalities proved
to be the only difference between the encephalopathy BA
and non-encephalopathic BA groups (80% v 43%, p < 0.04).
Randomised trials have shown that, although monitoring of
fetal heart rate can reduce the numbers of neonatal seizures,
there is no change in the incidence of long term neurological
damage,"" suggesting that some fetal heart rate abnormalities
may reflect prior compromise. Although meconium staining
alone has a high false positive rate," it is associated with
increased perinatal mortality and morbidity.56 It has been
hypothesised that intra-amniotic meconium may cause
vasoconstriction of the umbilical vessels" inducing fetal
hypoxia-ischaemia. This is difficult to substantiate after
delivery.
Neuropathology
About half (51%) of the 137 eligible infants had detailed
neuropathological investigation. The range of neuropatholo¬
gical abnormalities resembles those reported in previous
studies,28"15 58 00" "-69 71 although the prevalence of neuronal
damage and damage to the grey matter is higher than
elsewhere. Judgments about neuropathological abnormalities
are more difficult in the preterm than in the term brain.
Despite these difficulties, comparison of the asphyxiated
infants and those not apparently suffering from birth
asphyxia shows clear differences in terms of neuropatholo¬
gical changes. Examination confined to infants who died
within three days of the start of labour, and separation of
the asphyxiated group into those with and without neo¬
natal encephalopathy, identifies a spectrum of damage.
Unsurprisingly, the mature infants who died after displaying
neonatal encephalopathy are most likely to show neuro¬
pathological changes. All of the brains in this study were
carefully examined to determine whether any damage could
have occurred before the onset of labour. If it is accepted that
features such as focal or diffuse astrocytic hyperplasia and
parenchymal macrophage accumulation are cellular reactions
that require three days to become established, we may
conclude that most infants with features of birth asphyxia
had sustained brain damage prenatally, including all eight of
the full term encephalopathy group. We are unable to the
establish the age of the damage, but the background of
apparently normal brain development suggests that the
insult was sustained not long before the start of labour. It
is harder to draw conclusions about the preterm infants in
this study, but the absence of neuropathological changes in
virtually all the mature and most of the preterm infants who
did not display asphyxia is reassuring.
We do not underestimate the difficulty of interpreting
these neuropathological findings and attributing the time of
onset. Every abnormality has been included in supplemen¬
tary table 6, whether focal or diffuse, recent or old, but we
accept that interpretation is subjective. Establishing the
timing is difficult because experimental studies are not
possible in human infants, although classic studies were able
to relate pathology findings to major clinical incidents.6" 67
Some experts also comment that the results of animal work
may not be directly relevant to the human situation."167
Immunocytochemical investigation is mandatory to separate
reactive astrocytosis from myelination gliosis. A number of
the classic studies were conducted before cell specific
immunocytochemistry became available, although this is
not the case for more recent papers. Earlier papers may not
www.archdischild.com
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have always included, or added, the duration of labour as a
factor in timing, and interpretation may be hampered by
longer survival. It is noted that the infants with a history of
encephalopathy had survived for more than one day in most
instances. We concede that seizure activity may induce and
accelerate some of the changes seen in the brains of such
infants, but the presence of diffuse astrocytosis in other
infants who had survived very few hours and who died with
no evidence of seizure activity reinforces the possibility of
prenatal origin. A more secure evidence base for timing
neuropathological events awaits the evolution of new
markers of cell damage and irreversible cell death. The
clinical significance of some of the lesions described such as
diffuse astrocytosis, and in particular their contribution to
the cause of death, remains uncertain.
Correlation of clinical factors and neuropathology
This study has failed to identify any pointers that would
predict the birth of a compromised infant. Abnormal CTG,
and meconium staining of liquor were the only predictive
factors for birth asphyxia or prenatal brain damage. Previous
studies have reported an association between oligohydram¬
nios and prenatal brain damage possibly related to impaired
blood How in the umbilical cord. Abnormal CTG was the only
clinical factor differentiating the asphyxiated infants who
displayed encephalopathy and neuropathological abnormal¬
ity from those who did not. Recently the presence of prenatal
infection has been linked to brain damage. We found no
support for this association.
Implications for surviving infants
11 is possible that the neuropathological findings reported
here represent the most severe end of a spectrum of perinatal
brain damage resulting in a fatal outcome, while infants
surviving perinatal asphyxia might show lesser degrees of
similar pathology. However, the possibility also exists that
dead infants and survivors represent two completely different
groups in terms of both causation and pathology. Recent
neuroimaging studies of surviving neonates with encephalo¬
pathy, with or without seizures, have a bearing on these
questions. A large study by Cowan et al" concluded, on the
basis of magnetic resonance imaging performed in the first
two weeks of life, that brain damage in mature infants with
neonatal encephalopathy was most often acute and of
perinatal onset particularly in an encephalopathic group
without seizures. Very few infants in that study displayed
evidence of prenatal brain damage on magnetic resonance
imaging. Neuropathological corroboration was achieved in
very few cases. In the absence of immunocytochemical
investigation of gliosis and brain macrophage accumulation
in all deaths, their conclusions about the prevalence of
prenatal abnormalities may be an underestimate. We have
discussed the difficulty of timing the lesion in our own study,
in which conclusions on the presence or absence of prenatal
brain damage were confined to infants who died less than
three days after the onset of labour and based on neuro¬
pathological examination rather than imaging. We suggest
that the cerebral insult was probably sustained only shortly
before the onset of labour (even possibly precipitating the
onset of labour). Evidence of continuing neuronal damage
was also present in our series, not dissimilar to the findings
of Cowan et al, but this was often in addition to the damage
identified as occurring before labour within the constraints of
current knowledge. It might be expected that brain damage
in survivors would be less extensive and severe than in those
with a fatal outcome. Whether the brain damage observed in
our study represents the result of persisting or repeated
insult, or the onset of a potentially reversible cascade
accruing from a single insult, is uncertain. A multistep
pathological process might present opportunities for inter¬
vention to limit further brain damage.
The fact that a significant proportion of clinically
asphyxiated infants display no evidence of brain damage,
and that infants who are not asphyxiated at birth often
display only recent postnatal damage, offers hope for a good
clinical outcome if such infants could be identified and
"rescued" by medical intervention. This study shows that the
current battery of investigations associated with pregnancy
and labour remain blunt instruments in accurately predicting
Ihe arrival of an asphyxiated and prenalally brain damaged
infant. Future work must address the development of
methods for detecting antepartum damage so that optimal
management of these vulnerable fetuses can be planned.
Further evidence is also required on evolution of cellular
reactions in the developing brain. The findings in this study
support the notion that the birth of a compromised
"asphyxiated" encephalopathic infant is not necessarily the
result of a mismanaged labour nor the lack of vigilance in
pregnancy.
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Abstract
The different alleles of the human apolipoprotein E poly¬
morphism, ApoE s2, e3, e4, have important implications
for systemic lipid metabolism, immunological function
and for the brain in maintenance and in response to in¬
jury. Few studies have focussed on their role in early life.
The ApoE alleles and genotypes were ascertained in the
cord blood of 371 full-term and normal Scottish newborn
infants using PCR methodology. The results were com¬
pared to previously published data for Scottish adults in
late middle age. There was a marginally significant over-
representation of s4 and under-representation of s3 al¬
leles in healthy infants as compared with adults. Inspec¬
tion of the individual genotypes confirms the over-rep¬
resentation of ApoE 4/4 and 2/4 with a reduction in ApoE
2/3 and 3/3 when compared with Scottish adults. Al¬
though these results may have occurred by chance, the
ApoEs4allele mayconferan increased risk of premature
death.
Copyright © 2005 S. Karger AG, Basel
Introduction
Apolipoprotein E (ApoE) is a normal component of
the very-low-density lipoprotein (VLDP) fraction in plas¬
ma in humans and many animal species, with an impor¬
tant role in lipid uptake and binding to specific lipopro¬
tein receptors and in cholesterol metabolism. ApoE poly¬
morphism was demonstrated by isoelectric focussing and
absence of certain isoforms was associated with hyper-
lipidaemia III [ 1 ]. After initial confusion, the genetic con¬
trol of ApoE subtypes was narrowed down to a single
locus on chromosome 19 with three alleles [2], giving rise
to six phenotypes.
Much of the early clinical interest in ApoE related to
hyperlipidaemia, atherosclerosis and risk of coronary ar¬
tery disease [3]. The relative frequencies of the common
alleles in many populations were calculated from samples
from blood donors or healthy volunteers. The frequency
of the e3 allele in Caucasians is remarkably similar irre¬
spective of country ofdomicile, although there are differ¬
ences in s2 and e4 frequencies between some of the groups
studied [3],
Although the age range of the normal or control sub¬
jects is recorded in many studies, there are few where re¬
sults are stratified by age and only a single French study
[4] where a comparison was made between children and
parents, which showed no significant differences between
the two groups. Herrmann et al. [5] examined the plasma
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apolipoprotein levels in German newborns and related
these to the ApoE phenotype.
The importance of ApoE in neurodevelopment and
neurological disease, particularly Alzheimer's disease,
has emerged during the last decade [6-8]. The relation¬
ship of different alleles to the response to head trauma [9]
and ischaemic brain injury [10, 11] has been described
more recently.
Our interest in a potential role for ApoE in the devel¬
opment of prenatal and perinatal brain injury prompted
us to examine the relative frequency of ApoE alleles in
healthy Scottish newborns and compare the results with
data previously published for healthy Scottish adults [ 12],
providing a baseline for further studies.
Material and Methods
This study was approved by the Lothian Research Ethics Com¬
mittee (LREC 1998/6/53).
Healthy liveborn infants: Blood spots were collected on Guthrie
cards from umbilical cord blood samples obtained randomly from
placentas in the delivery unit in the Royal Infirmary of Edinburgh.
All infants were full-term infants with birth weights greater than
2 kg. No maternal or infant demographics were collected. How¬
ever, none of the infants gave cause for concern and all left hospital
when due to do so. The samples were collected anonymously and
stored before analysis in batches. Four hundred and eight blood
spots were obtained.
Healthy adults: Data previously published on ApoE distribu¬
tion in 400 healthy Scottish adults between the ages of 45 and 60
with a mean age of 53 ± 0.22, who were born in North East Scot¬
land, were used for comparison with healthy newborn infants in
this study [12], This adult sample was randomly selected from Gen¬
eral Practitioner lists.
Two 2-mm holes were punched from each blood spot into a
0.3-ml, 96-well PCR rack using a clean Harris micro-punch (Lab
Sales, Cambridge UK, Catalogue No. WB10-0007). 200 p.1 of FTA
reagent (Lab Sales Catalogue No. WE 12-0204) was added and the
rack placed in a shaker for 5 min at room temperature to remove
impurities. Washing was performed three times leaving bound
DNA on the card. The treated card was washed twice with Tris-
buffered EDTA. The card was allowed to dry thoroughly, overnight,
at room temperature. The ApoE PCR methodology was adapted
from Hixson and Vernier [13] and is detailed below.
An initial DNA denaturing at 95°C for 2 min was followed by
30 cycles at 94°C for 30 s, 62°C for 30 s, 72°C for 1 min and a final
extension of 72°C for 5 min. The PCR reaction mixture contained
34.55 pi double-distilled H20, 5 pi 10 x PCR buffer (Invitrogen),
1.8 pi 50 mWMgCL, 8 pi 1.25 mM dNTPs, 20 pmol of each prim¬
er, 1.25 U taq DNA polymerase (Invitrogen). The customised prim¬
ers were MWG (Biotech) and are shown below:
Downstream primer: ACA GAA TTC GCC CCG GCC TGG
TAC ACT GCC A
Upstream primer: TCC AAG GAG CTG CAG GCG GCG
CA
Table 1. Comparison of observed allele distribution with Hardy-
Weinberg expectation
E3 homo- E3 hetero- No Total
zygotes zygotes E3
Healthy newborns
Numbers observed 192 139 31 362
Hardy-Weinberg expectation 188 146 28 362
Adults
Numbers observed 232 152 16 400
Hardy-Weinberg expectation 237 142 21 400
10 pi of each PCR reaction was run on a 2% agarose gel and
visualised with ethidium bromide under UV light. The resultant
PCR product was 227 bp in size. This was digested overnight with
1 pi IJhal restriction digest enzyme (New England Biolabs) at 37°C.
Samples were then run on a 4% Metaphor agarose gel, visualised
with ethidium bromide under UV light and photographed.
The genotype for each sample was determined from the migra¬
tion pattern of bands in the gel. The number ofalleles in each group
was compared with published data forthc Scottish adult population
using the x2 test for trend.
Results
Unambiguous results were obtained from 371 of 408
samples. The failure of satisfactory analysis of the re¬
maining 37 samples was attributed to the extraction of
insufficient DNA from the blood spot or the degradation
of DNA in those blood spots stored for more than 12
months.
Table 1 shows the frequency of ApoE genotypes in
each population sample compared with the Hardy-Wein-
berg distribution. For each population, departure from
the Hardy-Weinberg equilibrium is trivial and not statis¬
tically significant (table 1).
The distribution and values ofalleles in normal healthy
babies is compared with published data from healthy
adults in a Scottish population [12] and comparison of
the genotypes within the two populations are shown in
table 2. The \2 for trend of the alleles shows a marginally
significant over-representation ofe4 and lesse3 in healthy
infants as compared with adults, and inspection of the
individual genotypes (table 2) confirms the over-repre¬
sentation of 4/4 and 2/4 with a reduction in 2/3 and 3/3
when compared with Scottish adults.
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Table 2. Contingency table comparing normal Scottish adults [12]
and healthy Scottish newborn infants
Cohort e2 s3 e4 Total
Alleles
Adults (n = 400) 66 (8%) 616(77%) 118 (15%) 800
Newborn (n = 371) 63 (8%) 538 (72%) 141(19%) 742
x2 for trend: e2 p = 0.93, e3 p = 0.049, e4 p= 0.024
2/2 3/3 4/4 2/3 2/4 3/4
Apo E genotypes
Adults 2 233 4 51 11 99
Newborn 2 199 15 44 15 96
X2 p = 0.109 overall
Discussion
Interest in ApoE initially concentrated on its impor¬
tance in lipoprotein and cholesterol metabolism [14]. It
has become apparent that ApoE has more diverse roles
in development and in reaction to insults, not only di¬
rectly in the central nervous system but also indirectly
through its modulation of immune responses [8]. The
three isoforms ofApoE differ by only a single amino acid
substitution at one of two sites [3], but these apparently
small differences alter their role in metabolism enor¬
mously [8],
ApoE is strongly expressed within the brain particu¬
larly in astrocytes [15] where ready availability of lipids
and cholesterol is essential for maintenance and repair of
cell membranes [16]. The relative frequency of different
alleles of ApoE has been calculated for many population
groups. The e3 allele is the commonest in all published
studies. In most populations, the next commonest is s4.
Amongst Caucasians, whose allele frequency has been
studied in many countries, the relative frequency of al¬
leles is remarkably similar, apart from Finnish subjects.
All studies in Caucasians have shown an e3 frequency of
<0.79, lower than the frequency amongst American Indi¬
ans, Chinese and Japanese (>0.82). There are, however,
differences in e4 and e2 distribution between geographi¬
cally separated Caucasian groups, most notably a signifi¬
cant reduction in e2 frequency with an excess of s4 in a
Finnish population [3].
Few investigators have looked at the effect of age on
ApoE allele frequency. No difference in the distribution
of ApoE alleles was shown between young and old [17],
nor between parents and children [4], Herrmann et al. [5]
examined 199 German newborns and found an excess of
ApoE e3 and e2 with reduced prevalence of e4, a result
which contrasts with the present findings.
Our study of healthy newborns from the South East of
Scotland was carried out to provide baseline information
for planned studies of ApoE status of defined groups of
babies dying in the prenatal and infant periods. We have
demonstrated an excess of the e4 allele and a correspond¬
ing decrease in the s3 allele amongst 371 healthy babies
at birth when compared with allele frequencies amongst
400 healthy Scottish adults. Although this population of
adults was a historical cohort, the distribution of allele
frequencies is similar to other adult Caucasian popula¬
tions reported in the literature [3], Davignon et al. [3]
reviewed the published data and found that in 5,805 Cau¬
casians the ApoE allele frequency was 0.08 for e2, 0.77
for s3 and 0.15 for e4, a distribution which is precisely
the same as that reported for the Scottish adult popula¬
tion used in this study. The decline in ApoE e4 between
birth and late middle age in the Scottish population may
reflect an increased mortality of e4 carriers between these
ages. Possession of the e4 allele in adults is strongly as¬
sociated with coronary heart disease [3], an important
cause ofmorbidity and premature mortality amongst the
Scottish adult population.
Our findings support the suggestions of Zetterberg et
al. [18] that the e4 allele may exert a protective effect on
the developing embryo or fetus resulting in an excess of
e4 at birth. Wright et al. [19] describe improved neuro-
developmental scores in children with ApoE e4 allele at
the age of 2 years. Other studies suggest that the e4 allele
may be associated with improved cognitive performance
and higher educational achievement in early adulthood
[20, 21], This is in contrast to the well-described adverse
effects of the e4 allele on memory function and the pre¬
disposition to dementia in later adulthood [7, 22], Natu¬
ral selection may favour genes conferring short-term ben¬
efits at the cost of deterioration in later life. Antagonistic
pleiotropic effects of the ApoE e4 allele may be respon¬
sible for protective effects early in life but deleterious ef¬
fects in late adulthood. It may be relevant that the high
cholesterol levels associated with the s4 allele do not be¬
come apparent until children are aged at least 3 years [23,
24] in keeping with delayed appearance of allele-associ-
ated deleterious effects.
ApoE has wider relevance than merely its influence on
lipid and cholesterol metabolism [8] and these other ef¬
fects should not be ignored. Mahley and Rail [8] have
speculated about a role for e4 in reducing susceptibility
to infection and it is well recognised that infection of the
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gestation sac is a common cause of spontaneous delivery
in the late second and early third trimester of pregnancy
[25-27], although fetal infection is a lesser, but neverthe¬
less important, cause of fetal wastage. The appreciation
that ApoE is involved in some intracellular signalling
pathways and may have a role in apoptosis [8] offers up
a wide range of targets for influencing embryonic devel¬
opment.
Another approach to the investigation of a potential
advantage of e4 to the embryo or fetus is to investigate
ApoE allele status at different gestations in the context of
the presence or absence of specific pathological disorders,
both generalised and organ specific. Such investigations
may further expand our understanding of the diverse
roles of ApoE and of the specific mechanisms involved.
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Summary
Despite the clinical and medicolegal significance attached
to perinatal asphyxia, the neuropathological basis of this
condition remains obscure. There are very few studies in
the literature which correlate the pathological findings in
neonatal brains with detailed epidemiological data, and
none which are population based. In a Scotland-wide
study of neonatal deaths, 70 brains have been examined.
On the basis of glial and macrophage reactions, we previ¬
ously identified infants with putative antepartum brain
damage in this cohort and have related these reactions to
signs of birth asphyxia The present study explores the
extent of neuronal/axonal injury in these infants since
this is likely to be the basis for neurological deficits in sur¬
viving infants. We have also investigated these brains for
P-amyloid precursor protein (pAPP) positivity to deter
mine whether this is a useful marker of neuronal injury
in neonates. Neuronal eosinophilia and karyorrhexes were
detected in 43% and 27% of the cohort, respectively; max¬
imally in the subiculum and ventral pons, but often present
elsewhere White matter damage was detected in 24% of
cases but without classic cystic lesions of periventricular
leucomalacia. pAPP positivity was present in neuronal
soma in 52% of cases and, in axons, in 27% of cases, and
was seen from as early as 25-weeks gestation. Axonal bulbs
were clearly delineated by PAPP positivity and were usu¬
ally located in the cerebral white matter and internal cap
sule, and infrequently in the brain stem. Although white
matter damage and pAPP axonal positivity were often
detected in the same cases (P = 0.034), these features also
occurred independently ofeach other. Both neuronal kary¬
orrhexes and white matter pAPP positivity were signific¬
antly correlated with the features of birth asphyxia,
particularly a history of seizures. Immunocytoehemistry
for both pAPP and glial fibrillary acidic protein proved
useful in detecting neuropathological features which
escaped detection on routine examination, particularly
in preterm infants. The presence together of recent and
older damage in individual brains suggests that there is
an ongoing neuronal response to cerebral insults. We
find that PAPP is a useful marker of white matter damage
in the neonatal brain. Immunopositivity for pAPP in these
circumstances is not attributable to inflicted or accidental
trauma. While birth related trauma cannot be ruled out,
hypoxia/ischaemia is a likely cause in these infants.
However, the exact pathogenesis ofneuronal/axonal injury
in the neonatal brain remains unclear.
Keywords: neonatal death; neuropathology; amyloid precursor protein; axonal injury; antepartum brain damage
Abbreviations: PAPP = p amyloid precursor protein; GFAP = glial fibrillary acidic protein; H&E = haematoxylin
and eosin
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Introduction
The origins of childhood neurological deficits are still poorly peripartum events are of uncertain predictive value. Perinatal
understood. Complications of pregnancy and adverse asphyxia in the majority of cases is not followed either by
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neonatal encephalopathyorby cerebral palsy (Hall, 1989; Nelson,
1989; Nelson and Leviton, 1991; Blair and Stanley, 1993;
Yudkin et al., 1995; Edwards and Nelson, 1998) and there is
international consensus (the International Cerebral Palsy Task
Force) that encephalopathy and cerebral palsy are infrequently
caused by perinatal asphyxia (Bakketeig, 1999; MacLennan,
1999). However preterm delivery is a recognized risk factor for
such conditions (Murphy etal., 1995,1997;Wood etc/., 2000).
Major cohort studies of neonatal encephalopathies and
related clinical conditions have shown that the associative
factors are surprisingly diverse (Badawi et al., 1998n, b).
However, these studies seldom include data on neuropatho-
logical findings of the deceased infants. On the other hand,
reported perinatal neuropathological studies usually represent
the collected experience of specialist referral centres (Gilles
and Murphy, 1969; Rorke, 1982; Levene etal., 1985; Pape and
Wigglesworth, 1989; Squier and Keeling, 1991; Marin-
Padilla, 1996, 1997, 1999), or focus on particular age groups
such as preterm infants (Skullerud and Westre, 1986; Leviton
and Paneth, 1990; Paneth et al., 1990; Golden et al., 1997;
Gilles et al., 1998). Only a small number of studies have
investigated the clinical correlates of identified neuropatho¬
logical features (Ellis et al., 1988; Mito et al., 1993; Gaffney
et at., 1994). Although in recent years neuroimaging has
proved to be a powerful tool for studying the extent and
location of lesions in the perinatal brain (Cowan et al., 2003),
neuropathological examination may be more sensitive for
defining the nature of lesions. There is a complete dearth of
studies designed tomatch detailed neuropathology with equally
detailed demographic data in unselected groups of neonates.
The Scottish Perinatal Neuropathology Study was set up to
investigate these issues and, in particular, to establish the
prevalence of brain damage in a national cohort of perinatal
deaths, including stillbirths and early neonatal deaths from
24 weeks gestation to 1 week of postnatal age, occurring
during a 2 year period in the late 1990s. We recently repor¬
ted that evidence of antepartum brain damage in the neonates
in this cohort was more prevalent in those displaying signs of
birth asphyxia than in non-asphyxiated infants (57% versus
8%), particularly in those who had suffered seizures (90%)
(P < 0.005) (Becher et al., 2004). The assessment of brain
damage in these neonatal deaths was based mainly on the
detection of glial and microglial/macrophage responses.
However, the important question of neuronal damage was
not explored in our previous study.
In the present study, we further investigated this group of
neonates to determine the prevalence of neuronal damage, and
particularly of axonal injury, in relation to reactive changes in
supporting cells and to the clinical history. One reliable mar¬
ker of axonal injury, p amyloid precursor protein (PAPP), has
rarely been investigated in the human infant brain other than
in medicolegal cases (Arai et al., 1995; Baiden-Amissah etal.,
1998; Geddes et al., 200la, b; Reichard et al., 2003). It is
recognized that both traumatic and hypoxic axonal injury is
associated with PAPP positivity (Geddes et al., 2001 a, b). In
this study, we examined 70 neonatal brains for the presence of
PAPP positivity in relation to other evidence of brain damage
and to the clinical history.
Material and methods
In the Scottish Perinatal Neuropathology Study, we set out to exam¬
ine the brain in all neonatal deaths (24 weeks gestation to 1 week
postnatal) occurring during a two-year period in Scotland. Infants
with chromosomal, cardiac and CNS abnormalities and with CNS
infections were excluded. Post-mortem examination was achieved in
51% of the eligible cases (n = 137 in total, 70 brains examined).
These 70 infants were divided into those who had died within 3 days
of the onset of labour (n = 59) and those who had died between 3 and
7 days (it = 11). The three-day cut-off point was selected because
changes such as macrophage accumulation and astrocytic hyper¬
plasia are thought to require 3 days to become evident, from
which we inferred an antepartum origin for these reactions.
Cases were co-ordinated from all 22 Scottish obstetric units
through obstetric, pacdiatric, paediatric pathology and ncuroputho
logy colleagues. Consent for research use was obtained from the
parents and the study was approved in each centre by the local
research ethics committee.
Clinico-epidemiological data was gathered for each case. Up to
20 paraffin blocks were prepared from each brain according to a
standard protocol and included representative samples from the
corobrum and hippocampus, basal ganglia and lhalami, midbrain,
pons, medulla, vermis and cerebellar hemispheres. Sections were
examined after staining with haematoxylin and eosin (H&E), and
with antibodies to glial fibrillary acidic protein (GFAP) (Dakocyto-
mation Ltd; Ely, UK; diluted 1:1000, with trypsin pretreatment at
37°C for 20 min), the macrophage marker CD68 (Dako; diluted
1:200, with microwave antigen retrieval) and (3APP (Chemicon
Europe Ltd; Chandlers Ford, UK; monoclonal clone 22C11, diluted
1:100, with microwave antigen retrieval).
Sections were assessed independently by two observers (J.E.B. and
B ,W.) without reference initially to the clinical history or to the results
of the other staining procedures. Neuronal damage was assessed in
routinoly otainod preparations by evidence of neuronal oosinophilia
and/or karyorrhexis as well as the presence of axonal swellings in the
white matter. The presence or otherwise of astrocytic hyperplasia,
macrophage accumulation and microglial uprcgulation as well as
(3APP positivity in neuronal soma and axons were scored as positive
or negative for each case. Concordance between the two observers
was achieved in >90% ofcases and discrepant cases were resolved at a
multiheaded microscope and by further review (J.K.). The localiza¬
tion and patterns of plAPP immunopositivity was correlated with
gestation, clinical history and evidence ofglial and macrophage reac¬
tions, as well as with evidence of neuronal and white matter damage
assessed on routine (H&E) staining throughout the brain.
Statistical analysis was performed using the x2 test (Fisher's exact
test where sample size was <20).
Results
Clinical details
Of the 70 neonates enrolled in this study, 26 were mature
infants (2=37 weeks of gestation) and 44 were preterm (24—
36 weeks) (Fig. 1). Thirty-eight infants were delivered by
Caesarean section, performed as an elective procedure in one
case and as an emergency in 37 (before the onset of labour in
half of these and usually precipitated by cardiotocograph
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Fig. 1 Cohort of neonatal deaths.
abnormalities). The mature infants lived for between 15 min
and 7 days with only three surviving for >3 days. The preterm
infants lived for between 5 min and 5.5 days, with only eight
infants surviving for >3 days. Neonatal encephalopathy was
observed in 10 mature and five preterm infants. Most infants
died of the effects of prematurity, or of congenital anomalies
other than those of the CNS (which were excluded from the
study), or of 'anoxia'. Fifty-three of the 70 neonates displayed
one or more clinical signs of perinatal asphyxia, including
15 with seizures (10 of those infants died aged <3 days),
while 17 did not appear to be asphyxiated. Perinatal asphyxia
was defined in this study by the presence of one or more of the
following: (i) an Apgar score of S5.0 at 5 min; (ii) a cord or
initial blood pH of <7.1; and/or (iii) grade 2/3 encephalo¬
pathy. Signs of birth asphyxia wore associated with a higher
prevalence of antepartum brain damage (57% versus 8%, P <
0.005), but were not predictive in all cases. Oligohydramnios
and meconium staining of the amniotic fluid were also
associated with antepartum brain damage, but there was no
concordance with placental pathology. A detailed anulysis of
these and other clinicoepidemiological factors, which may
have contributed to neonatal death and to antepartum brain
damage in this cohort, has been published previously (Becher
et al., 2004).
Routine neuropathological findings
Assessment of neuronal damage was first undertaken in
sections stained with H&E. Neuronal eosinophilia (Fig. 2A),
marking recent onset hypoxic change, was observed in some
or all differentiated nerve cell bodies in the cerebral cortex,
basal ganglia, brain stem, particularly in the ventral pons
and inferior olive, and in the cerebellar dentate nuclei and
Purkinje cell layer. Karyorrhectic neuronal nuclei (Fig. 2B)
were observed in a similar distribution, but additionally in the
dentate gyrus of the hippocampus and in the cerebellar granu¬
lar layer in occasional cases. If neuronal karyorrhexes were
only present in very small numbers, they were considered
indistinguishable from the normal neuronal drop out known to
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Fig. 2 Evidence of brain damage in grey matter. (A) Eosinophilic hippocampal neurons from a 41-week gestation infant who survived
for 1 day. H&E staining. (B) Pontine neurons in a 39-week gestation infant who survived <1 day. Karyorrhectic neurons are shown
(arrows) between more nearly normal neurons. H&E staining. (C) Cerebellar cortex from a 38-week gestation infant who survived just
under 2 days. Very few Purkinje cells survive at the interface between molecular and internal granular layers. H&E staining.
(D) Cerebral cortex from a 42-week gestation infant who survived 7 days and who displayed widespread cortical necrosis. Surviving cortex
showed neovascularization (arrows) and the tissue is beginning to disintegrate. H&E staining. (E) The cerebellar cortex shown in
(C) stained for microglia/macrophages using an antibody to CD68. Macrophages are concentrated along the former Purkinje cell layer.
(F) Cerebral cortex from a 26-week gestation infant who survived for 40 min. A focal infarct, marked by CD68 positive macrophages,
is shown in the cortex. (G) More generalized cortical CD68-positive macrophage infiltration is present in the cortex of the infant
shown in (D). (H) A GFAP-positive cortical glial response is also present in the case illustrated in (D) and (G).
occur during development and were disregarded. Even when
present in large numbers, the changes affected only a
subpopulation of neurons in the neocortex, but were more
numerous and concentrated in the subiculttm of the temporal
lobe (spreading to involve the entorhinal cortex and the
neighbouring sectors of the cornu ammonis) and in the ventral
pons. The most severely affected cases showed loss of
most Purkinje cells (Fig. 2C). Neuronal eosinophilia was
identified in 43% of the cohort and karyorrhexes in 27%.
Occasional infants showed cortical infarction with prominent
neovascularization and perivascular fibrosis (Fig. 2D).
Figures 2E-G show focal and diffuse macrophage responses
in the context of neuronal loss, not all of which had been
suspected on routine staining (Fig. 2F). Cortical damage also
results in a conspicuous glial response (Fig. 2H). Case-by-
case glial and macrophage reactions are shown in Table 1.
Evidence of white matter damage in routinely stained sec¬
tions was present in 24% of cases, ranging from eosinophilic
homogenization of the neuropil to areas of frank infarction, in
relation to which axonal retraction bulbs (Fig. 3A) were
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identified in three cases and with more widespread surround- hyperplasia (Fig. 3B). Even in apparently normal white
ing white matter damage. Moderate numbers of karyorrhectic matter (Fig. 3C), unexpected astrocytic hyperplasia was
glial nuclei were identified within damaged white matter, sometimes revealed by GFAP immunostaining (Fig. 3D). In
accompanied by macrophage infiltration and astrocytic contrast, Fig. 3E shows normal white matter astrocytic
Table 1 Pattern of $APP positivity in 70 neonatal deaths, correlated with glial and macrophage reactions
(A) Infants dying within 3 days (n = 59)
Cases with Gestation (3APP PAPP PAPP Metabolic Reactive Macrophage
antepartum (asphyxia neurons axons mineralizing astrocytosis astrocytosis reactions
damage (» = 27) at birth) foci
1 (E) 41 (+) + + — _ + +
2 (E) 41 (+) + + - + + +
3 (E) 40 (+) + - - - + +
4(E) 40 (+) + - + - + +
5 (E) 39 (+) + + + - - + +
6 (E) 38 (+) + _ - - + -
7 (E) 38 (+) + + - + + +
8 (E) 37 (+) + - - + + +
9 (E) 36 (+) + - - + + +
10 40 (+) + + - - + +
1 1 36 (+) + - + + - + +
12 35 (+) + - - - + +
13 36 (+) -F- + + + - + +
14 32 (+) + -+- + - + -
15 28 (+) - - + + + +
16 28 (+) + - - - + +
17 27 (+) + - - -+- + +
18 25 (+) - + + - +
19 26 (+) - - - - - +
20 24 (+) _ - - - + -
21 40 (+) - - - - + ±
22 40 (+) _ - - - + +
23 26 (+) - - - - - +
24 25 (+) + - - - - +
25 42 (—) + - + - + -
26 40 (+) - + - - + -
27 40 (+) + - - + + -
Cases with Gestation (3APP PAPP PAPP Metabolic Reactive Macrophage
postnatal (asphyxia neurons axons mineralizing astrocytosis astrocytosis reactions
damage (n - 21) at birth) foci
28 24 (+) _ _ _ _ _ _
29 36 (-) + - - - - -
30 28 (-) -+- - - - - -
31 24 (+) - - - - -
32 39 (+) + - - - - -
33 31 (-) + _ + - - -
34 24 (+) - - - - - -
35 24 (+) - - - - - -
36 36 (+) — - - - - -
37 40 (+) + + - - - -
38 25 (-) - - - - - -
39 42 (+) ■jr - - - - -
40 38 (-) - - - - - -
41 27 (-) - _ _ _ - -
42 29 (+) + - - - - -
43 (E) 25 (+) - - + - - -
44 41 (+) - - - - - -
45 30 (-) NA NA NA - - -
46 25 (+) - + - + - -
47 24 (-) - - - - - -
48 38 (+) - - + - - -
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Table 1 Continued
Cases with Gestation @APP (3APP (3APP Metabolic Reactive Macrophage
no damage (asphyxia neurons axons mineralizing astrocytosis astrocytosis reactions
(n = 11) at birth) foci
49 40 (+) +
50 32 (-) + - -
51 35 (-)
52 25 (+) -
53 25 (+) - -
54 27 (+) - +
55 42 (+) -
56 30 (+) - -
57 26 (-) -
58 38 (+) ± -
59 25 (-) +
(15) Infants dying at 4-7 days (n = 11)
Damaged and Gestation (3APP (3APP (3APP Metabolic Reactive Macrophage
undamaged (asphyxia neurons axons mineralizing astrocytosis astrocytosis reactions
cases (n = 11) at birth) foci
60 41 (-) + + + + + -
61 27 (+) + - - - + +
62 25 (-) - + - - - -
63 (E) 27 (+) - + + - + +
64 (E) 42 (+) + + - - + + + +
65 27 (-) - - - - - -
66 (E) 36 (+) + - + + - + +
67 (E) 29 (+) + - + - + +
68 (E) 39 (+) + + - - + +
69 34 (-) - + - - - -
70 26 (+) + + + - - + +
E = infants displaying encephalopathy; NA = blocks returned to source hospital before (3APP staining was performed.
negative; ±, occasional positive cells or features across the section; +, moderate number of positive cells or features across this section;
+ + , very numerous positive cells or features across this section.
immunoreactivity in this age group. No foci of cystic peri¬
ventricular Ieucomalacia were seen.
Small foci of perivascular mineralization were present
in the central white matter in 19% of the total cohort,
more commonly in the preterm infants. One case displayed
extensive mineralization in the basal ganglia and internal
capsule.
In nine cases, glial nuclei in both white and grey
matter were enlarged, pale and prominent (Fig. 3F), resem¬
bling the Alzheimer type II astrocytes observed in hepatic
encephalopathy. Although the cytoplasm of such cells was
not generally prominent, they were GFAP positive (Fig. 3G)
and, in most of these cases, a reactive astrocytosis was con¬
firmed in the white matter. Some mature neonates showed
prominent changes of so-called myelination gliosis (glial
cells with small darkly stained nuclei and prominent asym¬
metric cytoplasm, often arranged in rows) (Fig. 3H), but such
cells did not prove to be GFAP reactive in contrast to jux¬
taposed normal astrocytes (Fig. 31). Interpretation of such
cases sometimes proved difficult on routine staining, espe¬
cially in the presence of incipient white matter damage, and
GFAP staining proved essential for the detection of true
astrocytic hyperplasia.
Immunoreactivity for fiAPP
(3APP immunopositivity was more prevalent in grey matter
(neuronal perikarya, 53%) than in white matter (axons, 27%)
(Table 1) Three patterns of (3APP positivity were observed in
the cases in this study.
(3APP was detected in neuronal cell bodies in 52% of the
study cases; this occurred in both mature and preterm infants
(Table 1), varying from global expression in all differentiated
neurons to particular subsets of neurons in the cortex (Fig. 4A),
basal ganglia, cerebellum or brain stem. The inferior olivary
nuclei and neurons in the floorof the fourth ventricle, the dentate
nuclei and the Purkinje cells were particularly likely to display
(3APP positive neurons. The neurons of the immature cortex in
premature babies and the germinal matrix cells and migrating
foci were generally negative. Staining of the perikaryon
occurred both in morphologically normal cells and in those
which proved to be eosinophilic or frankly karyorrhectic on
routine staining, although not all karyorrhectic neurons were
positive (Fig. 4B). Within the hippocampus, the CA1 sector
neurons were occasionally unstained when the rest of the cornu
ammonis and the neurons of the subiculum were positive.
Axonal (3APP positivity was detected in 27% of study cases
(Table 1) and was seen predominantly in the periventricular
1076 J. E. Belle.t al.
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Fig. 3 Evidence of white matter damage and glial/macrophage reactions. (A) A focal area of white matter damage, marked by eosinophilic
axonal bulbs (arrowed) is seen in a 28-week gestation infant who survived for nearly 3 days. The area of damage was in the proximity of a
germinal matrix haemorrhage. H&E staining. (B) White matter damage characterized by astrocytic hyperplasia (fine arrow) and glial
karyorrhexes (broad arrow) present in a 42-week gestation infant who survived 7 days. H&E staining. (C) Survey of apparently
unremarkable white matter in a 42-week gestation infant who survived 4 h. H&E staining. (D) lmmunostaining with an antibody to GFAP
reveals reactive astrocytosis in the infant shown in (C). (E) lmmunostaining for GFAP in an infant age- and stage-matched with the infant
shown in (C) and (D) who did not show white matter astrocytic hyperplasia. (F) Glial nuclei in the basal ganglia of a 41-week gestation
infant who survived for nearly 2 days. Eosinophilic change is seen in neurons within this field and astrocytic nuclei are pale and somewhat
irregular. H&E staining (G) immunostaining of the basal ganglia shown in (F) reveals that the pale glial nuclei are associated with GFAP
positivity (arrows) without displaying cytoplasmic hyperplasia. (H) White matter from an infant of 41-weeks gestation who survived for
just over 1 day displaying 'myelination' gliosis. Lines of glial nuclei, some with eosinophilic cytoplasm (arrowed) are shown. H&E
staining. (I) Same case as (H) stained for GFAP. While the majority of cells in the glial columns are GFAP negative (fine arrow), there is an
occasional interposed GFAP-positive cell (broad arrow).
central white matter of the cerebral hemisphere and the white
matter of the cerebellum. Well-demarcated positive axons
were particularly common in the internal capsule (Fig. 4C).
Staining patterns varied from smudgy irregular patches of
positivity in otherwise apparently normal white matter, to
clearly demarcated single axons or bundles of axons, often
with evidence of axonal beading. Axonal bulbs and vari¬
cosities were most numerous in association with areas of
infarction or haemorrhage and were strongly positive for
PAPP. The brain stem showed only occasional axonal posi-
tivity, particularly in the cerebellar peduncles, in contrast with
frequent positivity observed in neuronal soma in the stem.
Perivascular and white matter mineralizing foci were
strongly positive for PAPP in all the cases in which this
feature had been noted in routinely stained sections (15 out
of the 70 study cases; 21%) (Fig. 4D), including the case with
significant mineralization in the internal capsule (Fig. 4E).
These foci were particularly common in the basal ganglia

















Fig. 4 (3APP immunoreactivity in the neonatal brain. (A) Hippocampal neurons from the infant shown in Fig. 2A displaying positivity
for PAPP, co-localizing with eosinophilia. (B) Pontine neurons from a 39-week gestation infant who survived 14 h and who displayed
prominent neuronal karyorrhexes in the ventral pons. Many karyorrhectic neurons are PAPP positive (fine arrow), but an occasional
affected neuron is negative (broad arrow). (C) Internal capsule from the infant whose pons is illustrated in (B). Bundles of PAPP positive
axons are seen and some of these display axonal bulbs. (D) Perivascular deposits of mineral in the basal ganglia are positive for PAPP in a
41-week gestation infant who survived 4 days. (E) Large focus of mineralization in the internal capsule of a 36-week gestation infant who
survived 7 h. The mineralized area is strongly positive for PAPP.
and associated white matter. Mineralized foci did not stain
positively with antibodies to GFAP and CD68.
Each of these patterns of [3APP positivity was sometimes
found in isolation but much more frequently in association
with glial and macrophage responses (Table 1). PAPP posi¬
tivity was found occasionally in neurons in cases in which no
other evidence of damage had been detected. Conversely, in
five cases displaying microglial/macrophage and/or glial
responses suggestive of antepartum damage, no PAPP posi¬
tivity was detected. Although faint pAPP positivity was noted
in reactive astrocytes, glia and blood vessels were generally
negative for this marker.
Table 2 summarizes the prevalence of PAPP positivity in
different groups of infants in the present study. One case was
not available for pAPP staining, but of those available,
37 (52%) showed neuronal and 19 (28%) showed axonal
PAPP positivity. The prevalence of pAPP in the 59 infants
dying at =s3 days was significantly related to the timing of
damage, being higher in both neuronal bodies (P = 0.08) and
axons (P = 0.03) in infants with antepartum damage. Even
some infants with no apparent damage on routine staining
showed occasional pAPP positivity (27% in neurons and 9%
in axons). In the 11 infants dying between 4 and 7 days of age,
36% (and all of the three infants born at term) showed both
neuronal and axonal pAPP positivity. In all groups, preterm
infants showed a lower prevalence of PAPP positivity in
neurons and axons. Table 2 also shows the declining pre¬
valence of pAPP positivity in neonates with postnatal and
no observable damage compared with those displaying ante¬
partum damage. In contrast, the infants aged &3 days dis¬
played the highest prevalence of axonal pAPP positivity.
White matter damage (24%) and pAPP positivity (27%)
were usually present together (P = 0.034).
Correlation of neuropathological findings
with clinical features
Neuronal eosinophilia was no more common in asphyxiated
infants (43%, n = 53) than in non-asphyxiated infants (41%,
n= 17) (P = 0.87). However, this feature was detected more
frequently in mature (62%, n = 26) than preterm (32%, n = 44)
infants {P = 0.015). In contrast with neuronal eosinophilia,
neuronal karyorrhexes were significantly increased in
asphyxiated infants (36%) compared with non-asphyxiated
infants (0%) (P < 0.01) and were also more prevalent in mature
(27%) than in preterm infants (7%), although not significantly
so (P = 0.08). Encephalopathic infants showed a particularly
high prevalence of neuronal eosinophilia and karyorrhexes
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Table 2 Neuronal $APP positivity in the cohort of 70 neonatal deaths
(A) Infants dying within 3 days (n = 59)
Localization of PAPP immunopositivity
Neurons Axons
Cases with antepartum damage Mature (n = 14) 11 (79%) (100% in eight 6 (43%) (50% in eight
(n = 27) (70% neuronal, encephalopathic infants) encephalopathic infants)
33% axonal PAPP positivity Preterm (n = 13) 8 (62%) (positive in one 3 (23%) (negative in one
in mature and preterm encephalopathic infant) encephalopathic infant)
taken together)
Cases with postnatal damage Mature (n = 6) 3 (50%) 1 (17%)
(n = 21) (40% neuronal, Preterm (n = 14) 5 (36%) 1 (7%)
10% axonal (3APP positivity (one case not available)
in mature and preterm taken
together)
Cases with no observable Mature (n = 3) i (33%) 1 (33%)
damage (n = 11) (27% neuronal, Preterm (n = 8) 2 (25%) (negative in one 0 (0%) (negative in one
9% axonal (3APP positivity encephalopathic infant) encephalopathic infant)
in mature and preterm taken
together)
(B) Infants dying at 4-7 days (n = 11)
Localization of PAPP immunopositivity
Neurons Axons
Cases with recent and Mature (n = 3) 3 (100%) 3 (100%)
older damage (n = 11) Preterm (n = 8) 4 (50%) 4(50%)
(64% neuronal, 64% axonal
(3APP positivity in mature
and preterm taken together)
(90%). White matter damage was significantly more common
in encephalopathic (90%) than in non-encephalopathic
asphyxiated (29%) and non-asphyxiated (12%) neonates
(P = 0.001). Infants who survived for >3 days had a higher
prevalence of white matter damage than those who survived
birth by only a few hours (P = 0.03). Encephalopathy was
significantly associated with reactive astrocytosis (P = 0.001),
with macrophage reactions (P = 0.002) and with metabolic
astrocytosis (P = 0.024), but not with deposits of mineral. The
minor differences in micromineralization in white matter par¬
enchyma between asphyxiated and non-asphyxiated infants
did not amount to significance.
White matter (3APP immunopositivity was confined to the
asphyxiated group (12 out of 46 cases) among infants who died
at =s3 days, but was not most prevalent in the encephalopathic
infants. However, somatic neuronal (3APP positivity was
significantly more common in encephalopathic infants than
in those infants who did not have seizures (P = 0.012) (Table 2).
A minority of cases showed no evidence of (3APP positivity
despite the focal presence of reactive astrocytosis and/or
macrophage infiltration of the white matter, suggesting that
damaged neurons may already have been removed in these
cases. Conversely in infants with postnatal brain damage,
mostly in the form of fresh haemorrhage, neuronal (3APP
positivity was present in six cases in the absence of astrocytic
or macrophage reactions. Overall, there was a significant
correlation between white matter damage observed in
routinely stained sections and axonal pAPP positivity (P =
0.034). The prevalence of axonal [3APP positivity following
forceps or Caesarean delivery (n = 38) was 37% compared with
only 16% in 32 infants delivered normally (P = 0.01).
Discussion
This paper documents the prevalence of neuronal damage and
(3APP positivity in a population based cohort of 44 preterm
and 26 mature neonatal deaths ascertained in a two-year study.
Based on the presence of glial and/or macrophage reactions,
we have concluded that brain damage occurred before the
onset of labour in 16% of the 59 infants who diod at or before
3 days of age (Becher et al., 2004). This assessment of the
timing of neuropathological damage was grounded in previ¬
ous observations in human infants (Norman, 1978; Low el al.,
1989; Squier and Keeling, 1991; Del Bigio and Becker, 1994;
Wigglesworth and Bridger, 1994; Norenberg, 1994; Squier,
2001; Kinney et al., 2002). However, our previous study
failed to identify any pointers which would reliably predict
the birth of an infant with antepartum brain damage. We did
find an association between brain damage and oligohydram¬
nios, meconium staining of the liquor and an abnormal car-
diotocograph, but we found no evidence for an association
with prenatal infection or placental inflammation.
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This study focuses on neuronal damage. Certain staining
and morphological changes (eosinophilia and karyorrhexis)
signify irretrievable neuronal death. Most animal studies of
timed cerebral insult indicate that neuronal karyorrhexis
is visible within 24 h (Ferrer et al., 1994; Ferrer, 1996;
Tan et al., 1998) and estimates of the time lapse between
insult and karyorrhexis in the human brain are similar
(Friede, 1972; Low et al., 1989; Wigglesworth and Bridget',
1994; Squier, 2001). The development of neuronal eosino¬
philia is thought to require at least 6 h in the rat model
(Graeber et al., 2002) and possibly longer in the human infant
(Norman, 1978; Low et al., 1989). From these estimates, it is
clearly impossible to infer a definite antepartum origin to the
neuronal changes in this cohort, in contrast with the glial and
macrophage changes reported previously. With respect to
eosinophilia, it is as likely that this was a postnatal event
as prenatal in infants surviving for more than a few hours.
However, more long-standing neuronal damage in the form of
karyorrhcxis may have commenced before labour in infants
who died during the first day of life.
Apart from two cases ofminor cortical dysplasia and one of
GM1 gangliosidosis, the damage observed in this study was
superimposed on otherwise normally developed brains and
is similar to that reported in previous studies (Gilles and
Murphy, 1969; Friede, 1972; Norman, 1978; Rorke, 1982;
Roessmann and Gambetti, 1986; Skullerud and Westre, 1986;
Ellis et al., 1988; Low et al., 1989; Leviton and Paneth, 1990;
Paneth et al., 1990; Squier and Keeling, 1991; Mito et al.,
1993; Del Bigio and Becker, 1994; Gaffney et al., 1994;
Norenberg, 1994; Wigglesworth and Bridger, 1994; Marin-
Padilla, 1996, 1997, 1999; Golden et al., 1997; Gilles et al.,
1998; Squier, 2001; Graeber et al., 2002; Kinney et al., 2002),
although the prevalence of grey matter and neuronal damage
is higher in the present cases. Both necrosis and apoptosis
have been implicated in perinatal neuronal loss (Edwards
et al., 1997). Unequivocal signs of cell death are more easily
detected in the differentiated neurons of the mature infant
brain and were particularly prevalent in asphyxiated babies
who suffered seizures. In very few of the present cases were
all neurons affected, even within a single target area of the
brain. Specific cell surface receptors may confer these dif¬
fering levels of vulnerability, as well as forming the basis of
perinatal patterns of neuronal involvement, as in ponto-
subicular necrosis (Kinney and Armstrong, 2002). The reac¬
tions of the immature brain to hypoxic/ischaemic and other
injury differ from those of the adult brain. The white matter
appears to be particularly vulnerable in the perinatal period
and both white matter infarction and the presence of axonal
swellings have been described previously (Norman. 1978;
Squier, 2001), although this latter feature has not been widely
recognized.
This study reports the first evaluation of pAPP immuno-
reactivity in a large series of cases with perinatal brain
damage. PAPP is known to be upregulated in neuronal stress
and is a recognized marker of traumatic axonal damage
(Graham et al., 2000). Geddes et al. (2001 a,b) have described
a geographic pattern of axonal PAPP staining in the cerebrum
and in the lower brain stem, particularly in the cortico-spinal
tracts, in babies with non-accidental head injury. Most of this
immunopositivity, with the exception of pAPP positive
axonal bulbs, was ascribed to hypoxic rather than traumatic
injury. Reichard et al. (2003) also described PAPP immuno-
positive bulbs in a series of 29 medicolegal infant cases, not
all of whom had sustained traumatic injury. Results in the
present study show that pAPP is a very useful marker for
axonal injury in neonates as young as 25 weeks gestation.
Similar findings were reported in a previous small study
(Baiden-Amissah et al., 1998). Inflicted trauma was ruled
out in the present cases since virtually all were under close
hospital supervision throughout life. The infants display¬
ing pAPP positivity were delivered by a variety of methods
including vaginal delivery and, in 19 cases, delivery by emer¬
gency Caesarean section, suggesting that axonal injury in
these infants originates with antepartum events rather than
prolonged birth-related trauma. It is apparent that PAPP
staining patterns in the developing brain should be interpreted
with caution and that the presence of PAPP positive axonal
bulbs should not necessarily be ascribed to a traumatic event.
Since PAPP positivity appears very rapidly after a neuronal
insult (Sherriff et al., 1994; Baiden-Amissah et al., 1998;
Graham et al., 2000), this feature is unlikely to be of use
in ascribing brain damage in the neonate to the antepartum,
intrapartum or postnatal period except perhaps in infants who
die immediately after birth and when labour has been short.
Immunodetection in the neuronal cell body implies upregu-
lation of PAPP expression whereas axonal positivity results
from disturbed axonal transport (Sherriff et al., 1994). Uncer¬
tainties remain as to the duration and/or reversibility of these
phenomena. A study of periventricular leucomalacia revealed
that pAPP immunoreactive axons which were detected
around early lesions were not present in mature lesions
(Arai et al., 1995). Perivascular amphophilic droplets and
foci of micromineralization were consistently PAPP positive
in the present study, supporting the thesis that these features
may result from breakdown of the blood brain barrier (Squier,
2001), since soluble APP is present in the circulation as well
as in CSF (Mattson, 1997). PAPP was not generally observed
in immature neuronal cell bodies, unlike preterm axons.
Overall, PAPP expression was more frequently observed
in mature than preterm brains.
With respect to reactive gliosis, some confusion exists in
the literature between the so-called myelination gliosis of
normal development and the pathological state of reactive
astrocytosis (Squier, 2001; Kinney and Armstrong, 2002).
The cells of 'myelination gliosis' are reminiscent of reactive
astrocytes in that they have eccentric flares of eosinophilic
cytoplasm but they are oriented in regular fashion in white
matter of undamaged appearance, which is in the process of
myelination. In the present study, we have found such cells to
be GFAP negative and infer that they are oligodendroglia.
In contrast, astrocytes which prove to be markedly reactive
on GFAP immunocytochemistry may be inconspicuous on
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routine staining. We conclude that a meaningful assessment
of gliosis in the neonatal brain requires GFAP immunocyto-
chemistry. The significance of the apparent Alzheimer type II
astrocytosis present in a number of cases is unclear, but has
been remarked upon previously in perinatal brains (Kinney
and Armstrong, 2002). It may represent the result of meta¬
bolic upset and, in our series, was more common in infants
with damaged brains.
Correlation between |3APP positive axonal injury and glial/
macrophage reactions, although significant (P = 0.034), was
lower than we had anticipated and quite a number of enceph¬
alopathy cases with reactive changes did not display white
matter (3APP positivity. This may be a sampling phenom¬
enon, since both pAPP reactive axons and gliosis may be
focal phenomena.
With respect to pathogenesis of brain damage in the neo¬
nate, many of the pathological features noted in this study
have been ascribed classically to hypoxic/ischaemic insults
(Rivkin and Volpe, 1993). However, consideration should
also be given to other possible mechanisms, including sys¬
temic infection and inflammation (Pape and Wigglesworth,
1989; Ellis et al., 2000; Wheater and Rennie, 2000)—
possibly mediated by pro-inflammatory cytokines (Yoon
et al., 1997; Duggan et al., 2001) or by free radicals (Tan
el al., 1998; Kinney and Armstrong, 2000). We did not find
any evidence of an association between brain damage and
intrauterine infection in the Scottish study (Becher et al.,
2004). The possibility exists that cytokine upregulation in
the brain may be a response to neural damage, rather than
its cause. Similarly, some of the observed neuronal changes
including |3APP expression may be the result rather than the
cause of seizures in encephalopathy infants. However, it
should be noted that these cellular changes also occurred
in infants who had not had seizures. This study highlights
the prevalence of recent onset neuronal damage in both
mature and preterm infants often co-present with older
lesions, suggesting an ongoing neuronal response to cerebral
insults. Unfortunately, the pregnancy-associated clinical
features that might predict the likelihood of brain damage
remain elusive (Becher et al., 2004) and the exact patho¬
genesis of neuronal/axonal injury remains unclear in the
neonatal brain.
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The distribution of apolipoprotein E alleles in Scottish
perinatal deaths
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Background: The apolipoprotein E (ApoE) polymorphism has been well studied in the adult human
population, in part because the e4 allele is a known risk factor for Alzheimer's disease. Little is known of
the distribution of ApoE alleles in newborns, and their association with perinatal brain damage has not
been investigated.
Methods: ApoE genofyping was undertaken in a Scottish cohort of perinatal deaths (n = 261), some of
whom had prenatal brain damage. The distribution of ApoE alleles in perinatal deaths was compared with
that in healthy liveborn infants and in adults in Scotland.
Results: ApoE e2 was over-represented in 251 perinatal deaths (13% v 8% in healthy newborns, odds
ratio (OR) = 1.63, 95% confidence interval (CI) 1.13 to 2.36 and 13% v 8% in adults, OR= 1.67, 95% CI
1.16 to 2.41), both in liveborn and stillborn perinatal deaths. In contrast, the prevalence of ApoE e4 was
raised in healthy liveborn infants (1 9%) compared with stillbirths (13%, OR= 1.59, 95% CI 1.11 to 2.26)
and with adults (15%, OR =1.35, 95% CI 1.04 to 1.76). However, no correlation was found between
ApoE genotype and the presence or absence of perinatal brain damage.
Conclusions: This study shows a shift in ApoE allelic distribution in early life compared with adults. The
raised prevalence of ApoE e2 associated with perinatal death suggests that this allele is detrimental to
pregnancy outcome, whereas ApoE e4 may be less so. However, ApoE genotype did not appear to
influence the vulnerability for perinatal hypoxic/ischaemic brain damage, in agreement with findings in
adult brains and in animal models.
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Apolipoprotein E (ApoE) is a 299 amino acid proteinprimarily concerned with lipoprotein and cholesterolmetab lism. The human ApoE gene is located on
chromosome 19 and has three allelic forms, e2, e3, and e4,
encoding different isoforms of the ApoE protein.' ApoE is
expressed at high levels in brain tissue where it is produced
mainly by astrocytes, which package ApoE with cholesterol
for presentation to neurones.2 ' ApoE e4 is a well known risk
factor for sporadic and familial Alzheimer's disease."' and is
also associated with a poorer outcome following head injury.''
On the other hand, ApoE e2 has been linked with other
central nervous system (CNS) disorders, including sporadic
Parkinson's disease.7
There is growing evidence that ApoE, lipid metabolism and
immune responses are related both systemically and in the
CNS."9 Thus ApoE appears to suppress the production by glia
of various pro-inflammatory cytokines, including tumour
necrosis factor-a, inlerleukin-l(l, and interleukin-6.10
Accumulating evidence suggests that ApoE e3 is more
effective than e4 in neuronal repair mechanisms and the
maintenance of synapses and dendrites."
Much of what is known of the role of ApoE in the CNS
relates to adult life and older age groups. The influence of
ApoE alleles on human development has received little
attention despite the importance attached to this polymorph¬
ism in relation to brain pathology in later life. We have
recently established that there is a high prevalence of
prenatal brain damage in Scottish perinatal deaths, both in
liveborn and stillborn infants.12 " In the present study, we
hypothesised that the absence of one or more ApoE e3 alleles
might predispose to brain injury in the perinatal period. It is
known from population studies that the distribution of ApoE
polymorphisms shows geographic and ethnic variations.14 For
this reason we took as our standards for comparison both the
data published previously for the adult Scottish population"
and our own study of the ApoE genotype distribution in
Scottish healthy newborns.16 We report here the ApoE
genotype distribution in a geographically matched cohort of
perinatal deaths and examine a possible association between
brain damage and particular ApoE alleles.
MATERIALS AND METHODS
In a Scotland wide study undertaken in the late 1990s, all
perinatal deaths that were at least 24 weeks gestation at birth
and <7 days at the lime of death were identified over a
2 year period (n = 745). The initial purpose of the study was
to investigate the epidemiology and neuropathological status
of these infant and fetal deaths and to identify any factors
that might predispose to brain damage, particularly of
prenatal origin. Neonates and fetuses with malformations
of the CNS (n = 12) and of the heart (n = 28), those with
major chromosomal abnormalities (n = 28) or with evidence
of CNS infection (n = 0), and extremely macerated stillbirths
(n= 118) were all excluded from the study. Consent for the
study was withheld in 229 cases and 69 deaths were notified
only after the close of the study. After these exclusions, 70
liveborn and 191 stillborn infants qualified for this study.
Two pairs of twins were enrolled in this study, one pair
liveborn and one stillborn. For the purposes of this study, the
ApoE result of the second twin was excluded from analysis.
In other multiple pregnancies occurring in the study, only
one infant of the siblings had died. No sequential sibling
pregnancies were entered in this 2 year study. Therefore, this
perinatal ApoE study investigated 261 perinatal deaths, each
born within a different family in Scotland during a 2 year
period, representing 35% of the total perinatal deaths in that
time.
Frozen tissue samples were not available. A PCR method
for ApoE genotyping, described by Hixson and Vernier," was
adapted for analysis of formalin fixed, paraffin embedded
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Figure 1 Metaphor gel showing the migration pattern for ApoE
genotypes. Band 1 shows the control ladder.
tissue. DNA was extracted in each case from two or three
5 pm sections using a commercial kit (Qiagen DNeasy tissue
kit, catalogue no 69506; Qiagem). The eluted DNA solution
was added to a master mix solution containing customised
primers (MWG Biotech; downstream primer: 5'-
ACAGAATTCGCCCCGGCCTGGTACACTGCCA-3', upstream
primer: 5'-TCCAAGGAGCTGCAGGCGGCGCA-3'). The mas¬
ter mix also contained 5 pi of 10 x PCR buffer, 8 pi of
5 mmol/1 nucleotides, 1.5 pi 50 mmol/1 MgCl, 1.25 pi Taq
polymerase (Invitrogen), and 20 pntol of each primer. DNA
cycling was run on a Techne Flexigene thermocycler at 95°C
for 3 minutes followed by 45 cycles at 94°C for 1 minute, 62°C
for 1 minute, and 72°C for 2 minutes, with a final extension
of 72°C for 8 minutes. The PCR product of 227 bp was
visualised with ethidium bromide on a 3% agarose gel. The
remaining PCR product was mixed with 1 pi Hhal restriction
digest enzyme (New England Biolabs) at 37°C overnight, run
on a 4% Metaphor gel, and again visualised with ethidium
bromide under ultraviolet light.
The genotype for each sample was determined from the
migration pattern of bands in the gel. After digestion,
fragments of different sizes allow ApoE genotyping (fig 1).
ApoE e2/2 is characterised by the presence of two fragments,
91 bp and 81 bp in size. ApoE e4/4 is characterised by a
unique 72 bp fragment, while ApoE e3/3 lacks the 81 bp and
72 bp fragments. Helerozygotes have a combination of
different fragments. PCR was repeated for cases in which
the band pattern was faint or equivocal until a definite result
was obtained. In the small number of cases in which paraffin
embedded brain tissue failed to yield a result despite repeated
extraction, blocks of spleen sometimes gave a positive result,
presumably due to shorter periods of formalin fixation.
When the ApoE analyses were complete for the whole
cohort, the cases were classified according to whether they
were liveborn or stillborn and analysed for association with
evidence of brain damage. The ApoE allele distribution for
these perinatal deaths was compared with published data for
Scottish adults" and healthy liveborn infants." The Scottish
adults were healthy, late middle aged men and women
randomly selected from General Practitioner lists in the mid
1980s. The healthy newborns were infants who were bom in
a single delivery unit within Edinburgh. Blood was collected
randomly from the placentas following delivery and all
infants were full term and had a birthweight >2 kg. No
infant required medical care and all left hospital when due to
do so.
Statistical analysis
Comparisons of ApoE distribution between populations were
made using the %2 test. Odds ratios (OR) and 95% confidence
intervals (CI) were calculated for p<0.05. Similarly, y2
analysis was used to determine differences between perinatal
deaths showing neuropathological changes and those with¬
out such change.
This study was approved by the Lothian research ethics
committee (LREC 1998/6/53). Additional to standard
necropsy consent, written parental consent was obtained
for extensive detailed neuropathological investigation.
RESULTS
Unequivocal results with clear ApoE banding patterns were
obtained for 67 liveborn infants who died at <7 days of age,
and 186 stillborn fetuses in this study. Both the stillborn and
liveborn groups contained a pair of twins, and all four babies
were found to have an ApoE 2/3 genotype. The second twin of
each pair was excluded from further analysis. Spleen blocks
were used in eight cases, all other results being from brain
tissue.
The distribution of ApoE alleles and genotypes for the 251
perinatal deaths included in this study is shown in tables 1-3,
which also includes previously published data for 400
Scottish adults" and for 371 healthy newborn infants."
Table 3 shows that departure from the Hardy-Weinberg
expectation is not significant for any of the three populations.
Tables 4 and 5 compare ApoE results in the present study for
infants who were liveborn but who died subsequently, and
those for stillbirths.
We found over-representation of ApoE e2 in perinatal
deaths (13%) compared with healthy newborns (8%,
OR = 1.63, 95% CI 1.13 to 2.36) and with adults (8%,
OR= 1.67, 95% CI 1.16 to 2.41) (table 1). The prevalence of
all genotypes possessing one or more e2 alleles (2/2, 2/3 and
2/4) was higher among perinatal deaths (24%) than among
healthy liveborn infants (16%, OR = 1.56, 95% CI 1.43 to
1.68) and adults (16%, OR= 1.64, 95% CI 1.51 to 1.77)
(table 2). The higher prevalence of ApoE e2 was found both
in liveborn and stillborn perinatal deaths (tables 4 and 5).
The prevalence of ApoE e4 was higher in healthy liveborn
infants (19%) than in both normal adults (15%, OR = 1.35,
Table 1 Comparison of adults, healthy newborns, and
perinatal deaths for apolipoprotein E genotype:
distribution of ApoE alleles
Cohort e2 e3 E4 Total
Adults (n = 400)' 66 (8%) 616 (77%) 118(15%) 800
HN (n = 371 )f 63 (8%) 538 (72%) 141 (19%) 742
PD(n = 251) 64 (13%) 365 (72%) 73 (15%) 502
"Cumming and Robertson, 198415; fBecher e/ al (in press)." HN, healthy
newborns; PD, perinatal deaths.
Table 1 Comparison of adults, healthy newborns, and perinatal deaths for
apolipoprotein E genotype: distribution of ApoE genotypes
Cohort 2/2 3/3 4/4 2/3 2/4 3/4
Adults(n = 400)* 2 (0.5%) 233 (58.2%) 4(1%) 51 (12.8%) 11 (2.7%) 99 (24.8%)
HN (n = 371)t 2 (0.5%) 199 (53.6%) 15 (4%) 44 (11.9%) 15 (4%) 96 (25.9%)
PD (n = 251) 5 (2%) 138 (54.9%) 3 (1.2%) 38(15.1%) 16 (6.4%) 51 (20.3%)
'Gumming and Robertson, 1984"; fBecher eta/ (in press).'6 HN, healthy newborns; PD, perinatal deaths.
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Table 3 Comparison of adults, healthy newborns, and
perinatal deaths for apolipoprotein E genotype:
distribution n of alleles with Hardy-Weinberg expectation
e3/3 e3/~ Others Total P
Adults
Observed 232 152 16 400 0.63
Expected 237 142 21 400
HN
Observed 199 140 32 371 0.58
Expected 195 148 28 371
PD
Observed 138 89 24 251 0.55
Expected 133 99 19 251
HN, healthy newborns; PD, perinatal deaths.
Table 4 ApoE genotype in perinatal deaths, liveborn
versus stillborn: distribution of ApoE alleles
Cohort e2 e3 e4 Total
Liveborn PD (n = 66) 16 (12%) 91 (69%) 25 (19%) 132
Stillbirths (n = 185) 48 (13%) 274 (74%) 48 (13%) 370
PD, perinatal deaths.
95% CI 1.04 to 1.76) and stillbirths (13%, OR = 1.59, 95% CI
1.11 to 2.26). Review of tables 4 and 5 suggests that liveborn
infants who die in the perinatal period have over-representa¬
tion of both e2 and e4 alleles compared with normal adults,
but the number of cases (n = 66) is too small to place reliance
on statistical analysis.
Table 6 shows the variation in allele distribution across
gestational groups. Although there appears to be an increase
in e2 in extremely preterm gestations, this difference is not
statistically significant.
Tables 7 and 8 show the distribution of ApoE genotype
according to the presence or absence of brain damage in this
cohort. No correlation was detected between ApoE status and
the neuropathological findings in liveborn or stillborn babies.
Similarly there was no link between ApoE and the presence
of haemorrhage in the brain (table 9).
Taken together, the results of this study suggest that the
absence of one or more ApoE e3 predisposes to perinatal
death but not to perinatal brain injury.
DISCUSSION
This study reveals significant differences in ApoE allele
distribution when comparing perinatal deaths with healthy
liveborn infants and with previously published data for the
adult population, all in Scotland. Cumming and Robertson"
showed that ApoE e2 was present in 8%, e3 in 77% ,and e4 in
15% of 400 adults aged 45-60 years, chosen randomly from
north Scotland. Although this is a historical cohort, the
distribution of allele frequencies is similar to that of other
while populations in the literature. In the review by
Davignon ct aP" of all published data, it was found that in
5805 while subjects, the ApoE allele frequency was 8% for e2,
Table 6 Allele distributions by gestational group in all
perinatal deaths
Total alleles (n = 502) e2 e3 e4
24-26 weeks (n = 92) 17(18%) 63 (68%) 12 (13%)
27-29 weeks (n = 62) 7(11%) 48 (77%) 7(11%)
30-32 weeks (n = 56) 6 (11%) 37 (66%) 13(23%)
33-35 weeks( n = 76) 12 (16%) 57 (75%) 7(9%)
36or >wks (n = 216) 22 (10%) 160 (74%) 34 (16%)
HN (n = 742 alleles) 63 (8%) 538 (72%) 141 (19%)
HN, healthy newborns.
Table 7 Correlation of ApoE alleles with prenatal brain






Infants with ApoE 3/3 (25) 12 (48%) 13 (52%)
Infants with >1 ApoE 2 (12) 5 (42%) 7 (58%)
Infants with >1 ApoE 4 (19) 10 (53%) 9(47%)
Infants with ApoE 2/4 (1) 0 1 (100%)
'The presence of prenatal damage cannot be determined reliably in
infants aged more than three days (Becher el of2).
Table 8 Correlation of ApoE alleles with brain damage
in stillborn babies (n= 185)
Established Recent
brain brain No brain
damage damage damage
Infants with ApoE 3/3 (110) 42 (38%) 34 (31%) 34 (31%)
Infants with >1 ApoE 2 (30) 10(33%) 7 (23%) 13 (43%)
Infants with 2*1 ApoE 4 (30) 12 (40%) 11 (37%) 7 (23%)
Infants with ApoE 2/4 (15) 2 (13%) 5 (33%) 8 (53%)
Table 9 Correlation of ApoE alleles with brain
haemorrhage in liveborn babies who died aged < 7 days




Infants with ApoE 3/3 (28) 14 (50%) 14 (50%)
Infants with >1 ApoE 2 (13) 7 (54%) 6 (46%)
Infants with s*l ApoE 4 (24) 11 (46%) 13 (54%)
Infants with ApoE 2/4 (1) 1 (100%) 0
Stillbirths
Infants with ApoE 3/3 (110) 48 (44%) 62 (56%)
Infants with 2* 1 ApoE 2 (30) 8 (27%) 22 (73%)
Infants with 2* 1 ApoE 4 (30) 7 (23%) 23 (77%)
Infants with ApoE 2/4 (15) 4(27%) 11 (73%)
Table 5 ApoE genotype in perinatal deaths, liveborn versus stillborn: distribution of
ApoE genotypes
Cohort 2/2 3/3 4/4 2/3 2/4 3/4
Liveborn PD (n = 66) 2 (3%) 28 (42.4%) 0 (0%) 11 (16.7%) 1 (1.5%) 24 (34.4%)
Stillbirths (n= 185) 3(1.6%) 110(59.5%) 3(1.6%) 27 (14.6%) 15 (8.1%) 27 (14.6%)
PD, perinatal deaths.
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77% for e3, and 15% for e4, which is precisely the same
distribution as that reported for the Scottish adult population
used in this study. The exceptions in this large survey were
adults in France and New Zealand, who have a raised
prevalence of e2, at 13% and 12%, respectively, and the
Finnish adult population, who have a reduced e2 (4%) and
higher e4 (22%) prevalence."1 These three studies comprised
223, 426, and 615 subjects, respectively, and are therefore
comparable in size with our study, although the adults were
younger than those in the Scottish adult study.
We have shown in 371 healthy newborn infants that the
corresponding ApoE distribution was 8% for e2, 72% for e3,
and 19% for e4 (p = 0.024 for over-representation of e4 in
healthy newborns compared to healthy adults)."' The present
study of 251 perinatal deaths shows that ApoE e2 is
significantly over-represented in both stillborn and liveborn
perinatal deaths, compared with the lower prevalence in both
healthy newborn and late middle aged adults in Scotland.
Infants who are born alive but who die in the first week of
life also show over-representation of e4 and resemble healthy
newborns in this respect. While it is possible that these shifts
in ApoE distribution have occurred by chance, the numbers
in our study are not small. The shift in genotype is also borne
out by examination of individual genotypes. However, the
limitations in comparing newborn with adult populations
should be noted, in that both ApoE e2 and e4 are associated
with diseases that have their onset in middle life and carry a
significant mortality risk. In addition, data from the French,
Finnish, and New Zealand studies quoted above"1 indicate
that the prevalence of non-e3 alleles is not entirely consistent
in adults.
Support in the literature for a developmental association
with different ApoE alleles comes from the small number of
studies already available in human infants and pregnancy
loss. Zetlerberg el al" found a decreased prevalence of e4 in
spontaneous abortions in Crete, 87% of which were earlier
than 12 weeks gestation, and proposed that e4 may have a
protective effect in pregnancy, which would be consistent
with our findings in healthy newborns. The contrast between
ApoE e4 prevalence in liveborn and in stillborn infants (e4
being higher in the former group), also suggests that e4 may
have a protective effect. Wright et al" showed that e4 infants
have a better mental developmental index at 2 years of age,
suggesting that the effects of e4 at an early age may be
beneficial rather than detrimental. Similar results have been
demonstrated in Brazilian children.2" Other studies suggest
that the e4 allele may be associated with improved cognitive
performance and higher educational achievement in early
adulthood.2122 In contrast, possession of one or more ApoE e2
alleles appears to be detrimental to pregnancy outcome.
Relatively little attention has been paid to this, the rarest
ApoE allele, perhaps because it is regarded as the "good"
gene with respect to Alzheimer's disease and ischaemic heart
disease. ApoE e2 was reported in an early study to be
associated with pre-eclampsia," but this was not upheld in
subsequent studies.2121 ApoE e2 is less often transmitted to
babies who are small for gestational age2" and perinatally
growth restricted babies are more likely to develop cardio¬
vascular disease later in life.27 According to the antagonistic
pleiotropic theory of ageing, natural selection favours genes
that confer short term benefits at the expense of deterioration
in later life. Such opposing effects of the e4 allele may result
in beneficial effects in early development but detrimental
effects in adulthood.
We found no evidence in this study for an association
between ApoE genotype and vulnerability for brain damage
or haemorrhage in the perinatal period. The relationship
between ApoE genotype and hypoxic/ischaemic injury in the
brain is complex, and conflicting results have been reported
in the literature. It seems that ApoE e2 is associated with
cerebral haemorrhage only in the context of amyloid
angiopathy28 while e4 is linked to poorer outcome after
haemorrhagic stroke but to better survival following ischae¬
mic damage in the adult.' However, no effect of ApoE allele
variations was noted in neonatal mouse models transgenic
for human ApoE e3 and e4 and subjected to ischaemic/
hypoxic or excitotoxic insults and neuronal survival appeared
to be similar in the two animal groups.2" Our findings for
human infants would be in keeping with these animal
experiments, and extend the results to the e2 allele.
The role of ApoE in brain tissue is not fully understood, but
appears to be neuroprotective and immunosuppressive.
Protein expression of ApoE is reported to be increased in
neurones following a global ischaemic insult in the human
brain, but this effect is not influenced by the host genotype in
respect of ApoE e3 or e4.'° ApoE e2 was not included in this
study due to the scarcity of this allele. Our findings suggest
that ApoE does not display allele specific neuroprotective
variations in the perinatal period.
In summary, this study demonstrates that ApoE e2 is
linked to a poor gestational outcome, while e4 may confer
benefits during pregnancy which make live birth more likely
than stillbirth. However, we have found no evidence that
ApoE status influences the likelihood of sustaining preg¬
nancy associated brain damage. The absence of one of more
ApoE e3 alleles did not predispose to brain injury or to
haemorrhage. More thorough investigation of the effects of
ApoE on the outcome of pregnancy may require paired
parent/felus analysis,2' as it is possible that fetal wellbeing
may vary according to the parental source of the e2 or e4
allele.
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